Page last updated: 2024-08-01 09:08:05

6-ketoprostaglandin f1 alpha

Description

6-Ketoprostaglandin F1 alpha: The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. [MeSH]

6-oxoprostaglandin F1alpha : A prostaglandin Falpha that is prostaglandin F1alpha bearing a keto substituent at the 6-position. [CHeBI]

Cross-References

ID SourceID
PubMed CID5280888
CHEMBL ID2074840
SCHEMBL ID4343736
CHEBI ID28158
MeSH IDM0023262

Synonyms (64)

Synonym
CHEBI:28158 ,
6-ketoprostaglandin f1alpha
6-oxoprostaglandin f1alpha
(13e,15s)-9alpha,11alpha,15-trihydroxy-6-oxoprost-13-en-1-oic acid
MLS000028869
6-keto prostaglandin f1alpha
smr000058896
SMP2_000282
LMFA03010001
6-oxo-pgf1alpha
6-oxo-prostaglandin f1alpha
6-oxo-9s,11r,15s-trihydroxy-13e-prostenoic acid
BSPBIO_001457
IDI1_033927
6-keto-pgf1a
58962-34-8
6-keto-prostaglandin f1a
C05961
6-keto-pgf1alpha
6-keto-prostaglandin f1alpha
NCGC00161289-02
NCGC00161289-01
NCGC00161289-03
prost-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9alpha,11alpha,13e,15s)-
6-ketoprostaglandin f1 alpha
prostaglandin f1a, 6-oxo-
DE7EA974-152E-4B77-88BF-F809636EB050
HMS1989I19
BML1-G02
HMS1791I19
HMS1361I19
SCHEMBL4343736
7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e,3s)-3-hydroxyoct-1-enyl]cyclopentyl]-6-oxoheptanoic acid
pgf1 alpha 6-keto
bdbm82211
cas_58962-34-8
prosta-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9alpha,11alpha,13e,15s)-
unii-8urb805jjj
8urb805jjj ,
6-keto-prostaglandin f1-alpha
6-ketoprostaglandin f1|a
CHEMBL2074840
KFGOFTHODYBSGM-ZUNNJUQCSA-N
6-keto pgf1alpha
6-keto-pgf1.alpha.
6-oxo-pgf1.alpha.
prost-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9.alpha.,11.alpha.,13e,15s)-
6-ketoprostaglandin f1.alpha.
HMS3402I19
HMS3648L05
6-oxoprostaglandin f1a
6-oxo-9s,11r,15s-trihydroxy-13e-prostenoate
6-oxo-pgf1a
7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((s,e)-3-hydroxyoct-1-enyl)cyclopentyl)-6-oxoheptanoic acid
Q27103534
SR-01000946444-1
sr-01000946444
6-keto-prostaglandin f1 alpha
6-oxo-9alpha,11alpha,15s-trihydroxy-prost-13e-en-1-oic acid
DTXSID001317937
PD020580
CS-0062290
6-keto prostaglandin f1|a
HY-113358

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).

Drug Classes (1)

ClassDescription
prostaglandins Falpha

Pathways (48)

6-ketoprostaglandin f1 alpha is involved in 48 pathway(s), involving a total of 3374 unique proteins and 4799 unique compounds

PathwayProteinsCompounds
Metabolism14961108
Metabolism of lipids500463
Fatty acid metabolism113203
Arachidonic acid metabolism3682
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)1135
Arachidonic Acid Metabolism2966
Leukotriene C4 Synthesis Deficiency2966
Piroxicam Action Pathway2967
Acetylsalicylic Acid Action Pathway2967
Etodolac Action Pathway2967
Ketoprofen Action Pathway2967
Ibuprofen Action Pathway5076
Rofecoxib Action Pathway2967
Diclofenac Action Pathway2967
Sulindac Action Pathway2967
Celecoxib Action Pathway3573
Ketorolac Action Pathway2967
Suprofen Action Pathway2967
Bromfenac Action Pathway2967
Indomethacin Action Pathway3067
Mefenamic Acid Action Pathway2967
Oxaprozin Action Pathway2967
Nabumetone Action Pathway2967
Naproxen Action Pathway2967
Diflunisal Action Pathway2967
Meloxicam Action Pathway2967
Valdecoxib Action Pathway2967
Antipyrine Action Pathway2967
Antrafenine Action Pathway2967
Carprofen Action Pathway2967
Etoricoxib Action Pathway2967
Fenoprofen Action Pathway2967
Flurbiprofen Action Pathway2967
Magnesium Salicylate Action Pathway2967
Lumiracoxib Action Pathway2967
Lornoxicam Action Pathway2967
Phenylbutazone Action Pathway2967
Nepafenac Action Pathway2967
Trisalicylate-Choline Action Pathway2967
Tolmetin Action Pathway2967
Tiaprofenic Acid Action Pathway2967
Tenoxicam Action Pathway2967
Salsalate Action Pathway2967
Salicylate-Sodium Action Pathway2967
Salicylic Acid Action Pathway2967
Acetaminophen Action Pathway2967
Eicosanoid metabolism via cyclooxygenases (COX)137
Arachidonic acid (AA, ARA) oxylipin metabolism076
Arachidonic acid metabolism via COX (Cyclooxygenase) pathway035

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
Solute carrier organic anion transporter family member 2A1Rattus norvegicus (Norway rat)Km7.5690AID681576

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
ISSN: 1091-6490
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
ISSN: 2211-1247
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
ISSN: 1872-9096
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
ISSN: 1464-3405
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID681576TP_TRANSPORTER: uptake in PGT-expressing HeLa cells1995Science (New York, N.Y.), May-12, Volume: 268, Issue:5212
ISSN: 0036-8075
Identification and characterization of a prostaglandin transporter.

Research

Studies (4,651)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902277 (48.96)18.7374
1990's1693 (36.40)18.2507
2000's509 (10.94)29.6817
2010's158 (3.40)24.3611
2020's14 (0.30)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials294 (6.08%)5.53%
Reviews31 (0.64%)6.00%
Case Studies20 (0.41%)4.05%
Observational0 (0.00%)0.25%
Other4,487 (92.86%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1979201634.4low183131484070
15-ketoprostaglandin f2alphaprostaglandins Falpha00low000000
prostaglandin f1prostaglandins Falphahuman metabolite00low000000
prostaglandin f3alphaprostaglandins Falpha00low000000
uf 021isopropyl ester;
ketone;
prostaglandins Falpha
antiglaucoma drug;
antihypertensive agent;
prodrug
00low000000
travoprost(trifluoromethyl)benzenes;
isopropyl ester;
prostaglandins Falpha
antiglaucoma drug;
antihypertensive agent;
ophthalmology drug;
prodrug;
prostaglandin receptor agonist
00low000000
15-keto-13,14-dihydroprostaglandin f2alphaketone;
prostaglandins Falpha
metabolite00low000000
fluprostenol(trifluoromethyl)benzenes;
hydroxy monocarboxylic acid;
prostaglandins Falpha
abortifacient;
antiglaucoma drug;
antihypertensive agent;
female contraceptive drug;
prostaglandin receptor agonist
00low000000
latanoprostisopropyl ester;
prostaglandins Falpha;
triol
antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
prodrug
00low000000
phxa 85hydroxy monocarboxylic acid;
prostaglandins Falpha
antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
00low000000
tafluprostisopropyl ester;
organofluorine compound;
prostaglandins Falpha
prostaglandin receptor agonist00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
acetylcarnitineO-acylcarnitinehuman metabolite1990199630.7low003000
2-oxo-3-methylvalerate2-oxo monocarboxylic acid;
branched-chain keto acid
human metabolite00low000000
alpha-ketoisovalerate2-oxo monocarboxylic acid;
branched-chain keto acid
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
2,3-diphosphoglyceratebisphosphoglyceric acid;
tetronic acid derivative
human metabolite00low000000
2-keto-4-methylvalerate2-oxo monocarboxylic acid;
branched-chain keto acid
algal metabolite;
human metabolite
00low000000
3-hydroxyanthranilic acidaminobenzoic acid;
monohydroxybenzoic acid
human metabolite;
mouse metabolite
00low000000
3-hydroxykynureninehydroxykynureninehuman metabolite00low000000
3-oxoadipic aciddicarboxylic fatty acid;
oxo dicarboxylic acid
bacterial xenobiotic metabolite;
human metabolite
00low000000
3-mercaptopyruvic acid2-oxo monocarboxylic acid;
thiol
antidote to cyanide poisoning;
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
phosphoserinenon-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative
human metabolite00low000000
3-phenylpropionic acidbenzenes;
monocarboxylic acid
antifungal agent;
human metabolite;
plant metabolite
00low000000
gamma-aminobutyric acidamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid
human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
00low000000
4-hydroxyphenylacetic acidmonocarboxylic acid;
phenols
fungal metabolite;
human metabolite;
mouse metabolite;
plant metabolite
00low000000
isocaproaldehydealpha-CH2-containing aldehydehuman metabolite;
mouse metabolite
00low000000
aminolevulinic acid4-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid
antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
00low000000
5-aminovaleric acidamino acid zwitterion;
delta-amino acid;
omega-amino fatty acid
human metabolite00low000000
5-hydroxytryptophanhydroxytryptophanhuman metabolite;
neurotransmitter
00low000000
acetaldehydealdehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
1987199335.5low031000
acetoneketone body;
methyl ketone;
propanones;
volatile organic compound
EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
00low000000
acetyl phosphateacyl monophosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
adenine6-aminopurines;
purine nucleobase
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1987198936.0low020000
allantoinimidazolidine-2,4-dione;
ureas
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite;
vulnerary
1992199232.0low001000
anthranilic acidaminobenzoic acidhuman metabolite;
mouse metabolite
00low000000
beta-alanineamino acid zwitterion;
beta-amino acid
agonist;
fundamental metabolite;
human metabolite;
inhibitor;
neurotransmitter
00low000000
betaine aldehydequaternary ammonium ionAspergillus metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
00low000000
1-butanolalkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol
human metabolite;
mouse metabolite;
protic solvent
00low000000
ureidosuccinic acidaspartic acid derivative;
C4-dicarboxylic acid;
N-carbamoyl-amino acid
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
carbon monoxidecarbon oxide;
gas molecular entity;
one-carbon compound
biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
1987200829.0low021100
carnitineamino-acid betainehuman metabolite;
mouse metabolite
1990199432.3low003000
cholinecholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
chlorinehalide anion;
monoatomic chlorine
cofactor;
Escherichia coli metabolite;
human metabolite
1983201429.4low367210
coumarincoumarinsfluorescent dye;
human metabolite;
plant metabolite
00low000000
aminoethylphosphonic acidphosphonic acids;
primary amino compound;
zwitterion
human metabolite;
metabolite;
mouse metabolite
00low000000
octanoic acidmedium-chain fatty acid;
straight-chain saturated fatty acid
antibacterial agent;
Escherichia coli metabolite;
human metabolite
00low000000
dihydrolipoic acidthio-fatty acidantioxidant;
human metabolite;
neuroprotective agent
00low000000
trimethylenediaminealkane-alpha,omega-diaminehuman metabolite;
mouse metabolite;
reagent
00low000000
3-hydroxybutyric acid(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid
human metabolite1996199628.0low101000
methylmalonic acidC4-dicarboxylic acidhuman metabolite00low000000
pyrrolidonecarboxylic acidoxoproline;
pyrrolidin-2-ones;
pyrrolidinemonocarboxylic acid
human metabolite00low000000
3,4-dihydroxyphenylacetic acidcatechols;
dihydroxyphenylacetic acid
human metabolite00low000000
alpha-keto-delta-guanidinovaleric acid2-oxo monocarboxylic acid;
zwitterion
human metabolite;
mouse metabolite
00low000000
creatineglycine derivative;
guanidines;
zwitterion
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
1991199133.0low001000
cytosineaminopyrimidine;
pyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
dihydrouracilpyrimidoneEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
00low000000
dihydrolipoamidedithiol;
monocarboxylic acid amide
cofactor;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
dihydroxyacetone phosphateglycerone phosphates;
primary alpha-hydroxy ketone
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
dihydroxyacetoneketotriose;
primary alpha-hydroxy ketone
antifungal agent;
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
dimethylglycineamino acid zwitterion;
N-methyl-amino acid;
N-methylglycines
Daphnia magna metabolite;
human metabolite;
mouse metabolite
00low000000
5,6-dimethylbenzimidazoledimethylbenzimidazoleEscherichia coli metabolite;
human metabolite
00low000000
ethanolamineethanolamines;
primary alcohol;
primary amine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
gamma-butyrobetaineamino-acid betaineEscherichia coli metabolite;
human metabolite
00low000000
glutaric acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
Daphnia magna metabolite;
human metabolite
00low000000
glycerolalditol;
triol
algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
1981199337.6low061000
alpha-glycerophosphoric acidglycerol monophosphatealgal metabolite;
human metabolite
00low000000
glycolaldehydeglycolaldehydesfundamental metabolite;
human metabolite
00low000000
glyoxylic acid2-oxo monocarboxylic acid;
aldehydic acid
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
glycocyamineguanidinoacetic acids;
zwitterion
bacterial metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
rat metabolite
00low000000
hydrogen cyanidehydracid;
one-carbon compound
Escherichia coli metabolite;
human metabolite;
poison
00low000000
hydrogen carbonatecarbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1984199435.9low062000
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1981201333.8low12716410
homogentisic aciddihydroxyphenylacetic acid;
hydroquinones
human metabolite;
plant metabolite
00low000000
hydrogenelemental hydrogen;
elemental molecule;
gas molecular entity
antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
1991199133.0low001000
indole-3-acetaldehydeindoleacetaldehydebacterial metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
indoleacetic acidindole-3-acetic acids;
monocarboxylic acid
auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
00low000000
itaconic aciddicarboxylic acid;
dicarboxylic fatty acid;
olefinic compound
fungal metabolite;
human metabolite
00low000000
potassiumalkali metal cation;
elemental potassium;
monoatomic monocation;
monovalent inorganic cation
cofactor;
human metabolite
00low000000
dihydroxyphenylalaninehydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative
human metabolite00low000000
kynureninearomatic ketone;
non-proteinogenic alpha-amino acid;
substituted aniline
human metabolite00low000000
lipoamidedithiolanes;
monocarboxylic acid amide
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
malonic acidalpha,omega-dicarboxylic acidhuman metabolite00low000000
methylmercaptanalkanethiolhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
pyruvaldehyde2-oxo aldehyde;
propanals
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1987198737.0low010000
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
1986200628.0low010100
n-acetylserotoninacetamides;
N-acylserotonin;
phenols
antioxidant;
human metabolite;
mouse metabolite;
tropomyosin-related kinase B receptor agonist
00low000000
n-methylphenylethanolaminealkaloid;
phenylethanolamines
human metabolite;
plant metabolite
00low000000
n'-acetylspermineacetamides;
acetylspermine
human metabolite00low000000
nitritesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
human metabolite1994201821.8low30151730
hydroxypyruvic acid2-oxo monocarboxylic acid;
3-hydroxy monocarboxylic acid;
primary alpha-hydroxy ketone
Escherichia coli metabolite;
human metabolite
00low000000
oxalic acidalpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
00low000000
4-hydroxyphenylpyruvic acid2-oxo monocarboxylic acid;
phenols
human metabolite00low000000
hexadecanal2,3-saturated fatty aldehyde;
long-chain fatty aldehyde
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
phenylacetaldehydealpha-CH2-containing aldehyde;
phenylacetaldehydes
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
phenylacetic acidbenzenes;
monocarboxylic acid;
phenylacetic acids
allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
00low000000
2-hydroxyphenethylaminephenylethanolamineshuman metabolite00low000000
phenethylaminealkaloid;
aralkylamine;
phenylethylamine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
phosphoric acidphosphoric acidsalgal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent
00low000000
phosphorylcholinephosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
00low000000
phosphorylethanolaminephosphoethanolamine;
primary amino compound
algal metabolite;
human metabolite;
mouse metabolite
00low000000
picolinic acidpyridinemonocarboxylic acidhuman metabolite;
MALDI matrix material
00low000000
pyridoxalhydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
pyridoxal phosphatemethylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate
coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
pyridoxamineaminoalkylpyridine;
hydroxymethylpyridine;
monohydroxypyridine;
vitamin B6
Escherichia coli metabolite;
human metabolite;
iron chelator;
mouse metabolite;
nephroprotective agent;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
pyridoxamine phosphateaminoalkylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6 phosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
pyridoxinehydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2002200222.0low000100
quinolinic acidpyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
00low000000
thiosulfatesdivalent inorganic anion;
sulfur oxide;
sulfur oxoanion
human metabolite00low000000
sarcosineN-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines
Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
00low000000
taurineamino sulfonic acid;
zwitterion
antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
1987199831.8low022000
thiamineprimary alcohol;
vitamin B1
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
thyminepyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
2-(4-methyl-1,3-thiazol-5-yl)ethanol1,3-thiazoles;
primary alcohol
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
tryptamineaminoalkylindole;
aralkylamino compound;
indole alkaloid;
tryptamines
human metabolite;
mouse metabolite;
plant metabolite
00low000000
uracilpyrimidine nucleobase;
pyrimidone
allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
00low000000
uric aciduric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
1983200831.4low233100
ureaisourea;
monocarboxylic acid amide;
one-carbon compound
Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1993199828.3low103000
vanilmandelic acid2-hydroxy monocarboxylic acid;
aromatic ether;
phenols
human metabolite00low000000
perillic acidalpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid
antineoplastic agent;
human metabolite;
mouse metabolite
00low000000
meglutol3-hydroxy carboxylic acid;
dicarboxylic acid;
tertiary alcohol
anticholesteremic drug;
antimetabolite;
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
human metabolite;
plant metabolite
00low000000
homovanillic acidguaiacols;
monocarboxylic acid
human metabolite;
mouse metabolite
00low000000
3-hydroxy-4-methoxyphenethylaminemonomethoxybenzene;
phenols;
phenylethylamine;
primary amino compound
human metabolite;
rat metabolite
00low000000
hydroxyindoleacetic acidindole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite
1995199529.0low001000
5-methoxytryptaminearomatic ether;
primary amino compound;
tryptamines
5-hydroxytryptamine 2A receptor agonist;
5-hydroxytryptamine 2B receptor agonist;
5-hydroxytryptamine 2C receptor agonist;
antioxidant;
cardioprotective agent;
human metabolite;
mouse metabolite;
neuroprotective agent;
radiation protective agent;
serotonergic agonist
00low000000
cetyl alcoholhexadecanol;
long-chain primary fatty alcohol
algal metabolite;
flavouring agent;
human metabolite;
plant metabolite
00low000000
4-cresolcresolEscherichia coli metabolite;
human metabolite;
uremic toxin
00low000000
debrisoquincarboxamidine;
isoquinolines
adrenergic agent;
antihypertensive agent;
human metabolite;
sympatholytic agent
00low000000
decanoic acidmedium-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
anti-inflammatory agent;
antibacterial agent;
human metabolite;
plant metabolite;
volatile oil component
00low000000
nordazepam1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
GABA modulator;
human metabolite;
sedative
00low000000
2,5-dihydroxybenzoic aciddihydroxybenzoic acidEC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
fungal metabolite;
human metabolite;
MALDI matrix material;
mouse metabolite
00low000000
tele-methylhistamineimidazoles;
primary amino compound
human metabolite;
mouse metabolite
00low000000
indolepropionic acidindol-3-yl carboxylic acidauxin;
human metabolite;
plant metabolite
00low000000
kynurenic acidmonohydroxyquinoline;
quinolinemonocarboxylic acid
G-protein-coupled receptor agonist;
human metabolite;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist;
Saccharomyces cerevisiae metabolite
00low000000
3-phenyllactic acid2-hydroxy monocarboxylic acidhuman metabolite00low000000
2-amino-3-phosphonopropionic acidalanine derivative;
non-proteinogenic alpha-amino acid;
phosphonic acids
human metabolite;
metabotropic glutamate receptor antagonist
00low000000
2-phenylglycinenon-proteinogenic alpha-amino acidhuman metabolite00low000000
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
1982200433.0low31114200
oxidopaminebenzenetriol;
catecholamine;
primary amino compound
drug metabolite;
human metabolite;
neurotoxin
1985199235.3low021000
sebacic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
human metabolite;
plant metabolite
00low000000
stearic acidlong-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
00low000000
succinylacetonebeta-diketone;
dioxo monocarboxylic acid
human metabolite00low000000
tolbutamideN-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
00low000000
retinoic acidalpha,beta-unsaturated monocarboxylic acid;
retinoid
human metabolite00low000000
tyraminemonoamine molecular messenger;
primary amino compound;
tyramines
EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
00low000000
corticosterone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1979201731.5low045010
estriol16alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid
estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
1992199232.0low001000
sorbitolglucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
1989199730.0low012000
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1987199831.2low024000
hydroxyproline4-hydroxyproline;
L-alpha-amino acid zwitterion
human metabolite;
mouse metabolite;
plant metabolite
1983199636.8low031000
thyroxine2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine
antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
1985199834.2low031000
aldosterone11beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde
human metabolite;
mouse metabolite
1983201432.8low102915320
cysteinecysteine zwitterion;
cysteine;
L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid
EC 4.3.1.3 (histidine ammonia-lyase) inhibitor;
flour treatment agent;
human metabolite
00low000000
estrone17-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols
antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
1981199238.5low031000
androsterone17-oxo steroid;
3alpha-hydroxy steroid;
androstanoid;
C19-steroid
androgen;
anticonvulsant;
human blood serum metabolite;
human metabolite;
human urinary metabolite;
mouse metabolite;
pheromone
00low000000
etiocholanolone17-oxo steroid;
3alpha-hydroxy steroid;
androstanoid
human metabolite;
mouse metabolite
00low000000
dehydroepiandrosterone17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid
androgen;
human metabolite;
mouse metabolite
1984199534.5low011000
triiodothyronine2-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine
human metabolite;
mouse metabolite;
thyroid hormone
1985199833.3low021000
isonicotinic acidpyridinemonocarboxylic acidalgal metabolite;
human metabolite
00low000000
serineL-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1988198836.0low010000
glutamineamino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2001200919.0low000200
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1985199833.0low023000
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1981200232.5low010100
adenosine diphosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
fundamental metabolite;
human metabolite
1980201332.3low62821630
uridineuridinesdrug metabolite;
fundamental metabolite;
human metabolite
00low000000
uridine monophosphatepyrimidine ribonucleoside 5'-monophosphate;
uridine 5'-phosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
levodopaamino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
00low000000
cysteamineamine;
thiol
geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
1986199335.2low031000
leucineamino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1993199728.7low003000
androstenedione17-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
1985199035.7low012000
cytidine monophosphatecytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
methionineaspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid
antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
00low000000
desoxycorticosterone20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1985199833.3low033000
cytidinecytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
17-alpha-hydroxyprogesterone17alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone
human metabolite;
metabolite;
mouse metabolite;
progestin
00low000000
asparagineamino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
histidineamino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
00low000000
n-pentanolpentanol;
short-chain primary fatty alcohol
human metabolite;
plant metabolite
00low000000
valineL-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2001200123.0low000100
threonineamino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
tryptophanerythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan
antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1981200428.4low013100
isoleucineaspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
ethylamineprimary aliphatic aminehuman metabolite00low000000
taurocholic acidamino sulfonic acid;
bile acid taurine conjugate
human metabolite1984200930.5low057200
skatolemethylindolehuman metabolite;
mammalian metabolite
1989199333.0low011000
quinaldic acidquinolinemonocarboxylic acidhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
3-methylpentanealkane;
volatile organic compound
allelochemical;
human metabolite;
non-polar solvent
00low000000
methylcyclopentanecycloalkane;
volatile organic compound
human metabolite;
plant metabolite
00low000000
phosphoribosyl pyrophosphate5-O-phosphono-D-ribofuranosyl diphosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
00low000000
1-phenethylaminephenylethylaminehuman metabolite00low000000
trehalosetrehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
isethionic acidalkanesulfonic acidhuman metabolite00low000000
methylcyclohexanecycloalkane;
volatile organic compound
aprotic solvent;
human metabolite;
plant metabolite
00low000000
piperidineazacycloalkane;
piperidines;
saturated organic heteromonocyclic parent;
secondary amine
base;
catalyst;
human metabolite;
non-polar solvent;
plant metabolite;
protic solvent;
reagent
00low000000
undecanoic acidmedium-chain fatty acid;
straight-chain saturated fatty acid
antifungal agent;
human metabolite
00low000000
1-tridecanollong-chain primary fatty alcohol;
tridecanol
bacterial metabolite;
human metabolite;
plant metabolite
00low000000
stearyl alcohollong-chain primary fatty alcohol;
octadecanol
algal metabolite;
human metabolite;
plant metabolite
00low000000
acetolmethyl ketone;
primary alcohol;
primary alpha-hydroxy ketone;
propanones
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
2-methylbutanoic acidmethylbutyric acidbacterial metabolite;
human metabolite
00low000000
hexanoic acidmedium-chain fatty acid;
straight-chain saturated fatty acid
human metabolite;
plant metabolite
00low000000
isopropyl palmitatefatty acid ester;
isopropyl ester
human metabolite00low000000
pregnenolone20-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid
human metabolite;
mouse metabolite
1983199336.0low011000
20-alpha-dihydroprogesterone20-hydroxypregn-4-en-3-onehuman metabolite;
mouse metabolite
1983198341.0low010000
homoargininehomoarginine;
L-lysine derivative;
non-proteinogenic L-alpha-amino acid
biomarker;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
human metabolite;
rat metabolite;
xenobiotic metabolite
00low000000
dibenzo(a,l)pyreneortho- and peri-fused polycyclic arenehuman metabolite;
mutagen
00low000000
diiodotyrosinediiodotyrosine;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
human metabolite;
mouse metabolite
00low000000
3-methoxytyrosinearomatic L-alpha-amino acid zwitterion;
L-tyrosine derivative;
monomethoxybenzene;
non-proteinogenic L-alpha-amino acid
human metabolite00low000000
thiocyanatepseudohalide anion;
sulfur molecular entity
human metabolite00low000000
4-hydroxyphenyllactic acid2-hydroxy carboxylic acid;
phenols
bacterial metabolite;
human metabolite
00low000000
citrullineamino acid zwitterion;
citrulline
Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
00low000000
lithocholic acidbile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid
geroprotector;
human metabolite;
mouse metabolite
00low000000
nandrolone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid
human metabolite00low000000
4-methylcatecholmethylcatecholantioxidant;
carcinogenic agent;
hapten;
human metabolite;
plant metabolite
00low000000
homocystineamino acid zwitterion;
homocystines
human metabolite00low000000
chenodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
00low000000
glycocholic acidbile acid glycine conjugatehuman metabolite00low000000
epitestosterone17alpha-hydroxy steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen antagonist;
human metabolite
00low000000
ninhydrinaromatic ketone;
beta-diketone;
indanones;
ketone hydrate
colour indicator;
human metabolite
00low000000
indicanaryl sulfate;
indoles
human metabolite00low000000
suberic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
human metabolite00low000000
hexadecanedioic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
human metabolite00low000000
androstenediol17beta-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid
androgen;
human metabolite;
mouse metabolite;
radiation protective agent
00low000000
dihydrotestosterone17beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
2007200717.0low000100
pyridoxamine dihydrochloridehydrochloride;
vitamin B6
Escherichia coli metabolite;
human metabolite;
iron chelator;
mouse metabolite;
nephroprotective agent;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
aceturic acidN-acetyl-amino acid;
N-acylglycine
human metabolite00low000000
myristic acidlong-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite
1989199333.0low111000
glycylglycinedipeptide zwitterion;
dipeptide
human metabolite00low000000
lignoceric acidstraight-chain saturated fatty acid;
very long-chain fatty acid
Daphnia tenebrosa metabolite;
human metabolite;
plant metabolite;
volatile oil component
00low000000
18-hydroxycorticosterone11beta-hydroxy steroid;
18-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo steroid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
2-hydroxybutyric acid2-hydroxy monocarboxylic acid;
hydroxybutyric acid
algal metabolite;
human metabolite
00low000000
3-methylhexanealkane;
volatile organic compound
human metabolite00low000000
ethylmalonic aciddicarboxylic acid;
dicarboxylic fatty acid
human metabolite00low000000
galactitolhexitolEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
00low000000
2-hydroxyphenylacetic acidhydroxy monocarboxylic acid;
phenols
human metabolite;
mouse metabolite
00low000000
acetylcysteineacetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid
antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
00low000000
5-methyl-2-furfuralaldehyde;
furans
EC 2.2.1.6 (acetolactate synthase) inhibitor;
flavouring agent;
human metabolite;
Maillard reaction product
00low000000
2-hexanolhexanol;
secondary alcohol
human metabolite;
plant metabolite;
semiochemical
00low000000
1,1,3,3-tetramethylureaureashuman metabolite00low000000
glycochenodeoxycholic acidbile acid glycine conjugatehuman metabolite00low000000
isocaproic acidbranched-chain saturated fatty acid;
medium-chain fatty acid;
methyl-branched fatty acid
human metabolite00low000000
dehydroepiandrosterone sulfate17-oxo steroid;
steroid sulfate
EC 2.7.1.33 (pantothenate kinase) inhibitor;
human metabolite;
mouse metabolite
1984199534.5low011000
homoserineamino acid zwitterion;
homoserine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
dodecanedioic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor;
human metabolite
00low000000
deoxycytidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
deoxyuridinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
2'-deoxyadenosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
cytidine diphosphate cholinenucleotide-(amino alcohol)s;
phosphocholines
human metabolite;
mouse metabolite;
neuroprotective agent;
psychotropic drug;
Saccharomyces cerevisiae metabolite
00low000000
1-pentene-3-oneenoneflavouring agent;
genotoxin;
human metabolite;
plant metabolite
00low000000
5 alpha-androstane-3 alpha,17 beta-diolandrostane-3alpha,17beta-diolDaphnia magna metabolite;
human metabolite
00low000000
9,10-epoxystearic acidepoxystearic acidhuman metabolite00low000000
5-hydroxyindolehydroxyindoleshuman metabolite00low000000
beta-hydroxymyristic acid3-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
long-chain fatty acid
bacterial metabolite;
human metabolite
00low000000
perillaldehydealdehyde;
olefinic compound
human metabolite;
mouse metabolite;
volatile oil component
00low000000
tricosanoic acidstraight-chain saturated fatty acid;
very long-chain fatty acid
Daphnia magna metabolite;
human metabolite;
plant metabolite
00low000000
uridine diphosphate glucuronic acidUDP-D-glucuronic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
tetrahydropapaverolinebenzylisoquinoline alkaloid;
benzyltetrahydroisoquinoline;
isoquinolinol
human metabolite00low000000
dithiothreitol1,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol
chelator;
human metabolite;
reducing agent
00low000000
cyclic cmp3',5'-cyclic pyrimidine nucleotidehuman metabolite00low000000
furoylglycinefurans;
N-acylglycine
human metabolite00low000000
3,3',5'-triiodothyronineiodothyroninehuman metabolite00low000000
limonenecycloalkene;
p-menthadiene
human metabolite00low000000
hypochlorous acidchlorine oxoacid;
reactive oxygen species
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
1996199628.0low001000
urobilinogenbilaneshuman metabolite00low000000
estetrol15alpha-hydroxy steroid;
16alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid;
steroid hormone
estrogen receptor agonist;
estrogen;
human metabolite;
human xenobiotic metabolite;
oral contraceptive
00low000000
irondivalent metal cation;
iron cation;
monoatomic dication
cofactor;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
1-methyladenosinemethyladenosinehuman metabolite00low000000
iodinehalide anion;
monoatomic iodine
human metabolite1981198143.0low010000
nonanalmedium-chain fatty aldehyde;
n-alkanal;
saturated fatty aldehyde
human metabolite;
plant metabolite
00low000000
dimethylacetamideacetamides;
monocarboxylic acid amide
human metabolite00low000000
ursodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
00low000000
pregnanolone3-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid
human metabolite;
intravenous anaesthetic;
sedative
00low000000
s-adenosylmethioninesulfonium betainehuman metabolite00low000000
acetylgalactosamineN-acetyl-D-hexosamine;
N-acetylgalactosamine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
00low000000
norsalsolinolisoquinolinolanimal metabolite;
apoptosis inducer;
human metabolite;
marine metabolite
00low000000
2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolineisoquinolinol;
tertiary amino compound
human metabolite;
neurotoxin;
rat metabolite
00low000000
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
1983201431.1low3810310
d-lactic acid2-hydroxypropanoic acidEscherichia coli metabolite;
human metabolite
00low000000
xanthosinepurines D-ribonucleoside;
xanthosines
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
1,5-anhydroglucitolanhydro sugarhuman metabolite00low000000
3-methylhistidineL-histidine derivative;
non-proteinogenic L-alpha-amino acid;
zwitterion
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
5-methylcytosinemethylcytosine;
pyrimidines
human metabolite00low000000
n-acetylaspartic acidN-acetyl-L-amino acid;
N-acyl-L-aspartic acid
antioxidant;
human metabolite;
mouse metabolite;
nutraceutical;
rat metabolite
00low000000
deoxyuridine triphosphatedeoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate
Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
homocitrullineamino acid zwitterion;
L-lysine derivative;
non-proteinogenic L-alpha-amino acid;
ureas
human metabolite;
mouse metabolite
00low000000
cholesteryl sulfatesteroid sulfatehuman metabolite00low000000
2'-deoxycytidine 5'-triphosphate2'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite00low000000
aica ribonucleotide1-(phosphoribosyl)imidazolecarboxamide;
aminoimidazole
cardiovascular drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
n-acetylserineacetyl-L-serine;
N-acetyl-L-amino acid
human metabolite00low000000
o-4-methylthyminearomatic ether;
methylthymine
human metabolite00low000000
tetraiodothyroacetic acid2-halophenol;
aromatic ether;
iodophenol;
monocarboxylic acid
apoptosis inducer;
human metabolite;
thyroid hormone
00low000000
lathosterol3beta-sterol;
C27-steroid;
cholestanoid;
Delta(7)-sterol
human metabolite;
mouse metabolite
00low000000
omega-aminocaprylic acidmedium-chain fatty acid;
omega-amino fatty acid
human metabolite00low000000
2-methoxyestradiol17beta-hydroxy steroid;
3-hydroxy steroid
angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite
00low000000
parabanic acidhydracid;
imidazolidinone
human metabolite00low000000
n-acetyl-l-arginineN-acetyl-L-amino acidhuman metabolite00low000000
cystinecystine zwitterion;
cystine;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid
EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
6-methyladenine6-alkylaminopurine;
methyladenine
human metabolite00low000000
phenylacetylglycinemonocarboxylic acid amide;
monocarboxylic acid;
N-acylglycine
human metabolite;
mouse metabolite
00low000000
hydracrylic acid3-hydroxy monocarboxylic acid;
omega-hydroxy-short-chain fatty acid
Escherichia coli metabolite;
human metabolite
00low000000
hordeninephenethylamine alkaloidhuman metabolite;
mouse metabolite
00low000000
4-methoxyestradiol17beta-hydroxy steroid;
3-hydroxy steroid;
aromatic ether;
phenols
estrogen;
human metabolite;
rat metabolite
00low000000
glutaurinedipeptide zwitterion;
dipeptide;
L-glutamine derivative;
sulfonic acid
anticonvulsant;
anxiolytic drug;
hormone;
human metabolite;
mammalian metabolite;
mouse metabolite
00low000000
plasmenylserineO-phosphoserineEC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor;
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
ubiquinone-oubiquinonesEscherichia coli metabolite;
human metabolite
00low000000
beta-hydroxyisovaleric acid3-hydroxy monocarboxylic acidhuman metabolite00low000000
n-acetylhistamineacetamides;
imidazoles
human metabolite00low000000
indole-3-carboxylic acidindol-3-yl carboxylic acidbacterial metabolite;
human metabolite
00low000000
5-hydroxymethylcytosineaminopyrimidine;
aromatic primary alcohol;
nucleobase analogue;
pyrimidone
human metabolite;
mouse metabolite
00low000000
n-acetylglutamic acidN-acetyl-L-amino acid;
N-acyl-L-glutamic acid
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
2,5-dihydroxybenzaldehydedihydroxybenzaldehydehuman metabolite;
mouse metabolite;
Penicillium metabolite
00low000000
D-serineD-alpha-amino acid;
serine zwitterion;
serine
Escherichia coli metabolite;
human metabolite;
NMDA receptor agonist
00low000000
D-alaninealanine zwitterion;
alanine;
D-alpha-amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
Escherichia coli metabolite;
human metabolite
00low000000
2-ketopentanoic acid2-oxo monocarboxylic acid;
oxopentanoic acid
human metabolite00low000000
hydroxyindoleacetaldehydehydroxyindoles;
indoleacetaldehyde
human metabolite;
mouse metabolite
00low000000
leucylleucinedipeptide;
L-aminoacyl-L-amino acid zwitterion
human metabolite;
Mycoplasma genitalium metabolite
00low000000
5-hydroxymethyluracilprimary alcohol;
pyrimidone
human metabolite00low000000
12-hydroxydodecanoic acidomega-hydroxy-medium-chain fatty acidhuman metabolite00low000000
decane-1,2-diolglycol;
volatile organic compound
anti-inflammatory agent;
antioxidant;
human metabolite
00low000000
4-nitrophenyl sulfatearyl sulfate;
C-nitro compound
human metabolite00low000000
glucose-1,6-bisphosphateD-glucose 1,6-bisphosphateEscherichia coli metabolite;
human metabolite
00low000000
biotinamidebiotins;
monocarboxylic acid amide
human metabolite00low000000
3,4-dihydroxymandelic acid2-hydroxy monocarboxylic acid;
catechols
antioxidant;
drug metabolite;
human metabolite;
mouse metabolite
00low000000
3-hydroxymandelic acid2-hydroxy monocarboxylic acid;
phenols
human metabolite00low000000
n-acetylalanineL-alanine derivative;
N-acetyl-L-amino acid
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
17-alpha-hydroxypregnenolone17alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
hydroxypregnenolone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1980198044.0low010000
cholest-4-en-3-one3-oxo-Delta(4) steroid;
cholestanoid
human metabolite;
plant metabolite
00low000000
mephentermine2-aminooctadecane-1,3-diolEC 2.7.11.13 (protein kinase C) inhibitor;
human metabolite;
mouse metabolite
00low000000
2-pinene oxideepoxide;
pinane monoterpenoid
bacterial xenobiotic metabolite;
fragrance;
human metabolite
00low000000
1-methylhistidineL-histidine derivative;
non-proteinogenic L-alpha-amino acid;
zwitterion
human metabolite00low000000
3-hydroxybutyric acid3-hydroxybutyric acid;
ketone body
fungal metabolite;
human metabolite;
pheromone
00low000000
L-2-aminoadipic acid2-aminoadipic acidEscherichia coli metabolite;
human metabolite
00low000000
testosterone acetate3-oxo-Delta(4) steroid;
androstanoid;
sterol ester
human metabolite00low000000
phenylacetylglutamineN(2)-phenylacetylglutaminehuman metabolite00low000000
5beta-pregnane-3,20-dione20-oxo steroid;
3-oxo-5beta-steroid;
C21-steroid
human metabolite;
mouse metabolite
00low000000
zymosterol3beta-sterol;
cholestanoid
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
brexanolone3-hydroxy-5alpha-pregnan-20-oneantidepressant;
GABA modulator;
human metabolite;
intravenous anaesthetic;
sedative
00low000000
5-alpha-dihydroprogesterone20-oxo steroid;
3-oxo-5alpha-steroid;
C21-steroid hormone
human metabolite;
progestogen
00low000000
n-epsilon-acetyllysineacetyl-L-lysine;
amino acid zwitterion;
N(6)-acyl-L-lysine
human metabolite00low000000
2-hydroxyhexadecanoic acid2-hydroxy fatty acid;
hydroxypalmitic acid
human metabolite00low000000
19-oxo-delta(4) androstene-3,17-dione17-oxo steroid;
19-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid;
steroid aldehyde
human metabolite00low000000
gamma-glutamylglutamatedipeptidehuman metabolite00low000000
indole-3-lactic acidhydroxy monocarboxylic acid;
indol-3-yl carboxylic acid
human metabolite00low000000
n(alpha)-acetyllysineacetyl-L-lysine;
amino acid zwitterion
human metabolite00low000000
glycyl-l-phenylalaninedipeptide zwitterion;
dipeptide
human metabolite;
metabolite
00low000000
5,6-dihydrothyminepyrimidonehuman metabolite;
metabolite;
mouse metabolite
00low000000
gamma-glutamyltyrosinedicarboxylic acid;
dipeptide;
phenols;
primary amino compound;
secondary carboxamide
human metabolite00low000000
cholest-5-ene-3 beta,26-diol26-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite
00low000000
2-hydroxyisovaleric acid2-hydroxy monocarboxylic acidhuman metabolite00low000000
aminomalonic acidamino dicarboxylic acidDaphnia magna metabolite;
human metabolite
00low000000
zymostenol3beta-sterol;
cholestanoid
human metabolite;
mouse metabolite
00low000000
16-hydroxydehydroepiandrosterone16alpha-hydroxy steroid;
17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid;
secondary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
cortisol 21-sulfate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
cortisol ester;
steroid sulfate;
tertiary alpha-hydroxy ketone
human metabolite00low000000
1,2-distearoylphosphatidylethanolaminephosphatidylethanolamine zwitterion;
phosphatidylethanolamine
human metabolite00low000000
hydrogen sulfitesulfur oxoanionhuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
aflatoxin b1-2,3-oxideaflatoxinhuman metabolite00low000000
fructose 2,6-diphosphateD-fructofuranose 2,6-bisphosphatehuman metabolite;
mouse metabolite
00low000000
pregnenolone sulfatesteroid sulfateEC 2.7.1.33 (pantothenate kinase) inhibitor;
human metabolite
00low000000
3,3'-diiodothyronine3,3'-diiodothyronine;
amino acid zwitterion
human metabolite00low000000
l-lactic acid(2S)-2-hydroxy monocarboxylic acid;
2-hydroxypropanoic acid
Escherichia coli metabolite;
human metabolite
00low000000
propionylcarnitineO-acylcarnitineanalgesic;
antirheumatic drug;
cardiotonic drug;
human metabolite;
peripheral nervous system drug
00low000000
hypotaurineaminosulfinic acid;
zwitterion
human metabolite;
metabolite;
mouse metabolite
00low000000
testosterone 17-glucosiduronate3-oxo steroid;
beta-D-glucosiduronic acid;
enone;
steroid glucosiduronic acid
human metabolite00low000000
3-chloro-L-tyrosinechloroamino acid;
L-alpha-amino acid zwitterion;
L-tyrosine derivative;
monochlorobenzenes;
non-proteinogenic L-alpha-amino acid
biomarker;
human metabolite
00low000000
androsterone glucuronidebeta-D-glucosiduronic acid;
steroid glucosiduronic acid
human metabolite;
metabolite;
mouse metabolite
00low000000
selenomethylselenocysteinenon-proteinogenic alpha-amino acid;
selenocysteines
antineoplastic agent;
human metabolite
00low000000
1,5(10)-estradiene-3,4,17-trione17-oxo steroid;
3-oxo-Delta(1) steroid;
orthoquinones
human metabolite00low000000
s-sulphocysteineorganic thiosulfate;
S-substituted L-cysteine
human metabolite;
plant metabolite
00low000000
estrone-3-glucuronide17-oxo steroid;
beta-D-glucosiduronic acid;
steroid glucosiduronic acid
human metabolite;
mouse metabolite
00low000000
3,4-dihydroxyphenylacetaldehydealpha-CH2-containing aldehyde;
catechols;
phenylacetaldehydes
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
caprylatesfatty acid anion 8:0;
straight-chain saturated fatty acid anion
human metabolite;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
1-hydroxyethyl radicalorganic anionhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
(20s)-20-hydroxycholesterol20-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
human metabolite;
mouse metabolite
00low000000
deoxyhypusineL-lysine derivative;
non-proteinogenic L-alpha-amino acid
human metabolite00low000000
3,7,12-trihydroxycoprostanic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
cholestanoic acid;
hydroxy monocarboxylic acid
human metabolite00low000000
triiodothyronine sulfatearyl sulfate;
O-sulfoamino acid
human metabolite00low000000
3,7,12-trihydroxycholestan-26-oic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
hydroxy monocarboxylic acid;
steroid acid
human metabolite00low000000
erythrose 4-phosphateerythrose phosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
n(8)-acetylspermidineacetylspermidineEscherichia coli metabolite;
human metabolite
00low000000
7 alpha-hydroxy-4-cholesten-3-one3-oxo-Delta(4) steroid;
7alpha-hydroxy steroid;
cholestanoid
human metabolite;
mouse metabolite
00low000000
pristanic acidbranched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid
human metabolite00low000000
gamma-glutamylcysteinegamma-glutamylcysteineEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
27-hydroxycholesterol26-hydroxycholesterolapoptosis inducer;
human metabolite;
mouse metabolite;
neuroprotective agent
00low000000
3-carboxy-4-methyl-5-propyl-2-furanpropionic aciddicarboxylic acid;
furoic acid
human metabolite;
uremic toxin
00low000000
dehydroalanine2,3-dehydroamino acid;
alpha,beta-unsaturated monocarboxylic acid;
amino acid zwitterion;
enamine;
non-proteinogenic alpha-amino acid
alkylating agent;
human metabolite;
mouse metabolite
00low000000
hypothiocyanite ionone-carbon compound;
sulfur oxoacid
antibacterial agent;
antifungal agent;
antiviral agent;
human metabolite;
oxidising agent;
rat metabolite
00low000000
3-c-methylerythritoltetritolhuman metabolite00low000000
succinylacetoacetatealpha,omega-dicarboxylic acid;
beta-diketone
human metabolite00low000000
isoursodeoxycholic aciddihydroxy-5beta-cholanic acidhuman metabolite00low000000
mannitol-1-phosphatealditol 1-phosphate;
hexitol phosphate
Escherichia coli metabolite;
human metabolite
00low000000
triiodothyroninetetrahydrothiophenes;
thiolactone
human metabolite00low000000
kinetensinoligopeptidehistamine releasing agent;
human metabolite
00low000000
estra-1(10),4-diene-2,3,17-trione17-oxo steroid;
3-oxo-Delta(4) steroid;
orthoquinones
human metabolite00low000000
2'-deoxycytidine diphosphate2'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-diphosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
00low000000
n-methylserotoninphenols;
tryptamines
human metabolite;
plant metabolite
00low000000
gamma-glutamylglutaminedipeptidehuman metabolite00low000000
3,4-dihydroxybutanoic acid3-hydroxy fatty acid;
omega-hydroxy-short-chain fatty acid
human metabolite00low000000
n-palmitoylglycinefatty amide;
N-acylglycine 16:0
human metabolite;
marine metabolite
00low000000
gamma-glutamyl-leucineglutamyl-L-amino acidhuman metabolite00low000000
ribuloseribuloseEscherichia coli metabolite;
human metabolite
00low000000
3,4-dihydroxyphenylglycolaldehydecatechols;
hydroxyaldehyde
human metabolite;
mouse metabolite;
neurotoxin
00low000000
androsterone sulfate17-oxo steroid;
androstanoid;
steroid sulfate
human metabolite;
mouse metabolite
00low000000
3,7,12-trihydroxycoprostane12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid
human metabolite;
mouse metabolite
00low000000
saccharopineamino acid opine;
L-lysine derivative
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
allysineallysine;
amino acid zwitterion;
aminoadipate semialdehyde;
non-proteinogenic L-alpha-amino acid
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
orotidylic acidpyrimidine ribonucleoside 5'-monophosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
allocholic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
allo-bile acid;
C24-steroid
human metabolite;
marine metabolite;
rat metabolite
00low000000
beta-ureidoisobutyric acidureidocarboxylic acidhuman metabolite;
mouse metabolite
00low000000
kynurenineamino acid zwitterion;
kynurenine;
non-proteinogenic L-alpha-amino acid
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
nicotinate ribonucleosideammonium betainehuman metabolite00low000000
n(6)-(n-threonylcarbonyl)adenosineL-threonine derivative;
N-(adenosin-N(6)-ylcarbonyl)threonine
Escherichia coli metabolite;
human metabolite
00low000000
sedoheptulose 7-phosphateketoheptose phosphate;
sedoheptulose derivative
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
histidinolamino alcohol;
imidazoles
EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
thiocysteineamino acid zwitterion;
S-substituted L-cysteine
human metabolite;
mouse metabolite
00low000000
nicotinic acid adenine dinucleotidenicotinic acid dinucleotideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol3beta-sterolhuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
bradykinin, des-phe(8)-des-arg(9)-oligopeptidehuman metabolite;
rat metabolite
00low000000
isobutyryl-1-carnitinemethyl-branched fatty acyl-L-carnitine;
O-isobutyrylcarnitine;
saturated fatty acyl-L-carnitine
human metabolite00low000000
threitolthreitolhuman metabolite00low000000
biotinbiotins;
vitamin B7
coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
1987198737.0low010000
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite1981201731.7low449471160
aceglutamideN-acetyl-L-amino acid;
N(2)-acetylglutamine;
N(2)-acyl-L-glutamine
human metabolite00low000000
aflatoxin b1aflatoxin;
aromatic ether;
aromatic ketone
carcinogenic agent;
human metabolite
00low000000
isospaglumic aciddipeptidehuman metabolite00low000000
2'-deoxyadenosine triphosphate2'-deoxyadenosine 5'-phosphate;
purine 2'-deoxyribonucleoside 5'-diphosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
2-ethylhydracrylic acidbranched-chain saturated fatty acid;
hydroxy fatty acid;
short-chain fatty acid
human metabolite00low000000
2-methyl-3-oxovaleric acid3-oxo monocarboxylic acidhuman metabolite00low000000
monoacetylcadaverineacetamides;
N-substituted cadaverine;
primary amino compound;
secondary carboxamide
human metabolite00low000000
beta-citrylglutamic acidN-acyl-L-glutamic acid;
tetracarboxylic acid
human metabolite;
iron chelator
00low000000
maltotriosemaltotriose trisaccharidehuman metabolite00low000000
cholestane-3,7,12,26-tetrol12alpha-hydroxy steroid;
26-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid
human metabolite;
mouse metabolite
00low000000
beta-leucinebeta-amino acidhuman metabolite00low000000
2-methylbutyrylglycineN-acylglycinehuman metabolite00low000000
neurotensin (1-8)peptide zwitterion;
peptide
human metabolite00low000000
cholic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
bile acid;
C24-steroid;
trihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
2004200420.0low000100
erythritolbutane-1,2,3,4-tetrolantioxidant;
human metabolite;
plant metabolite
00low000000
cortisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1993199331.0low001000
5 alpha-androstane-3 beta,17 beta-diol17beta-hydroxy steroid;
3beta-hydroxy steroid;
androstane-3,17-diol
Daphnia magna metabolite;
human metabolite
00low000000
cholesteryl palmitatecholesteryl esterhuman metabolite;
mouse metabolite
00low000000
lanosterol14alpha-methyl steroid;
3beta-sterol;
tetracyclic triterpenoid
bacterial metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
2-hydroxyestradiol17beta-hydroxy steroid;
2-hydroxy steroid
carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug
00low000000
5-hydroxyisourateoxopurinehuman metabolite;
mouse metabolite
00low000000
5-formyluracilaldehyde;
nucleobase analogue;
pyrimidone
human metabolite;
mutagen
00low000000
taurochenodeoxycholic acidbile acid taurine conjugatehuman metabolite;
mouse metabolite
00low000000
5'-methylthioadenosinethioadenosinealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
5'-deoxyadenosine5'-deoxyribonucleoside;
adenosines
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
isomaltoseglycosylglucosehuman metabolite;
metabolite;
mouse metabolite
00low000000
n-acetylneuraminic acidN-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
00low000000
glucosamine 6-phosphate2-amino-2-deoxy-D-glucopyranose 6-phosphatehuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
carnosineamino acid zwitterion;
dipeptide
anticonvulsant;
antineoplastic agent;
antioxidant;
Daphnia magna metabolite;
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent
00low000000
5-hydroxytryptophan5-hydroxytryptophan;
amino acid zwitterion;
hydroxy-L-tryptophan;
non-proteinogenic L-alpha-amino acid
human metabolite;
mouse metabolite;
plant metabolite
00low000000
dopaquinone1,2-benzoquinones;
amino acid zwitterion;
L-phenylalanine derivative
human metabolite;
mouse metabolite
00low000000
pantetheinepantetheines;
thiol
human metabolite;
metabolite;
mouse metabolite
00low000000
tryptophanamideamino acid amide;
tryptophan derivative
human metabolite00low000000
5-diphosphomevalonic acidcarboxyalkyl phosphatehuman metabolite;
mouse metabolite
00low000000
7-dehydrocholesterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
cholestanoid;
Delta(5),Delta(7)-sterol
human metabolite;
mouse metabolite
00low000000
cysteinylglycinedipeptide zwitterion;
dipeptide
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
desmosterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
C27-steroid;
cholestanoid
human metabolite;
mouse metabolite
00low000000
monoiodotyrosineamino acid zwitterion;
L-tyrosine derivative;
monoiodotyrosine;
non-proteinogenic L-alpha-amino acid
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor;
human metabolite;
mouse metabolite
1989198935.0low010000
taurolithocholic acidbile acid taurine conjugate;
monocarboxylic acid amide
human metabolite00low000000
n'-formylkynurenineamino acid zwitterion;
N-formylkynurenine;
non-proteinogenic amino acid derivative;
non-proteinogenic L-alpha-amino acid
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
fuculose 1-phosphatedeoxyaldohexose phosphatehuman metabolite00low000000
nicotinamide-beta-ribosideN-glycosylnicotinamide;
pyridine nucleoside
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
4-hydroxyphenylacetaldehydealpha-CH2-containing aldehyde;
phenylacetaldehydes
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
trimethyllysinealpha-amino-acid cationhuman metabolite;
mouse metabolite
00low000000
inositol 3,4-bisphosphatemyo-inositol bisphosphatehuman metabolite;
mouse metabolite
00low000000
n-acetylglucosamine-1-phosphateN-acetyl-D-glucosamine 1-phosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
24,25-dihydrolanosterol3beta-sterol;
tetracyclic triterpenoid
human metabolite;
mouse metabolite
00low000000
2-hydroxyestrone2-hydroxy steroid;
catechols
human metabolite00low000000
2-methoxyestrone17-oxo steroid;
3-hydroxy steroid;
alicyclic ketone;
aromatic ether;
phenolic steroid;
phenols
human metabolite;
mouse metabolite
00low000000
cortodoxonedeoxycortisol;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
estradiol-3-glucuronide17beta-hydroxy steroid;
beta-D-glucosiduronic acid;
steroid glucosiduronic acid
human metabolite;
mouse metabolite
00low000000
acetyl adenylate5'-acylphosphoadenosinhuman metabolite;
mouse metabolite
00low000000
epiandrosterone17-oxo steroid;
3beta-hydroxy steroid;
androstanoid
androgen;
human metabolite
00low000000
4,4-dimethylcholesta-8,14,24-trienol3beta-sterol;
Delta(14) steroid
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
enkephalin, methioninepentapeptide;
peptide zwitterion
analgesic;
antineoplastic agent;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist
00low000000
7-ketolithocholic acid3alpha-hydroxy steroid;
bile acid;
monohydroxy-5beta-cholanic acid;
oxo-5beta-cholanic acid
human metabolite00low000000
dephosphocoenzyme aadenosine 5'-phosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
1985198539.0low010000
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1981202134.2low113081613372
3-hydroxy-3-methylglutaryl-coenzyme a3-hydroxy-3-methylglutaryl-CoA;
3-hydroxy fatty acyl-CoA
human metabolite;
mouse metabolite
00low000000
retinolretinol;
vitamin A
human metabolite;
mouse metabolite;
plant metabolite
1992199630.0low002000
ribothymidinemethyluridineantigen;
Escherichia coli metabolite;
human metabolite
00low000000
docosahexaenoatedocosahexaenoic acid;
omega-3 fatty acid
algal metabolite;
antineoplastic agent;
Daphnia tenebrosa metabolite;
human metabolite;
mouse metabolite;
nutraceutical
00low000000
tetragastrinpeptidyl amide;
tetrapeptide
anxiogenic;
human metabolite
1986198638.0low010000
prostaglandin d2prostaglandins Dhuman metabolite;
mouse metabolite
1982201332.2low246291240
hexanoyl-coenzyme amedium-chain fatty acyl-CoAEscherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
enkephalin, leucinepentapeptide;
peptide zwitterion
analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
1996199628.0low001000
tyrosine o-sulfatearyl sulfate;
L-tyrosine derivative;
O-sulfoamino acid
human metabolite00low000000
retinaldehyderetinal;
vitamin A
gap junctional intercellular communication inhibitor;
human metabolite;
mouse metabolite
00low000000
squalenetriterpenehuman metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
thyrotropin-releasing hormonepeptide hormone;
tripeptide
human metabolite00low000000
n-methylprolineL-alpha-amino acid zwitterion;
L-proline derivative;
tertiary amino compound
human metabolite;
plant metabolite
00low000000
citraconic aciddicarboxylic acid;
dicarboxylic fatty acid
human metabolite00low000000
flavin-adenine dinucleotideflavin adenine dinucleotide;
vitamin B2
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
00low000000
flavin mononucleotideflavin mononucleotide;
vitamin B2
bacterial metabolite;
coenzyme;
cofactor;
human metabolite;
mouse metabolite
00low000000
mannose 1-phosphatemannose phosphatefundamental metabolite;
human metabolite
00low000000
glycerylphosphorylcholinephosphocholines;
sn-glycerol 3-phosphates
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neuroprotective agent;
parasympatholytic;
Saccharomyces cerevisiae metabolite
00low000000
urocanic acidurocanic acidhuman metabolite00low000000
cysteine sulfinic acidorganosulfinic acid;
S-substituted L-cysteine
Escherichia coli metabolite;
human metabolite;
metabotropic glutamate receptor agonist;
mouse metabolite
00low000000
cholesterol acetateacetate ester;
cholesteryl ester
human metabolite00low000000
1,6-anhydro-beta-glucopyranoseanhydrohexoseArabidopsis thaliana metabolite;
biomarker;
human metabolite
00low000000
glycylvalinedipeptidehuman metabolite00low000000
sodium taurodeoxycholatebile acid taurine conjugatehuman metabolite1995199529.0low001000
estrone sulfate17-oxo steroid;
steroid sulfate
human metabolite;
mouse metabolite
00low000000
hydroxylysine5-hydroxylysine;
hydroxy-L-lysine
human metabolite00low000000
glycodeoxycholic acidbile acid glycine conjugatehuman metabolite00low000000
isobutyryl-coenzyme amethyl-branched fatty acyl-CoA;
short-chain fatty acyl-CoA
human metabolite;
mouse metabolite
00low000000
galactaric acidhexaric acidhuman metabolite00low000000
dihydroxycoprostane3alpha-hydroxy steroid;
7alpha-hydroxy steroid
human metabolite;
mouse metabolite
00low000000
angiotensin i, ile(5)-angiotensin;
peptide zwitterion
human metabolite;
neurotransmitter agent
00low000000
fructosyl-glycinefructosamine;
glycine derivative;
glyco-amino acid
human metabolite00low000000
arachidoyl-coenzyme a11,12-saturated fatty acyl-CoA;
long-chain fatty acyl-CoA
human metabolite00low000000
lignoceroyl-coenzyme avery long-chain fatty acyl-CoAhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
5-hydroxybenzimidazolebenzimidazoles;
phenols
bacterial metabolite;
human metabolite;
rat metabolite
00low000000
n-carbamylglutamateglutamic acid derivative;
ureas
human metabolite00low000000
citramalatedicarboxylic acid dianionhuman metabolite;
plant metabolite
00low000000
4-cresol sulfatearyl sulfategut flora metabolite;
human metabolite;
uremic toxin
00low000000
sphingosinesphing-4-eninehuman metabolite;
mouse metabolite
00low000000
bilirubinbiladienes;
dicarboxylic acid
antioxidant;
human metabolite;
mouse metabolite
1990200526.5low001100
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
1979202133.3low41612466105101
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1979201634.4low183131484070
leukotriene a4epoxy fatty acid;
leukotriene;
long-chain fatty acid;
oxylipin;
polyunsaturated fatty acid
human metabolite;
mouse metabolite;
plant metabolite
1990200230.2low003100
prostaglandin b1prostaglandins Bhuman metabolite00low000000
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1985199234.2low013000
psychosineglycosylsphingoidhuman metabolite00low000000
ubiquinone 9ubiquinonesantioxidant;
human metabolite
00low000000
beta carotenecarotenoid beta-end derivative;
cyclic carotene
antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
2007200717.0low100100
11-cis-retinalretinalchromophore;
human metabolite;
mouse metabolite
00low000000
leukotriene b4dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid
human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
1981201631.1low636841020
leukotriene c4leukotrienebronchoconstrictor agent;
human metabolite;
mouse metabolite
1994200626.2low4024500
prostaglandin f2betaprostaglandins Fbetahuman metabolite00low000000
8,11,14-eicosatrienoic acidfatty acid 20:3;
long-chain fatty acid
fungal metabolite;
human metabolite;
nutraceutical
1985200529.8low046200
15-keto-5,8,11,13-eicosatetraenoic acidoxoicosatetraenoic acidhuman metabolite00low000000
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
1979201734.1low53316610
15-hydroxy-5,8,11,13-eicosatetraenoic acid(5Z,8Z,11Z,13E)-15-HETEhuman metabolite;
mouse metabolite
00low000000
5-hydroxy-6,8,11,14-eicosatetraenoic acidHETEhuman metabolite;
mouse metabolite
00low000000
cholecalciferolD3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone
geroprotector;
human metabolite
1991199133.0low001000
leukotriene d4dipeptide;
leukotriene;
organic sulfide
bronchoconstrictor agent;
human metabolite;
mouse metabolite
1994200922.6low005300
prostaglandin a2prostaglandins Ahuman metabolite00low000000
prostaglandin b2prostaglandins Bhuman metabolite00low000000
prostaglandin g2prostaglandins Ghuman metabolite;
mouse metabolite
00low000000
9-deoxy-delta-9-prostaglandin d2prostaglandins Jhuman metabolite00low000000
11-dehydro-thromboxane b2thromboxanehuman metabolite00low000000
lipoxin a4hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid
human metabolite;
metabolite
00low000000
gamma-linolenic acidlinolenic acid;
omega-6 fatty acid
human metabolite;
mouse metabolite;
plant metabolite
1985200032.9low354000
prostaglandin e3prostaglandins Ehuman metabolite00low000000
leukotriene f-4dipeptide;
leukotriene;
organic sulfide
human metabolite00low000000
prostaglandin f1prostaglandins Falphahuman metabolite00low000000
previtamin d(3)D3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol
human metabolite00low000000
brassicasterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
ergostanoid;
phytosterols
algal metabolite;
animal metabolite;
biomarker;
EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor;
human metabolite;
marine metabolite;
plant metabolite;
sterol biosynthesis inhibitor
00low000000
retinoyl beta-glucuronideglucuronic acids;
retinoid
human metabolite00low000000
coenzyme q10ubiquinonesantioxidant;
ferroptosis inhibitor;
human metabolite
00low000000
prostaglandin d3prostaglandins Dhuman metabolite00low000000
glyceryl 2-arachidonate2-acylglycerol 20:4;
endocannabinoid
human metabolite00low000000
tocotrienol, alphatocotrienol;
vitamin E
ferroptosis inhibitor;
human metabolite;
neuroprotective agent;
plant metabolite
00low000000
11-ketotestosterone11-oxo steroid;
17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen;
human metabolite;
marine xenobiotic metabolite
00low000000
menatetrenonemenaquinoneanti-inflammatory agent;
antioxidant;
bone density conservation agent;
human metabolite;
neuroprotective agent
00low000000
phthioic acidbranched-chain saturated fatty acid;
fatty acid 26:0;
methyl-branched fatty acid;
very long-chain fatty acid
Aspergillus metabolite;
human metabolite
00low000000
2-decenoic acid2-decenoic acidhuman metabolite00low000000
9,11-linoleic acidoctadeca-9,11-dienoic acidanti-inflammatory agent;
antiatherogenic agent;
antineoplastic agent;
apoptosis inducer;
bacterial xenobiotic metabolite;
human metabolite
00low000000
9-hydroxy-10,12-octadecadienoic acidHODE;
octadecadienoic acid
human metabolite;
metabolite;
mouse metabolite;
plant metabolite
00low000000
17-phenyltrinorprostaglandin e2alicyclic ketone;
beta-hydroxy ketone;
hydroxy monocarboxylic acid;
olefinic compound;
oxo monocarboxylic acid;
prostanoid;
secondary alcohol
human metabolite;
prostaglandin receptor agonist
00low000000
thromboxane b2thromboxanes Bhuman metabolite;
mouse metabolite
1979202132.8high1771,103953167621
thromboxane b3thromboxanes Bhuman metabolite;
mouse metabolite
00low000000
12-hydroxy-5,8,10,14-eicosatetraenoic acid(5Z,8Z,10E,14Z)-12-hydroxyicosatetraenoic acid;
HETE
human metabolite;
pro-angiogenic agent
00low000000
20-hydroxy-5,8,11,14-eicosatetraenoic acidHETE;
hydroxy monocarboxylic acid
human metabolite;
mouse metabolite
00low000000
5-oxo-6,8,11,14-eicosatetraenoic acidoxoicosatetraenoic acidhuman metabolite;
immunomodulator;
mouse metabolite
00low000000
8-isoprostaglandin e2cyclic ketone;
diol;
prostanoid;
secondary alcohol
bronchoconstrictor agent;
human metabolite;
rat metabolite;
vasoconstrictor agent
00low000000
oleylamideprimary fatty amidehuman metabolite;
plant metabolite
00low000000
monolinolein1-acylglycerol 18:2;
rac-1-monoacylglycerol
antiviral agent;
human metabolite;
plant metabolite
00low000000
1,25-dihydroxy-24-oxo-vitamin d3hydroxycalciol;
oxocalciol;
tertiary alpha-hydroxy ketone
human metabolite00low000000
calcifediolD3 vitamins;
diol;
hydroxycalciol
bone density conservation agent;
human metabolite;
metabolite;
mouse metabolite;
nutraceutical
00low000000
hyodeoxycholic acid5beta-cholanic acids;
6alpha,20xi-murideoxycholic acid;
bile acid;
C24-steroid
human metabolite;
mouse metabolite
00low000000
vitamin k 1phylloquinones;
vitamin K
cofactor;
human metabolite;
plant metabolite
00low000000
ceriumCE(18:2);
cholesteryl octadeca-9,12-dienoate
human metabolite;
mouse metabolite
00low000000
xylulosexyluloseEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
11-dehydrocorticosterone11-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
1-butyl oleatefatty acid esterhuman metabolite00low000000
8-hydroxyadenine6-aminopurines;
heteroaryl hydroxy compound;
nucleobase analogue;
oxopurine
bacterial metabolite;
human metabolite
00low000000
erucyl amide13-docosenamideEC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite;
mammalian metabolite;
plant metabolite;
rat metabolite
00low000000
vitamin mk 8menaquinoneEscherichia coli metabolite;
human metabolite
00low000000
2,3-oxidosqualene2,3-epoxysqualenehuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
2-keto-4-hydroxyglutarateoxo dicarboxylatehuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
deoxyribosedeoxypentosehuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
iditoliditolfungal metabolite;
human metabolite
00low000000
glutamateglutamate(1-);
polar amino acid zwitterion
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
fumaratesbutenedioate;
C4-dicarboxylate
human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
00low000000
cerotatefatty acid anion 26:0;
omega-methyl fatty acid anion;
very long-chain fatty acid anion
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
adenosine triphosphatenucleoside 5'-triphoshate(4-)cofactor;
fundamental metabolite;
human metabolite
00low000000
docosapentaenoic aciddocosapentaenoic acid;
omega-3 fatty acid
algal metabolite;
human metabolite
00low000000
3-methylbutyrylcarnitineC5-acylcarnitinehuman metabolite00low000000
hexanoylcarnitinehexanoate ester;
O-acylcarnitine
human metabolite00low000000
linoleamideprimary fatty amidehuman metabolite00low000000
13-cis-retinalretinalhuman metabolite00low000000
4-hydroxyretinoic acidretinoid;
secondary allylic alcohol
human metabolite00low000000
4-oxo-2-nonenalenal;
enone
human metabolite00low000000
20,22-dihydroxycholesterol20-hydroxy steroid;
22-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
cholestanoid;
oxysterol
human metabolite;
mouse metabolite
00low000000
biotinatemonocarboxylic acid anion;
vitamin B7
cofactor;
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
6 beta-hydroxycortisol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
6beta-hydroxy steroid;
C21-steroid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mammalian metabolite;
probe
00low000000
fuculosedeoxyketohexoseEscherichia coli metabolite;
human metabolite
00low000000
gamma-glutamylvalineglutamyl-L-amino acidhuman metabolite00low000000
ophthalmic acidL-glutamine derivativebiomarker;
human metabolite
00low000000
acetylcarnitineO-acetylcarnitine;
saturated fatty acyl-L-carnitine
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
adenosine diphosphatenucleoside 5'-diphosphate(3-)fundamental metabolite;
human metabolite
00low000000
cyclic amporganophosphate oxoanionhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
1,23,25-trihydroxyvitamin d3D3 vitamins;
hydroxy seco-steroid;
hydroxycalciol;
tetrol
human metabolite00low000000
phosphocreatinephosphagen;
phosphoamino acid
human metabolite;
mouse metabolite
00low000000
ursodoxicoltaurinebile acid taurine conjugateanti-inflammatory agent;
apoptosis inhibitor;
bone density conservation agent;
cardioprotective agent;
human metabolite;
neuroprotective agent
00low000000
arachidonoylserotoninN-acylserotonin;
phenols
anti-inflammatory agent;
anticonvulsant;
antioxidant;
capsaicin receptor antagonist;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
human metabolite;
signalling molecule
00low000000
homocarnosinedipeptide zwitterion;
dipeptide;
homocarnosine;
L-histidine derivative;
N-acyl-L-alpha-amino acid anion;
N-acyl-L-alpha-amino acid
human metabolite00low000000
3-hydroxyproline3-hydroxyproline;
amino acid zwitterion;
D-proline derivative
bacterial metabolite;
human metabolite
00low000000
cytidine diphosphate cholinenucleotide-(amino alcohol)s;
phosphocholines
human metabolite;
mouse metabolite;
neuroprotective agent;
psychotropic drug;
Saccharomyces cerevisiae metabolite
00low000000
octanoylcarnitineO-octanoylcarnitine;
saturated fatty acyl-L-carnitine
human metabolite00low000000
palmitoylcarnitineO-palmitoylcarnitine;
saturated fatty acyl-L-carnitine
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
human metabolite;
mouse metabolite
00low000000
cyclic 3',5'-thymidine monophosphate3',5'-cyclic pyrimidine nucleotidehuman metabolite00low000000
pristanal2-methyl-branched fatty aldehyde;
saturated fatty aldehyde
human metabolite00low000000
lanosten-3-ol-32-al14alpha-formyl steroid;
3beta-sterol;
tetracyclic triterpenoid
human metabolite00low000000
thiamine pyrophosphateorganophosphate oxoanion;
vitamin B1
human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
adenosine monophosphatenucleoside 5'-monophosphate(2-)cofactor;
fundamental metabolite;
human metabolite
00low000000
nadorganophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
1978198941.3low030000
cob(ii)alamincobalamincofactor;
human metabolite
00low000000
nociceptinorganic molecular entity;
polypeptide
human metabolite;
rat metabolite
00low000000
3-hydroxy-3-methyl-hexanoic acid3-hydroxy monocarboxylic acid;
volatile organic compound
human metabolite00low000000
uridine diphosphatenucleoside 5'-diphosphate(3-)human metabolite;
Saccharomyces cerevisiae metabolite
00low000000
n-acetylgalactosamine-1-phosphateD-galactosamine 1-phosphatehuman metabolite00low000000
1-phospho-5-s-methylthioribuloseorganophosphate oxoanionhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
s-adenosylmethionineorganic cation;
sulfonium compound
coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1997199727.0low001000
10-nitro-oleic acidlong-chain fatty acid;
monounsaturated fatty acid;
nitro fatty acid
human metabolite00low000000
ticrynafenmonocarboxylic acid anion;
organophosphate oxoanion
human metabolite00low000000
s-(1,2-dicarboxyethyl)cysteineL-cysteine thioether;
tricarboxylic acid
human metabolite;
Maillard reaction product
00low000000
neurotensinpeptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
1997199727.0low001000
apelin-13 peptideoligopeptideantihypertensive agent;
autophagy inhibitor;
biomarker;
human metabolite;
neuroprotective agent
00low000000
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phepolypeptideapoptosis inhibitor;
human metabolite;
neuroprotective agent
00low000000
taurolithocholic acid 3-sulfatesteroid sulfate oxoanionhuman metabolite00low000000
inositol 1,3,4-trisphosphateinositol phosphate oxoanionhuman metabolite00low000000
diadenosine tetraphosphateorganophosphate oxoanionhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
2-ketoarginine2-oxo monocarboxylic acid;
zwitterion
human metabolite;
mouse metabolite
00low000000
adenosine diphosphate glucoseNDP-alpha-D-glucose(2-);
ribonucleoside 5'-diphosphate-alpha-D-glucose(2-)
human metabolite00low000000
nicotinate mononucleotideorganophosphate oxoanionhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
oleoylcarnitinemonounsaturated fatty acyl-L-carnitineglycine transporter 2 inhibitor;
human metabolite
00low000000
uridine diphosphate n-acetylgalactosaminenucleotide-sugar oxoanionhuman metabolite00low000000
6-phosphogluconolactoneorganophosphate oxoanionhuman metabolite;
Saccharomyces cerevisiae metabolite
00low000000
3-hydroxyisovalerylcarnitineO-acylcarnitinehuman metabolite00low000000
angiotensin iangiotensin;
peptide zwitterion
antihypertensive agent;
cardioprotective agent;
human metabolite;
rat metabolite
00low000000
9-PAHSAFAHFA;
long-chain fatty acid
anti-inflammatory agent;
human metabolite;
hypoglycemic agent
00low000000
angiotensin iangiotensin;
peptide zwitterion
human metabolite;
neurotransmitter agent
1986201527.5low016210
lugduninhomodetic cyclic peptide;
indoles;
macrocycle;
peptide antibiotic;
thiazolidines
human metabolite;
rat metabolite
00low000000
cyclic gmp3',5'-cyclic purine nucleotide;
guanyl ribonucleotide
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1982201328.5low49431110
deoxyguanosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
deoxyinosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
deoxyguanosine triphosphatedeoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-triphosphate
Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
7,8-dihydroneopterindihydropterin;
neopterins
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
deoxyinosine monophosphatedeoxyinosine phosphate;
purine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
00low000000
guanosine diphosphate mannoseGDP-D-mannoseEscherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
00low000000
guanine2-aminopurines;
oxopurine;
purine nucleobase
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1999199925.0low001000
inosinic acidinosine phosphate;
purine ribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
inosineinosines;
purines D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1987198737.0low110000
inosine triphosphateinosine phosphate;
purine ribonucleoside 5'-triphosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
00low000000
sapropterin5,6,7,8-tetrahydrobiopterincoenzyme;
cofactor;
diagnostic agent;
human metabolite
00low000000
folic acidfolic acids;
N-acyl-amino acid
human metabolite;
mouse metabolite;
nutrient
201920195.0low000010
dyspropterinbiopterins;
tetrahydropterin
human metabolite;
metabolite;
mouse metabolite
00low000000
8-nitroguanosine 3',5'-cyclic monophosphate3',5'-cyclic purine nucleotide;
C-nitro compound
biomarker;
Brassica napus metabolite;
human metabolite;
signalling molecule
00low000000
n(2),n(2)-dimethylguanosinemethylguanosinehuman metabolite00low000000
creatinineimidazolidinone;
lactam
diagnostic agent;
human metabolite
00low000000
apelin-12 peptideoligopeptidebiomarker;
human blood serum metabolite;
human metabolite;
neuroprotective agent
00low000000
alpha-hydroxyglutarate2-hydroxydicarboxylic acid;
dicarboxylic fatty acid
metabolite;
mouse metabolite
00low000000
alpha-ketoadipic acidoxo dicarboxylic acidhuman urinary metabolite;
mouse metabolite
00low000000
n-carbamoyl-beta-alaninebeta-alanine derivativemetabolite;
mouse metabolite
00low000000
4-aminobutyraldehydeaminobutanal;
omega-aminoaldehyde
Escherichia coli metabolite;
mouse metabolite
00low000000
4-hydroxybenzaldehydehydroxybenzaldehydeEC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor;
mouse metabolite;
plant metabolite
00low000000
ethylene glycolethanediol;
glycol
metabolite;
mouse metabolite;
solvent;
toxin
00low000000
agmatineguanidines;
primary amino compound
Escherichia coli metabolite;
mouse metabolite
00low000000
allantoic acidureasmouse metabolite;
plant metabolite
00low000000
aminoacetonemethyl ketone;
propanones
Escherichia coli metabolite;
mouse metabolite
00low000000
ammonium hydroxideazane;
gas molecular entity;
mononuclear parent hydride
EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
1988200129.0low011100
hydrobromic acidgas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite00low000000
butyraldehydebutanalsbiomarker;
Escherichia coli metabolite;
mouse metabolite
00low000000
cadaverinealkane-alpha,omega-diamineDaphnia magna metabolite;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite
00low000000
carbamyl phosphateacyl monophosphate;
one-carbon compound
Escherichia coli metabolite;
mouse metabolite
00low000000
hydrochloric acidchlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite1984200431.8low040200
coproporphyrinogen iiicoproporphyrinogenEscherichia coli metabolite;
mouse metabolite
00low000000
1,2-dihydroxy-1,2-dihydronaphthalenedihydronaphthalenes;
naphthalenediols
bacterial xenobiotic metabolite;
mouse metabolite
00low000000
4-nitrophenylphosphatearyl phosphatemouse metabolite00low000000
n(1)-methylnicotinamidepyridinium ionalgal metabolite;
anti-inflammatory agent;
human urinary metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
phosphonoacetaldehydephosphonic acidsmouse metabolite00low000000
gamma-guanidinobutyric acidguanidines;
monocarboxylic acid;
zwitterion
fungal metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
phosphoglycolatecarboxyalkyl phosphateEscherichia coli metabolite;
mouse metabolite
00low000000
hydrogen selenidemononuclear parent hydride;
selenium hydride
Escherichia coli metabolite;
mouse metabolite
00low000000
3,3-dimethylallyl pyrophosphateprenol phosphateepitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
00low000000
diethyl phosphatedialkyl phosphatehuman xenobiotic metabolite;
mouse metabolite
00low000000
o,o-diethyl phosphorothionateorganic thiophosphatehuman xenobiotic metabolite;
mouse metabolite
00low000000
formaldehydealdehyde;
one-carbon compound
allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
carbonic acidcarbon oxoacid;
chalcocarbonic acid
mouse metabolite00low000000
hydantoin-5-propionic acidimidazolidine-2,4-dione;
monocarboxylic acid
metabolite;
mouse metabolite
00low000000
hydroquinonebenzenediol;
hydroquinones
antioxidant;
carcinogenic agent;
cofactor;
Escherichia coli metabolite;
human xenobiotic metabolite;
mouse metabolite;
skin lightening agent
00low000000
hydroxymethylbilanebilanesEscherichia coli metabolite;
mouse metabolite
00low000000
lactaldehydehydroxyaldehyde;
propanals
mouse metabolite00low000000
naphthalenenaphthalenes;
ortho-fused bicyclic arene
apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component
00low000000
niacinamidepyridine alkaloid;
pyridinecarboxamide;
vitamin B3
anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
2007201611.3low000120
niacinpyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3
antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
1987200229.5low010100
hydroxide ionoxygen hydridemouse metabolite00low000000
orotic acidpyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
1991199133.0low001000
4-nitrophenol4-nitrophenolshuman xenobiotic metabolite;
mouse metabolite
00low000000
parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
mouse metabolite
00low000000
phenanthreneortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes
environmental contaminant;
mouse metabolite
00low000000
phenolphenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
1984198440.0low010000
porphobilinogenaralkylamino compound;
dicarboxylic acid;
pyrroles
Escherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
propylene glycolglycol;
propane-1,2-diols
allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
00low000000
pyridoxine 5-phosphatevitamin B6 phosphateEscherichia coli metabolite;
mouse metabolite
00low000000
succinic semialdehydealdehydic acidEscherichia coli metabolite;
mouse metabolite
00low000000
tartronate semialdehyde2-hydroxy monocarboxylic acid;
3-oxo monocarboxylic acid;
aldehyde
Escherichia coli metabolite;
mouse metabolite
00low000000
uroporphyrinogen iiiuroporphyrinogenEscherichia coli metabolite;
mouse metabolite
00low000000
isopentenyl pyrophosphateprenol phosphateantigen;
antioxidant;
epitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
00low000000
6-hydroxymelatoninacetamides;
tryptamines
metabolite;
mouse metabolite
00low000000
adrenic aciddocosatetraenoic acidmouse metabolite00low000000
benzo(a)pyreneortho- and peri-fused polycyclic arenecarcinogenic agent;
mouse metabolite
1993199331.0low003000
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
1988200428.3low014100
chloral hydratealdehyde hydrate;
ethanediol;
organochlorine compound
general anaesthetic;
mouse metabolite;
sedative;
xenobiotic
00low000000
quinone1,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
00low000000
1,7-dimethylxanthinedimethylxanthinecentral nervous system stimulant;
human blood serum metabolite;
human xenobiotic metabolite;
mouse metabolite
00low000000
theobrominedimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
1984200135.0low251100
aspartic acidaspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
1989201225.0low011010
uridine diphosphatepyrimidine ribonucleoside 5'-diphosphate;
uridine 5'-phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
galactoseD-galactose;
galactopyranose
Escherichia coli metabolite;
mouse metabolite
1989198935.0low010000
cytidine diphosphatecytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-diphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
uridine triphosphatepyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate
Escherichia coli metabolite;
mouse metabolite
1996199628.0low001000
phenylalanineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid
algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
cytidine triphosphatecytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
1-naphthaldehydenaphthaldehydemouse metabolite00low000000
2-naphthaldehydenaphthaldehydemouse metabolite00low000000
ornithinenon-proteinogenic L-alpha-amino acid;
ornithine
algal metabolite;
hepatoprotective agent;
mouse metabolite
00low000000
argininearginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1988200629.6low2132300
methylaminemethylamines;
one-carbon compound;
primary aliphatic amine
mouse metabolite00low000000
ethylene oxidegas molecular entity;
oxacycle;
saturated organic heteromonocyclic parent
allergen;
mouse metabolite;
mutagen
00low000000
vinylidene chloridechloroethenescarcinogenic agent;
mouse metabolite;
mutagen
00low000000
trichloroacetaldehydealdehyde;
organochlorine compound
mouse metabolite00low000000
trichloroacetic acidmonocarboxylic acid;
organochlorine compound
carcinogenic agent;
metabolite;
mouse metabolite
00low000000
gibberellic acidC19-gibberellin;
gibberellin monocarboxylic acid;
lactone;
organic heteropentacyclic compound
mouse metabolite;
plant metabolite
00low000000
trichloroethylenechloroethenesinhalation anaesthetic;
mouse metabolite
00low000000
pyridoxic acidhydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6
human urinary metabolite;
mouse metabolite
00low000000
1-nitronaphthalenemononitronaphthaleneenvironmental contaminant;
mouse metabolite
00low000000
beta-glucono-1,5-lactonealdono-1,5-lactone;
gluconolactone
animal metabolite;
mouse metabolite
00low000000
2-naphthoic acidnaphthoic acidmouse metabolite;
xenobiotic metabolite
00low000000
methylphenyl carbinolaromatic alcoholmouse metabolite00low000000
4-hydroxyacetophenonemonohydroxyacetophenonefungal metabolite;
mouse metabolite;
plant metabolite
00low000000
styrenestyrenes;
vinylarene;
volatile organic compound
mouse metabolite;
mutagen;
plant metabolite
00low000000
2-phenylacetamidemonocarboxylic acid amidemouse metabolite00low000000
4-bromophenolbromophenolhuman urinary metabolite;
human xenobiotic metabolite;
marine metabolite;
mouse metabolite;
persistent organic pollutant;
rat metabolite
00low000000
ethylene dibromidebromoalkane;
bromohydrocarbon
algal metabolite;
carcinogenic agent;
fumigant;
marine metabolite;
mouse metabolite;
mutagen
00low000000
bromobenzenebromoarene;
bromobenzenes;
volatile organic compound
hepatotoxic agent;
mouse metabolite;
non-polar solvent
00low000000
2-heptanonedialkyl ketone;
methyl ketone
mouse metabolite;
pheromone
00low000000
2,2,2-trichloroethanolchloroethanolmouse metabolite00low000000
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1988198836.0low010000
D-prolineD-alpha-amino acid zwitterion;
D-alpha-amino acid;
proline
mouse metabolite00low000000
paraoxonaryl dialkyl phosphate;
organophosphate insecticide
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
mouse metabolite
00low000000
aminoimidazole carboxamideaminoimidazole;
monocarboxylic acid amide
mouse metabolite00low000000
methyl-4-tyraminetyraminesmouse metabolite00low000000
phosphoadenosine phosphosulfateacyl sulfate;
adenosine bisphosphate;
purine ribonucleoside bisphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
adenosine phosphosulfateacyl monophosphate;
acyl sulfate;
adenosine 5'-phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
fructose-1,6-diphosphateD-fructofuranose 1,6-bisphosphatemouse metabolite00low000000
hydroxyhydroquinonebenzenetriolmouse metabolite00low000000
1,2-dihydroxynaphthalenenaphthalenediolmouse metabolite00low000000
propiolaldehydeterminal acetylenic compound;
ynal
mouse metabolite00low000000
phenylphosphatearyl phosphatemouse metabolite00low000000
n-cyclohexylformamidealicyclic compound;
formamides
mouse metabolite00low000000
deoxycytidine monophosphate2'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
nicotinamide mononucleotidenicotinamide mononucleotideEscherichia coli metabolite;
mouse metabolite
00low000000
dihydroferulic acidguaiacols;
monocarboxylic acid;
phenylpropanoid
antioxidant;
human xenobiotic metabolite;
mouse metabolite;
plant metabolite
00low000000
2'-deoxyadenosine triphosphate2'-deoxyadenosine 5'-phosphate;
purine 2'-deoxyribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
fucosefucopyranose;
L-fucose
Escherichia coli metabolite;
mouse metabolite
00low000000
uridine diphosphate galactoseUDP-D-galactosemouse metabolite00low000000
1-naphthalenemethanolnaphthylmethanolmouse metabolite00low000000
diadenosine tetraphosphatediadenosyl tetraphosphateEscherichia coli metabolite;
mouse metabolite
00low000000
d-glutamateD-alpha-amino acid;
glutamic acid
Escherichia coli metabolite;
mouse metabolite
00low000000
hydroiodic acidgas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite00low000000
trichloroepoxyethaneepoxidemouse metabolite00low000000
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
1989199432.0low012000
adenosine diphosphate riboseADP-sugarEscherichia coli metabolite;
mouse metabolite
1986198638.0low010000
phosphopantothenic acidamidoalkyl phosphateEscherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
cyromazinetriamino-1,3,5-triazinemouse metabolite;
triazine insecticide
00low000000
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
1980201731.9low01011120
thymidine 5'-triphosphatepyrimidine 2'-deoxyribonucleoside 5'-triphosphate;
thymidine phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
2'-deoxyuridylic aciddeoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
obtusifoliol14alpha-methyl steroid;
3beta-sterol
mouse metabolite;
plant metabolite
00low000000
glutathione disulfideglutathione derivative;
organic disulfide
Escherichia coli metabolite;
mouse metabolite
2013201311.0low000010
3'-cmpcytidine 3'-phosphate;
pyrimidine ribonucleoside 3'-monophosphate
Escherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
7-methylxanthineoxopurine;
purine alkaloid
human xenobiotic metabolite;
mouse metabolite;
plant metabolite
00low000000
cifostodine2',3'-cyclic pyrimidine nucleotideEscherichia coli metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
00low000000
n'-methyl-2-pyridone-5-carboxamidemethylpyridines;
pyridinecarboxamide;
pyridone
metabolite;
mouse metabolite
00low000000
1-methyluric acidoxopurinehuman xenobiotic metabolite;
mouse metabolite
00low000000
cyclopropylamineprimary aliphatic aminemouse metabolite00low000000
6-hydroxynicotinic acidmonohydroxypyridineArabidopsis thaliana metabolite;
human urinary metabolite;
mouse metabolite
00low000000
xanthosine 5'-triphosphatepurine ribonucleoside 5'-monophosphate;
xanthosine 5'-phosphate
Escherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
2-naphthalenemethanolnaphthylmethanolmouse metabolite;
xenobiotic metabolite
00low000000
xanthurenic acid 8-methyl etheraromatic ether;
monohydroxyquinoline;
quinolinemonocarboxylic acid
carcinogenic agent;
metabolite;
mouse metabolite
00low000000
glucoseD-glucopyranosemouse metabolite00low000000
1,3,7-trimethylurateoxopurinehuman blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite
00low000000
1-methylxanthine1-methylxanthinemouse metabolite00low000000
3,7-dimethyluric acidoxopurinemetabolite;
mouse metabolite
00low000000
biocytinazabicycloalkane;
L-alpha-amino acid zwitterion;
L-lysine derivative;
monocarboxylic acid amide;
non-proteinogenic L-alpha-amino acid;
thiabicycloalkane;
ureas
mouse metabolite00low000000
d-aspartic acidaspartic acid;
D-alpha-amino acid
mouse metabolite00low000000
coenzyme aadenosine 3',5'-bisphosphatecoenzyme;
Escherichia coli metabolite;
mouse metabolite
1988199333.5low011000
3,4-dihydroxyphenylglycolcatechols;
tetrol
metabolite;
mouse metabolite
00low000000
homocysteineamino acid zwitterion;
homocysteine;
serine family amino acid
fundamental metabolite;
mouse metabolite
1986201922.8low012210
1,7-dimethyluric acidoxopurinehuman xenobiotic metabolite;
mouse metabolite
00low000000
24-methylenecholesterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol
mouse metabolite00low000000
succinyl-coenzyme aomega-carboxyacyl-CoAEscherichia coli metabolite;
inhibitor;
mouse metabolite
00low000000
acetoacetyl coa3-oxo-fatty acyl-CoAEscherichia coli metabolite;
mouse metabolite
00low000000
2,8-dihydroxyadenine6-aminopurines;
diol;
heteroaryl hydroxy compound;
oxopurine
human urinary metabolite;
mammalian metabolite;
mouse metabolite;
nephrotoxic agent
00low000000
propionyl-coenzyme aacyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
21-deoxycortisol11beta-hydroxy steroid;
17alpha-hydroxy-C21-steroid;
deoxycortisol;
tertiary alpha-hydroxy ketone
human blood serum metabolite;
mouse metabolite
00low000000
stearoyl-coenzyme a11,12-saturated fatty acyl-CoA;
long-chain fatty acyl-CoA
Escherichia coli metabolite;
mouse metabolite
00low000000
imidazoleacetic acidimidazoles;
monocarboxylic acid
metabolite;
mouse metabolite
00low000000
1-hydroxyphenanthrenephenanthrolmouse metabolite00low000000
2,5-dihydroxypyridinedihydroxypyridinemouse metabolite00low000000
ceriumcholesteryl estermouse metabolite00low000000
6,6-dimethyl-2-methylenebicyclo(3.1.1)heptan-3-olcarbobicyclic compound;
pinane monoterpenoid;
secondary alcohol
GABA modulator;
mouse metabolite;
plant metabolite;
volatile oil component
00low000000
ecgonine methyl estermethyl ester;
tertiary amino compound;
tropane alkaloid
analgesic;
central nervous system depressant;
metabolite;
mouse metabolite;
opioid analgesic;
peripheral nervous system drug
00low000000
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridinehydroxylamine;
imidazopyridine
carcinogenic agent;
genotoxin;
human xenobiotic metabolite;
mouse metabolite;
mutagen;
neurotoxin;
rat metabolite
00low000000
cholest-5-en-3 beta,7 alpha-diol3beta-hydroxy-Delta(5)-steroid;
7alpha-hydroxy steroid;
oxysterol
mouse metabolite00low000000
s-chloromethylglutathioneorganochlorine compound;
S-substituted glutathione
alkylating agent;
bacterial xenobiotic metabolite;
mouse metabolite
00low000000
5-acetylamino-6-formylamino-3-methyluracilformamidopyrimidinemouse metabolite00low000000
anserinebeta-alanine derivative;
dipeptide;
zwitterion
animal metabolite;
mouse metabolite
00low000000
5,6-dihydroxyindoledihydroxyindolemouse metabolite00low000000
5,6-dihydroxy-2-indolylcarboxylic aciddihydroxyindolemouse metabolite00low000000
protoporphyrinogenporphyrinogensEscherichia coli metabolite;
mouse metabolite
00low000000
inositol-3,4,5,6-tetrakisphosphatemyo-inositol tetrakisphosphatemouse metabolite00low000000
24-hydroxycholesterol24-hydroxycholesterolbiomarker;
human blood serum metabolite;
mouse metabolite
00low000000
phytosphingosineamino alcohol;
sphingoid;
triol
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
butyryl-coenzyme abutanoyl-CoAsEscherichia coli metabolite;
mouse metabolite
00low000000
n-acetylputrescineN-monoacetylalkane-alpha,omega-diamine;
N-substituted putrescine
metabolite;
mouse metabolite
00low000000
cdp ethanolaminenucleotide-(amino alcohol)s;
phosphoethanolamine
mouse metabolite00low000000
galactose-1-phosphatealpha-D-hexose 1-phosphate;
D-galactopyranose 1-phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine;
phosphatidylcholine 30:0;
tetradecanoate ester
mouse metabolite00low000000
prolineamino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid
algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1981199736.6low043000
d-glutamineamino acid zwitterion;
D-alpha-amino acid;
glutamine
mouse metabolite00low000000
diquafosolpyrimidine ribonucleoside 5'-tetraphosphate;
uridine 5'-phosphate
mouse metabolite;
P2Y2 receptor agonist
00low000000
19-hydroxytestosterone17beta-hydroxy steroid;
19-hydroxy steroid;
3-oxo-Delta(4) steroid
mouse metabolite00low000000
2-hydroxy-1,4-benzoquinonemonohydroxy-1,4-benzoquinonesmouse metabolite00low000000
sorbitol 6-phosphatealditol 6-phosphate;
glucitol phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
adenosine 3'-phosphate-5'-phosphateadenosine bisphosphateEscherichia coli metabolite;
mouse metabolite
00low000000
alpha-ribazole1-ribosylbenzimidazole;
dimethylbenzimidazole
Escherichia coli metabolite;
mouse metabolite
00low000000
saicar1-(phosphoribosyl)imidazolecarboxamideEscherichia coli metabolite;
mouse metabolite
00low000000
thymidine 5'-diphosphatepyrimidine 2'-deoxyribonucleoside 5'-diphosphate;
thymidine phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
hydromethylthioninearomatic amine;
phenothiazines;
tertiary amino compound
bacterial xenobiotic metabolite;
fluorochrome;
mouse metabolite;
rat metabolite
00low000000
5-hydroxykynuraminehydroxykynurenamine;
primary amino compound
mouse metabolite00low000000
sedoheptulose 1,7-bisphosphateketoheptose phosphate;
sedoheptulose derivative
Escherichia coli metabolite;
mouse metabolite
00low000000
diadenosine triphosphatediadenosyl triphosphatemouse metabolite00low000000
carboxyaminoimidazole ribotide1-(phosphoribosyl)imidazole;
aminoimidazole;
imidazole-4-carboxylic acid
Escherichia coli metabolite;
mouse metabolite
00low000000
isovaleryl-coenzyme amethylbutanoyl-CoA;
short-chain fatty acyl-CoA
mouse metabolite00low000000
lauroyl-coenzyme amedium-chain fatty acyl-CoAEscherichia coli metabolite;
mouse metabolite
00low000000
phenylacetyl-coenzyme aacyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
5-formamidoimidazole-4-carboxamide ribotide1-(phosphoribosyl)imidazolecarboxamideEscherichia coli metabolite;
mouse metabolite
00low000000
campesterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
C28-steroid;
phytosterols
mouse metabolite00low000000
gamma-glutamyl phosphategamma-glutamyl phosphateEscherichia coli metabolite;
mouse metabolite
00low000000
5-amino-6-ribitylamino-2,4-(1h,3h)pyrimidinedioneaminouracil;
hydroxypyrimidine
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
sitosterol, (3beta)-isomer3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
C29-steroid;
phytosterols;
stigmastane sterol
anticholesteremic drug;
antioxidant;
mouse metabolite;
plant metabolite;
sterol methyltransferase inhibitor
00low000000
androstane-3,17-dione, (5alpha)-isomer3-oxo-5alpha-steroid;
androstane-3,17-dione
mouse metabolite00low000000
21-hydroxypregnenolone21-hydroxy steroid;
hydroxypregnenolone;
primary alpha-hydroxy ketone
mouse metabolite00low000000
epietiocholanolone17-oxo steroid;
3beta-hydroxy steroid;
androstanoid
androgen;
animal metabolite;
human blood serum metabolite;
mouse metabolite;
rat metabolite
00low000000
19-hydroxy-4-androstene-3,17-dione17-oxo steroid;
19-hydroxy steroid;
3-oxo steroid;
androstanoid
mouse metabolite00low000000
glyceraldehyde 3-phosphateglyceraldehyde 3-phosphatemouse metabolite00low000000
ribulose 5-phosphateribulose 5-phosphatemouse metabolite00low000000
xylulose-5-phosphate, (d)-isomerxylulose 5-phosphateEscherichia coli metabolite;
mouse metabolite
00low000000
glycerate 1,3-biphosphate2,3-bisphosphoglyceric acid;
acyl monophosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
arabinoseL-arabinoseEscherichia coli metabolite;
mouse metabolite
00low000000
glucosamineD-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
1983198341.0low010000
raffinoseraffinose family oligosaccharide;
trisaccharide
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2001200123.0low100100
xanthosine 5'-triphosphatepurine ribonucleoside 5'-triphosphate;
xanthosine 5'-phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
galactoseD-galactopyranoseepitope;
mouse metabolite
00low000000
galactoseD-galactopyranosemouse metabolite00low000000
s-adenosyl-3-methylthiopropylamineadenosines;
sulfonium compound
Escherichia coli metabolite;
human urinary metabolite;
mouse metabolite;
rat metabolite
00low000000
6-phosphonoglucono-delta-lactonealdonolactone phosphateEscherichia coli metabolite;
mouse metabolite
00low000000
inositol 1,4,5-trisphosphatemyo-inositol trisphosphatemouse metabolite1987199633.3low021000
stachyoseraffinose family oligosaccharide;
tetrasaccharide
mouse metabolite;
plant metabolite
00low000000
ketodihydrosphingosine2-amino-1-hydroxyoctadecan-3-onemouse metabolite00low000000
androstane-3,17-dione, (5beta)-isomer3-oxo-5beta-steroid;
androstane-3,17-dione
mouse metabolite00low000000
pantothenylcysteine 4'-phosphateL-cysteine derivativeEscherichia coli metabolite;
mouse metabolite
00low000000
dehydroascorbic aciddehydroascorbic acid;
vitamin C
coenzyme;
mouse metabolite
00low000000
beta-sulfopyruvic acidcarboxyalkanesulfonic acidmouse metabolite00low000000
2-hydroxypropylphosphonic acidphosphonic acids;
secondary alcohol
mouse metabolite00low000000
inositol-1,4,5,6-tetrakisphosphatemyo-inositol tetrakisphosphatemouse metabolite00low000000
maleic acidbutenedioic acidalgal metabolite;
mouse metabolite;
plant metabolite
00low000000
n(1)-(5-phosphoribosyl)-5,6-dimethylbenzimidazole1-ribosylbenzimidazole;
dimethylbenzimidazole;
ribose monophosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
prostaglandin h2olefinic compound;
oxylipin;
prostaglandins H;
secondary alcohol
mouse metabolite1982200434.0low01511200
oleic acidoctadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
1982200430.0low127200
farnesyl pyrophosphatefarnesyl diphosphateEscherichia coli metabolite;
mouse metabolite
00low000000
geranyl pyrophosphatepolyprenyl diphosphateEscherichia coli metabolite;
mouse metabolite
00low000000
1,5-dihydro-fadflavin adenine dinucleotideEscherichia coli metabolite;
mouse metabolite
00low000000
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
1994200127.8low103100
eicosapentaenoic acidicosapentaenoic acid;
omega-3 fatty acid
anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1981200733.5low21311400
s-hydroxymethylglutathioneS-substituted glutathioneEscherichia coli metabolite;
mouse metabolite
00low000000
geranylgeranyl pyrophosphategeranylgeranyl diphosphatemouse metabolite00low000000
cytidine monophosphate n-acetylneuraminic acidCMP-N-acyl-beta-neuraminic acidmouse metabolite00low000000
4-phosphoerythronate4-phosphoerythronic acidEscherichia coli metabolite;
mouse metabolite
00low000000
colfosceril palmitate1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine;
phosphatidylcholine 32:0
mouse metabolite;
surfactant
00low000000
lyso-pc1-O-acyl-sn-glycero-3-phosphocholine;
lysophosphatidylcholine 16:0
mouse metabolite00low000000
riboflavinflavin;
vitamin B2
anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
00low000000
trans-4-coumaric acid4-coumaric acidfood component;
mouse metabolite;
plant metabolite
00low000000
3-hydroxybutyryl-coenzyme a3-hydroxyacyl-CoA;
hydroxybutanoyl-CoA
mouse metabolite00low000000
malonyl coenzyme amalonyl-CoAsEC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor;
Escherichia coli metabolite;
metabolite;
mouse metabolite
00low000000
palmitoyl coenzyme a11,12-saturated fatty acyl-CoA;
3-substituted propionyl-CoA;
long-chain fatty acyl-CoA;
palmitoyl bioconjugate
Escherichia coli metabolite;
mouse metabolite
00low000000
dihydrosphingosine 1-phosphatesphingoid 1-phosphatemouse metabolite00low000000
caffeic acidcaffeic acidgeroprotector;
mouse metabolite
00low000000
coniferyl alcoholguaiacols;
phenylpropanoid
animal metabolite;
monolignol;
mouse metabolite;
pheromone;
plant metabolite;
volatile oil component
00low000000
raphanusamic acidthiazolidinemonocarboxylic acidArabidopsis thaliana metabolite;
mouse metabolite;
xenobiotic metabolite
00low000000
glutaryl-coenzyme aglutaryl-CoAsmouse metabolite00low000000
thromboxane a2epoxy monocarboxylic acid;
thromboxanes A
mouse metabolite1980201732.9medium4524319643100
arachidonic acid 5-hydroperoxide5-HPETEmouse metabolite00low000000
arachidonic acid omega-9 hydroperoxideHPETEmouse metabolite00low000000
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (s)-(e,z,z,z)-isomer15-HPETEmouse metabolite00low000000
alpha-linolenic acidlinolenic acid;
omega-3 fatty acid
micronutrient;
mouse metabolite;
nutraceutical
1984200730.0low026100
1-palmitoyl-2-oleoyl-sn-glycerol1,2-diacyl-sn-glycerol;
1-palmitoyl-2-oleoylglycerol
mouse metabolite00low000000
epoprostenolprostaglandins Imouse metabolite00low000000
11,12-dihydroxyeicosatrienoic acidDHETmouse metabolite00low000000
14,15-dihydroxyeicosatrienoic acidDHET;
diol;
secondary allylic alcohol
mouse metabolite00low000000
5,6-epoxy-8,11,14-eicosatrienoic acidEETmouse metabolite00low000000
8,9-epoxyeicosatrienoic acidEETmouse metabolite00low000000
1-palmitoyl-2-oleoylphosphatidylethanolamine, (z & r)-isomer1,2-diacyl-sn-glycero-3-phosphoethanolamine;
phosphatidylethanolamine 34:1 zwitterion;
phosphatidylethanolamine
mouse metabolite00low000000
sphingosine 1-phosphatesphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
00low000000
cholesteryl oleateCE(18:1);
cholesteryl octadec-9-enoate
mouse metabolite00low000000
stearidonic acidlong-chain fatty acid;
octadecatetraenoic acid;
omega-3 fatty acid
Daphnia galeata metabolite;
mouse metabolite;
plant metabolite
00low000000
trilinolein1,2-diacyl-3-linoleoylglycerol;
1,3-diacyl-2-linoleoylglycerol;
linoleoyl containing 1,2,3-triacyl-sn-glycerol;
TG(18:2/18:2/18:2);
triglyceride
mouse metabolite00low000000
dimyristoylphosphatidylcholine1,2-diacyl-sn-glycero-3-phosphocholine;
phosphatidylcholine 28:0;
tetradecanoate ester
antigen;
mouse metabolite
00low000000
monodehydroascorbateorganic radicalmouse metabolite00low000000
oleoyl-coenzyme aoctadecenoyl-CoAEscherichia coli metabolite;
mouse metabolite
00low000000
vitamin a2retinoid;
vitamin A
human xenobiotic metabolite;
marine xenobiotic metabolite;
mouse metabolite
00low000000
1,2-dioleoylphosphatidylserinephosphatidylserine(18:1/18:1)mouse metabolite00low000000
5-hydroxy-6,8,11,14,17-eicosapentaenoic acidHEPEmouse metabolite00low000000
1-stearoyl-2-linoleoylphosphatidylcholinephosphatidylcholine 36:2mouse metabolite00low000000
1-stearoyl-2-linoleoyl-sn-glycerol1,2-diacyl-sn-glycerol;
diacylglycerol 36:2
mouse metabolite00low000000
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholinephosphatidylcholine 38:6mouse metabolite00low000000
13(S)-HODEHODEantineoplastic agent;
human xenobiotic metabolite;
mouse metabolite
00low000000
1-stearoyl-2-oleoyl-sn-glycerol1,2-diacyl-sn-glycerol;
1-stearoyl-2-oleoylglycerol;
diacylglycerol 36:1
mouse metabolite00low000000
1-palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine1-acyl-2-palmitoleoyl-sn-glycero-3-phosphocholine;
phosphatidylcholine 32:1
mouse metabolite00low000000
13-oxo-9,11-octadecadienoic acid13-oxo-9,11-octadecadienoic acidmetabolite;
mouse metabolite
00low000000
n-stearoylsphingomyelinsphingomyelin 36:1;
sphingomyelin d18:1
mouse metabolite00low000000
cholesteryl arachidonatecholesteryl icosatetraenoateantibacterial agent;
mouse metabolite
00low000000
acryloyl-coenzyme a2-enoyl-CoA;
monounsaturated fatty acyl-CoA
mouse metabolite00low000000
samariumsphingomyelin d18:1/16:0mouse metabolite00low000000
n-palmitoylgalactosylsphingosineHexCer(d18:1/16:0);
N-acyl-beta-D-galactosylsphingosine
mouse metabolite00low000000
s-tetradecanoyl-coenzyme a11,12-saturated fatty acyl-CoA;
long-chain fatty acyl-CoA
Escherichia coli metabolite;
mouse metabolite
00low000000
prosomatostatinheterodetic cyclic peptide;
peptide hormone
fungal metabolite;
mouse metabolite;
rat metabolite
00low000000
phosphatidylcholinesphosphatidylcholine 40:6mouse metabolite00low000000
cyclosporineketo-disaccharidemouse metabolite00low000000
g(m3) gangliosidealpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide;
sialodiosylceramide;
sialotriaosylceramide
mouse metabolite1993199331.0low001000
diguanosine tetraphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-tetraphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
2'-deoxyguanosine 5'-phosphatedeoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
dihydrofolatedihydrofolic acidsEscherichia coli metabolite;
mouse metabolite
00low000000
dihydroneopterin triphosphatedihydropterin;
neopterins;
pterin phosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
2'-deoxyinosine triphosphatedeoxyinosine phosphate;
purine 2'-deoxyribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
guanosine diphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
00low000000
gdp-4-keto-6-deoxymannoseGDP-sugarEscherichia coli metabolite;
mouse metabolite
00low000000
guanosine pentaphosphateguanosine 5'-phosphate;
guanosine bisphosphate
Escherichia coli metabolite;
mouse metabolite
00low000000
guanosine monophosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
1998199826.0low001000
guanosine triphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
1984200032.7low012000
guanosine tetraphosphateguanosine bisphosphateEscherichia coli metabolite;
mouse metabolite
00low000000
leucovorinformyltetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
00low000000
5,10-methenyltetrahydrofolatemethylenetetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
00low000000
10-formyltetrahydrofolateformyltetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1979201634.4low183131484070
prostaglandin f1prostaglandins Falphahuman metabolite00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
1995199529.0low001000
sulfobromophthalein sodiumorganic sodium saltdye1995199529.0low001000
bromcresol greenbenzofurans1995199529.0low001000
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1995199529.0low001000
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
1995199529.0low001000
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1995199529.0low001000
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
1995199529.0low001000
thromboxane b2thromboxanes Bhuman metabolite;
mouse metabolite
1995199529.0low001000
iloprostcarbobicyclic compound;
monocarboxylic acid;
secondary alcohol
platelet aggregation inhibitor;
vasodilator agent
1995199529.0low001000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
acetylcarnitineO-acylcarnitinehuman metabolite1990199630.7low003000
protocatechuic acidcatechols;
dihydroxybenzoic acid
antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
201720177.0low000010
acetoacetic acid3-oxo fatty acid;
ketone body
metabolite1996199628.0low101000
acetic acidmonocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
1999200522.0low001100
acetaldehydealdehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
1987199335.5low031000
adenine6-aminopurines;
purine nucleobase
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1987198936.0low020000
allantoinimidazolidine-2,4-dione;
ureas
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite;
vulnerary
1992199232.0low001000
ammonium hydroxideazane;
gas molecular entity;
mononuclear parent hydride
EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
1988200129.0low011100
arsenic acidarsenic oxoacidEscherichia coli metabolite1986198638.0low010000
quinacrineacridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
1983199437.2low082000
benzoic acidbenzoic acidsalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
1986199135.5low011000
bromidehalide anion;
monoatomic bromine
1995199529.0low001000
butyric acidfatty acid 4:0;
straight-chain saturated fatty acid
human urinary metabolite;
Mycoplasma genitalium metabolite
1988198836.0low010000
carbon monoxidecarbon oxide;
gas molecular entity;
one-carbon compound
biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
1987200829.0low021100
carnitineamino-acid betainehuman metabolite;
mouse metabolite
1990199432.3low003000
methanealkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound
bacterial metabolite;
fossil fuel;
greenhouse gas
1988198836.0low010000
cholinecholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
chlorinehalide anion;
monoatomic chlorine
cofactor;
Escherichia coli metabolite;
human metabolite
1983201429.4low367210
hydrochloric acidchlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite1984200431.8low040200
salicylic acidmonohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
1983201231.7low155010
phloroglucinolbenzenetriol;
phenolic donor
algal metabolite2009200915.0low000100
gallic acidtrihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
1981199636.0low075000
3-hydroxybutyric acid(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid
human metabolite1996199628.0low101000
n(1)-methylnicotinamidepyridinium ionalgal metabolite;
anti-inflammatory agent;
human urinary metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
201520168.5low000020
guaiacolguaiacolsdisinfectant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
expectorant;
plant metabolite
1984199037.7low021000
creatineglycine derivative;
guanidines;
zwitterion
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
1991199133.0low001000
lactic acid2-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
1982200932.2low3710100
dimethyl sulfoxidesulfoxide;
volatile organic compound
alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
1983200530.7low011100
glycinealpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
1983200430.6low022100
glycerolalditol;
triol
algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
1981199337.6low061000
hydrogen carbonatecarbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1984199435.9low062000
dalteparin2001200620.5low100200
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1981201333.8low12716410
hydrogenelemental hydrogen;
elemental molecule;
gas molecular entity
antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
1991199133.0low001000
imidazoleimidazole1981198938.9low0110000
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1987198737.0low010000
inositolcyclitol;
hexol
1984199633.2low022000
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
1986200628.0low010100
niacinamidepyridine alkaloid;
pyridinecarboxamide;
vitamin B3
anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
2007201611.3low000120
niacinpyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3
antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
1987200229.5low010100
nitratesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
1985201822.6low52101830
nitritesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
human metabolite1994201821.8low30151730
nitrous oxidegas molecular entity;
nitrogen oxide
analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
1986198638.0low110000
orotic acidpyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
1991199133.0low001000
4-aminobenzoic acidaminobenzoic acid;
aromatic amino-acid zwitterion
allergen;
Escherichia coli metabolite;
plant metabolite
1988198836.0low010000
palmitic acidlong-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
2008200816.0low000100
phenolphenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
1984198440.0low010000
1-propanolpropan-1-ols;
short-chain primary fatty alcohol
metabolite;
protic solvent
1993199829.0low103000
propionic acidsaturated fatty acid;
short-chain fatty acid
antifungal drug1989198935.0low010000
pyridoxinehydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2002200222.0low000100
pyruvic acid2-oxo monocarboxylic acidcofactor;
fundamental metabolite
1991199630.5low002000
sulfitesdivalent inorganic anion;
sulfur oxide;
sulfur oxoanion
1993199331.0low001000
succinic acidalpha,omega-dicarboxylic acid;
C4-dicarboxylic acid
anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
201620168.0low000010
taurineamino sulfonic acid;
zwitterion
antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
1987199831.8low022000
uric aciduric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
1983200831.4low233100
ureaisourea;
monocarboxylic acid amide;
one-carbon compound
Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1993199828.3low103000
xanthinexanthineSaccharomyces cerevisiae metabolite1989199532.0low012000
gallopamilbenzenes;
organic amino compound
1988199632.0low011000
1,2-dimethylhydrazinehydrazinesalkylating agent;
carcinogenic agent
1995199529.0low001000
1,2-dioctanoylglycerol1991199133.0low001000
1-anilino-8-naphthalenesulfonateaminonaphthalene;
naphthalenesulfonic acid
fluorescent probe1992199729.8low006000
14,15-epoxy-5,8,11-eicosatrienoic acidlong-chain fatty acid1989199731.7low012000
n-(3-(aminomethyl)benzyl)acetamidinearalkylamine;
carboxamidine;
primary amino compound
angiogenesis inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector
1998199826.0low001000
17-octadecynoic acidacetylenic fatty acid;
long-chain fatty acid;
monounsaturated fatty acid;
terminal acetylenic compound
EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor;
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor;
P450 inhibitor
1998199826.0low001000
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-oneoxadiazoloquinoxalineEC 4.6.1.2 (guanylate cyclase) inhibitor2003200321.0low000100
mercaptoethanolalkanethiol;
primary alcohol
geroprotector1991199133.0low001000
enprofyllineoxopurineanti-arrhythmia drug;
anti-asthmatic drug;
bronchodilator agent;
non-steroidal anti-inflammatory drug
1983198341.0low010000
4-aminopyridineaminopyridine;
aromatic amine
avicide;
orphan drug;
potassium channel blocker
2014201410.0low000010
phenytoinimidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
1982199237.0low011000
5,8,11,14-eicosatetraynoic acidlong-chain fatty acid1984198838.7low030000
5-carboxamidotryptaminetryptamines2001200421.5low000200
hydroxyindoleacetic acidindole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite
1995199529.0low001000
7-nitroindazole2014201410.0low000010
8-phenyltheophylline1987199632.5low011000
oxyquinolinemonohydroxyquinolineantibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator
1997199727.0low001000
aa 8611,4-benzoquinones;
acetylenic compound;
primary alcohol
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor
1986200330.5low023100
acetaminophenacetamides;
phenols
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1981201529.1low455410
acetazolamidemonocarboxylic acid amide;
sulfonamide;
thiadiazoles
anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
1999199925.0low001000
alprazolamorganochlorine compound;
triazolobenzodiazepine
anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
1984198440.0low110000
aluminum fluoridealuminium coordination entity1990199034.0low001000
am 251amidopiperidine;
carbohydrazide;
dichlorobenzene;
organoiodine compound;
pyrazoles
antidepressant;
antineoplastic agent;
apoptosis inducer;
CB1 receptor antagonist
2007200717.0low000100
diatrizoic acidacetamides;
benzoic acids;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
1985198638.5low020000
aminoglutethimidedicarboximide;
piperidones;
substituted aniline
adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
1983198341.0low010000
pimagedineguanidines;
one-carbon compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
2002200222.0low000100
p-aminohippuric acidN-acylglycineDaphnia magna metabolite1984200133.6low435100
ampyroneprimary amino compound;
pyrazolone
antipyretic;
antirheumatic drug;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
marine xenobiotic metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
1986198638.0low010000
theophyllinedimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
1983199735.0low063000
amlodipinedihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound
antihypertensive agent;
calcium channel blocker;
vasodilator agent
1995199628.3low303000
antipyrinepyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1986200633.0low030100
apraclonidinedichlorobenzene;
guanidines;
imidazolines
alpha-adrenergic agonist;
antiglaucoma drug;
beta-adrenergic agonist;
diagnostic agent;
ophthalmology drug
1987198737.0low010000
arecolineenoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine
metabolite;
muscarinic agonist
1991199133.0low002000
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
1996200026.0low002000
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
2006200618.0low000200
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
1980201931.8low4312310330110
astemizolebenzimidazoles;
piperidines
anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
1995199529.0low001000
atenololethanolamines;
monocarboxylic acid amide;
propanolamine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
1984199437.2low031000
azathioprinearyl sulfide;
C-nitro compound;
imidazoles;
thiopurine
antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
1987201825.8low212010
azelastinemonochlorobenzenes;
phthalazines;
tertiary amino compound
anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
1990199034.0low001000
bay-k-8644(trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester
1995200224.7low001200
bendroflumethiazidebenzothiadiazine;
sulfonamide
antihypertensive agent;
diuretic
1981199635.5low111000
benzethoniumalkylbenzene1985198539.0low010000
benzo(a)pyreneortho- and peri-fused polycyclic arenecarcinogenic agent;
mouse metabolite
1993199331.0low003000
bepridilpyrrolidines;
tertiary amine
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
1994199430.0low101000
berberinealkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound
antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
1991200029.5low004000
beta-naphthoflavoneextended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound
aryl hydrocarbon receptor agonist1986198638.0low010000
bethanecholcarbamate ester;
quaternary ammonium ion
muscarinic agonist1984198440.0low010000
bisindolylmaleimide i2004200420.0low000100
seratrodastorganic molecular entity1990199929.0low104000
bumetanideamino acid;
benzoic acids;
sulfonamide
diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
1988199433.0low011000
bupivacainearomatic amide;
piperidinecarboxamide;
tertiary amino compound
1989198935.0low010000
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
1988200428.3low014100
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
1981200634.6low21610100
calmidazoliumimidazolium ionapoptosis inducer;
calmodulin antagonist
1985198539.0low020000
camostatbenzoate ester;
carboxylic ester;
diester;
guanidines;
tertiary carboxamide
anti-inflammatory agent;
anticoronaviral agent;
antifibrinolytic drug;
antihypertensive agent;
antineoplastic agent;
antiviral agent;
serine protease inhibitor
1988198836.0low010000
carprofencarbazoles;
organochlorine compound
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug;
photosensitizing agent
1985198539.0low010000
carvedilolcarbazoles;
secondary alcohol;
secondary amino compound
alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
2006200618.0low000100
celecoxiborganofluorine compound;
pyrazoles;
sulfonamide;
toluenes
cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1998201618.2low4051260
celiprololaromatic ketone1999199925.0low001000
cgs 15943aromatic amine;
biaryl;
furans;
organochlorine compound;
primary amino compound;
quinazolines;
triazoloquinazoline
adenosine A1 receptor antagonist;
adenosine A2A receptor antagonist;
antineoplastic agent;
central nervous system stimulant
1994201420.0low001010
chelerythrinebenzophenanthridine alkaloid;
organic cation
antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
2000200024.0low001000
chloroquineaminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
1988199234.0low011000
chlorpheniraminemonochlorobenzenes;
pyridines;
tertiary amino compound
anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
2005200519.0low000100
chlorpropamidemonochlorobenzenes;
N-sulfonylurea
hypoglycemic agent;
insulin secretagogue
1981198441.5low120000
cilostamidequinolines1989199034.5low011000
cilostazollactam;
tetrazoles
anticoagulant;
bronchodilator agent;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
fibrin modulating drug;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
1990199233.0low002000
cimetidinealiphatic sulfide;
guanidines;
imidazoles;
nitrile
adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
1984199734.1low055000
ciprofloxacinaminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion
antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
1997199727.0low001000
clonidineclonidine;
imidazoline
1984198738.5low020000
clotrimazoleconazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
antiinfective agent;
environmental contaminant;
xenobiotic
1991199133.0low001000
cyclandelatecarboxylic ester;
secondary alcohol
vasodilator agent1987198737.0low010000
cyproheptadinepiperidines;
tertiary amine
anti-allergic agent;
antipruritic drug;
gastrointestinal drug;
H1-receptor antagonist;
serotonergic antagonist
1992199431.0low002000
dantrolenehydrazone;
imidazolidine-2,4-dione
muscle relaxant;
neuroprotective agent;
ryanodine receptor antagonist
1985198837.3low030000
deferoxamineacyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
1988198836.0low010000
eflornithinealpha-amino acid;
fluoroamino acid
trypanocidal drug1992199232.0low001000
diazepam1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
1982198242.0low010000
diazoxidebenzothiadiazine;
organochlorine compound;
sulfone
antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent
2004200420.0low000100
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1985201527.1low2712910
diethylcarbamazineN-carbamoylpiperazine;
N-methylpiperazine
1985201332.6low052010
pentetic acidpentacarboxylic acidcopper chelator1987198836.5low020000
dimethoatemonocarboxylic acid amide;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
2010201014.0low000100
diphenhydramineether;
tertiary amino compound
anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
1990199432.0low002000
dipyridamolepiperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
1981199936.6low3176000
disopyramidemonocarboxylic acid amide;
pyridines;
tertiary amino compound
anti-arrhythmia drug1996199628.0low001000
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
1993199331.0low001000
racemetirosine1992199232.0low001000
thiorphanN-acyl-amino acid2002200222.0low000100
dup 697thiophenes2009200915.0low000100
econazoledichlorobenzene;
ether;
imidazoles;
monochlorobenzenes
2003200321.0low000100
emodintrihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
1997199727.0low001000
enfluraneether;
organochlorine compound;
organofluorine compound
anaesthetic1987198737.0low010000
epirizolearomatic ether1986198638.0low010000
erythrosine1984200331.2low012100
ethacrynic acidaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid
EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
1981199335.2low013000
eicosapentaenoic acid ethyl ester1982199436.0low011000
etodolacmonocarboxylic acid;
organic heterotricyclic compound
antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1985200233.5low041100
famotidine1,3-thiazoles;
guanidines;
sulfonamide
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
2005200718.0low000200
felodipinedichlorobenzene;
dihydropyridine;
ethyl ester;
methyl ester
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
1993199331.0low101000
fentanylanilide;
monocarboxylic acid amide;
piperidines
adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
1986198638.0low110000
fleroxacindifluorobenzene;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
quinolines
antibacterial drug;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
1997199727.0low001000
flufenamic acidaromatic amino acid;
organofluorine compound
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1985198539.0low010000
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
1986200727.2low012100
flurbiprofenfluorobiphenyl;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1984201725.1low323120
fp 83organic molecular entity201220179.5low200020
fomepizolepyrazolesantidote;
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor;
protective agent
1993199331.0low001000
furegrelatebenzofurans1986199335.6low073000
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
1982200833.6low7179300
gabexatebenzoate ester1988199333.5low011000
gemfibrozilaromatic etherantilipemic drug1998199826.0low001000
gentamicin1985199832.5low011000
glutaraldialdehydecross-linking reagent;
disinfectant;
fixative
1994199430.0low001000
glyburidemonochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
1984201428.8low031110
gossypol1991199133.0low003000
guaifenesinmethoxybenzenes1986199334.8low022000
guanidinecarboxamidine;
guanidines;
one-carbon compound
1997199727.0low001000
1-(5-isoquinolinesulfonyl)-2-methylpiperazineisoquinolines;
N-sulfonylpiperazine
EC 2.7.11.13 (protein kinase C) inhibitor1989199531.0low012000
halothanehaloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound
inhalation anaesthetic1985198837.3low030000
hexahydrosiladifenidol1991199133.0low001000
hexamethoniumquaternary ammonium salt1991199133.0low001000
hydralazineazaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines
antihypertensive agent;
vasodilator agent
1983198539.7low030000
hydrochlorothiazidebenzothiadiazine;
organochlorine compound;
sulfonamide
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
1983199835.7low342000
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
1987201623.7low011010
ibudilastpyrazolopyridine1986201225.0low010010
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
1981201034.8low95420400
lidocainebenzenes;
monocarboxylic acid amide;
tertiary amino compound
anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
1980199933.8low144000
amrinonebipyridinesEC 3.1.4.* (phosphoric diester hydrolase) inhibitor1983198639.5low020000
indapamideindoles;
organochlorine compound;
sulfonamide
antihypertensive agent;
diuretic
1993199331.0low001000
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1980201733.4low283031965760
indoprofengamma-lactam;
isoindoles;
monocarboxylic acid
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1981198143.0low010000
1-methyl-3-isobutylxanthine3-isobutyl-1-methylxanthine1981201634.5low093010
isofluraneorganofluorine compoundinhalation anaesthetic1987200428.5low110100
2-propanolsecondary alcohol;
secondary fatty alcohol
protic solvent1984199835.1low052000
isoproterenolcatechols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
1981200735.2low01710200
isradipinebenzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester
1991199829.5low102000
staurosporine aglycone1990199034.0low001000
ketanserinaromatic ketone;
organofluorine compound;
piperidines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
1984199136.7low021000
ketoconazoledichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
1984200233.7low120100
ketoprofenbenzophenones;
oxo monocarboxylic acid
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
1990199631.0low002000
ketorolacamino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate
analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2000200024.0low001000
ketotifencyclic ketone;
olefinic compound;
organic heterotricyclic compound;
organosulfur heterocyclic compound;
piperidines;
tertiary amino compound
anti-asthmatic drug;
H1-receptor antagonist
1995199529.0low001000
3-phenyllactic acid2-hydroxy monocarboxylic acidhuman metabolite1986198638.0low010000
labetalolbenzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
1986198638.0low110000
lauric acidmedium-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
antibacterial agent;
plant metabolite
1993201321.0low101010
leflunomide(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide
antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
1999201815.5low101010
losartanbiphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
1994200623.7low003300
loxoprofencyclopentanones;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
1991199133.0low001000
ly 171883acetophenones;
aromatic ether;
phenols;
tetrazoles
anti-asthmatic drug;
leukotriene antagonist
1988199035.0low021000
6-anilino-5,8-quinolinedioneaminoquinoline;
aromatic amine;
p-quinones;
quinolone
antineoplastic agent;
EC 4.6.1.2 (guanylate cyclase) inhibitor
2003200321.0low000100
mechlorethaminenitrogen mustard;
organochlorine compound
alkylating agent1987199929.0low013000
meclofenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1981200136.4low02710100
mefenamic acidaminobenzoic acid;
secondary amino compound
analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
1984198539.5low020000
mesalamineamino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug1989199731.2low015000
metaproterenolaralkylamino compound;
phenylethanolamines;
resorcinols;
secondary alcohol;
secondary amino compound
1989198935.0low010000
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
1985198539.0low010000
methoxyfluraneether;
organochlorine compound;
organofluorine compound
hepatotoxic agent;
inhalation anaesthetic;
nephrotoxic agent;
non-narcotic analgesic
1990199034.0low001000
metoclopramidebenzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound
antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
1989198935.0low120000
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
1986199930.8low315000
metyraponearomatic ketoneantimetabolite;
diagnostic agent;
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
1991199133.0low001000
mexiletinearomatic ether;
primary amino compound
anti-arrhythmia drug1996199628.0low001000
miconazoledichlorobenzene;
ether;
imidazoles
2003200321.0low000100
midazolamimidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
2000201218.0low201010
milrinonebipyridines;
nitrile;
pyridone
cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
2000200024.0low001000
minoxidildialkylarylamine;
tertiary amino compound
1988199434.0low021000
mofezolacmethoxybenzenes1998199826.0low001000
molsidomineethyl ester;
morpholines;
oxadiazole;
zwitterion
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
1983200328.6low015200
n-(6-aminohexyl)-1-naphthalenesulfonamidenaphthalenes;
sulfonic acid derivative
1985198539.0low010000
ethylmaleimidemaleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
1980199137.7low021000
apneapurine nucleoside1999199925.0low001000
nabumetonemethoxynaphthalene;
methyl ketone
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
1987199930.6low116000
nafamostatbenzoic acids;
guanidines
1997199727.0low001000
nafronylnaphthalenes1993199331.0low001000
nicardipinebenzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
1986199733.2low133000
niceritrolorganic molecular entity1987198737.0low010000
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
1982200433.0low31114200
niflumic acidaromatic carboxylic acid;
pyridines
1984198440.0low010000
nilvadipinedihydropyridine;
isopropyl ester;
methyl ester;
nitrile
1994199430.0low001000
nimesulidearomatic ether;
C-nitro compound;
sulfonamide
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
1996200823.0low404600
nimodipine2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
1985199834.4low043000
nisoldipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
methyl ester
1985199734.4low123000
nitrendipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester
antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
1990199034.0low001000
nitroglycerinnitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
1982199935.4low0116000
nizofenonebenzophenones1999199925.0low001000
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamidearomatic ether;
C-nitro compound;
sulfonamide
antineoplastic agent;
cyclooxygenase 2 inhibitor
1993200922.7low00192200
nylidrinalkylbenzene1992199232.0low001000
ofloxacin3-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
1997199727.0low001000
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
1992201522.7low002010
oxonic acid1,3,5-triazines;
monocarboxylic acid
2008200816.0low000100
oxidopaminebenzenetriol;
catecholamine;
primary amino compound
drug metabolite;
human metabolite;
neurotoxin
1985199235.3low021000
oxyphenbutazonephenols;
pyrazolidines
antimicrobial agent;
antineoplastic agent;
antipyretic;
drug metabolite;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite
1984198440.0low010000
papaverinebenzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
1984199534.4low034000
pd 98059aromatic amine;
monomethoxyflavone
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
1999200621.5low001100
pentobarbitalbarbituratesGABAA receptor agonist1990199034.0low001000
pentoxifyllineoxopurine1984199732.4low159000
phenoxybenzaminearomatic amine1982198939.0low050000
oxophenylarsinearsine oxidesantineoplastic agent;
apoptosis inducer;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
1991199133.0low001000
phenylbutazonepyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
1984199635.6low052000
picotamidebenzamides1988199731.5low111000
pimobendanbenzimidazoles;
pyridazinone
cardiotonic drug;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
1986198638.0low010000
pindololindoles;
secondary amine
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
1990199034.0low001000
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2008200816.0low000100
pirenzepinepyridobenzodiazepineanti-ulcer drug;
antispasmodic drug;
muscarinic antagonist
1986198638.0low110000
piretanidearomatic ether1989198935.0low010000
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer1983200232.6low022100
4-aminobenzoic acidaminobenzoate;
aromatic amino-acid anion
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1988198836.0low010000
practololacetamides;
ethanolamines;
propanolamine;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug;
beta-adrenergic antagonist
1983198440.5low020000
ono 1078chromones1991199133.0low001000
prazosinaromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
1982199436.6low053000
prilocaineamino acid amide;
monocarboxylic acid amide
anticonvulsant;
local anaesthetic
1999199925.0low001000
proadifendiarylmethane1989200328.0low010100
probenecidbenzoic acids;
sulfonamide
uricosuric drug1983198639.5low020000
proglumetacinaromatic ether;
benzamides;
carboxylic ester;
monochlorobenzenes;
N-acylindole;
N-alkylpiperazine
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
1986198638.0low010000
propofolphenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
2003200619.5low100200
propranololnaphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
1981200135.7low22010100
propyl gallatetrihydroxybenzoic acid1983198341.0low010000
pyrilaminearomatic ether;
ethylenediamine derivative
H1-receptor antagonist1985199733.2low013000
rabeprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2007200717.0low000100
opc 12759secondary carboxamide1993199331.0low001000
pf 5901quinolines2002200222.0low000100
ro 31-8220imidothiocarbamic ester;
indoles;
maleimides
EC 2.7.11.13 (protein kinase C) inhibitor1998199826.0low001000
rofecoxibbutenolide;
sulfone
analgesic;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
1999200721.0low301600
roliprampyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
2012201212.0low000010
s-methylisothiopseudouronium2006200618.0low000100
sb 202190imidazoles;
organofluorine compound;
phenols;
pyridines
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2006200618.0low000100
linsidominemorpholines1992200327.7low005100
sodium fluoridefluoride saltmutagen1984199035.4low023000
ponalrestatphthalazines1991199133.0low001000
stearic acidlong-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
1984200131.3low211100
sulfaphenazoleprimary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor
2005200519.0low000100
sulfapyridinepyridines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic
1991199133.0low001000
sulfasalazine1991199133.0low001000
sulfinpyrazonepyrazolidines;
sulfoxide
uricosuric drug1981198541.0low020000
suprofenaromatic ketone;
monocarboxylic acid;
thiophenes
antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
1987200728.7low211100
theobrominedimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
1984200135.0low251100
tiaprofenic acidaromatic ketone;
monocarboxylic acid;
thiophenes
drug allergen;
non-steroidal anti-inflammatory drug
1985199636.8low041000
ticlopidinemonochlorobenzenes;
thienopyridine
anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
1984201828.1low153120
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoatetrihydroxybenzoic acid1981199635.5low065000
tolazolineimidazolesalpha-adrenergic antagonist;
antihypertensive agent;
vasodilator agent
1984198440.0low010000
tolmetinaromatic ketone;
monocarboxylic acid;
pyrroles
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1988199532.5low011000
tranexamic acidamino acid1987198737.0low010000
trapidiltriazolopyrimidines1981199535.2low153000
trifluoperazineN-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines
antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
1983199137.8low072000
w 71985199137.5low031000
ici 204,219carbamate ester;
indoles;
N-sulfonylcarboxamide
anti-asthmatic agent;
leukotriene antagonist
2000200024.0low001000
zomepiracaromatic ketone;
monocarboxylic acid;
monochlorobenzenes;
pyrroles
cardiovascular drug;
non-steroidal anti-inflammatory drug
1988198836.0low010000
mitomycinmitomycinalkylating agent;
antineoplastic agent
1988199234.0low011000
corticosterone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1979201731.5low045010
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
1985199734.5low042000
estriol16alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid
estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
1992199232.0low001000
reserpinealkaloid ester;
methyl ester;
yohimban alkaloid
adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
1982198242.0low010000
phentolamineimidazoles;
phenols;
substituted aniline;
tertiary amino compound
alpha-adrenergic antagonist;
vasodilator agent
1983199634.8low045000
sorbitolglucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
1989199730.0low012000
alloxanpyrimidonehyperglycemic agent;
metabolite
1992201321.0low001110
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1987199831.2low024000
hydroxyproline4-hydroxyproline;
L-alpha-amino acid zwitterion
human metabolite;
mouse metabolite;
plant metabolite
1983199636.8low031000
thyroxine2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine
antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
1985199834.2low031000
carbacholammonium salt;
carbamate ester
cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
1980199836.5low042000
norethindrone acetate3-oxo-Delta(4) steroid;
acetate ester;
terminal acetylenic compound
progestin;
synthetic oral contraceptive
2000200024.0low101000
spironolactone3-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester
aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
1986198638.0low010000
aldosterone11beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde
human metabolite;
mouse metabolite
1983201432.8low102915320
penicillaminenon-proteinogenic alpha-amino acid;
penicillamine
antirheumatic drug;
chelator;
copper chelator;
drug allergen
1987199632.5low011000
lynestrenolsteroid1990199034.0low001000
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
1984201827.6low213010
estrone17-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols
antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
1981199238.5low031000
dehydroepiandrosterone17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid
androgen;
human metabolite;
mouse metabolite
1984199534.5low011000
penicillin gpenicillin allergen;
penicillin
antibacterial drug;
drug allergen;
epitope
1988198836.0low010000
pentylenetetrazoleorganic heterobicyclic compound;
organonitrogen heterocyclic compound
2014201410.0low000010
triiodothyronine2-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine
human metabolite;
mouse metabolite;
thyroid hormone
1985199833.3low021000
isoflurophatedialkyl phosphate2001200123.0low000100
carbon tetrachloridechlorocarbon;
chloromethanes
hepatotoxic agent;
refrigerant
1988201423.5low011110
alaninealanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
1988199333.5low011000
serineL-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1988198836.0low010000
aspartic acidaspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
1989201225.0low011010
glutamineamino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2001200919.0low000200
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1985199833.0low023000
cyanidespseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor1987198737.0low010000
physostigminecarbamate ester;
indole alkaloid
antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
1990199034.0low001000
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1981198143.0low010000
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1981200232.5low010100
ethinyl estradiol17-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound
xenoestrogen1983199932.0low215000
tubocurarinebisbenzylisoquinoline alkaloiddrug allergen;
muscle relaxant;
nicotinic antagonist
1984199037.0low011000
aminopyrinepyrazolone;
tertiary amino compound
antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1985200630.7low020100
puromycin aminonucleoside3'-deoxyribonucleoside;
adenosines
1982199137.0low021000
adenosine diphosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
fundamental metabolite;
human metabolite
1980201332.3low62821630
galactoseD-galactose;
galactopyranose
Escherichia coli metabolite;
mouse metabolite
1989198935.0low010000
carbostyrilmonohydroxyquinoline;
quinolone
bacterial xenobiotic metabolite1989200031.2low014000
phenylephrinephenols;
phenylethanolamines;
secondary amino compound
alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
1982202028.0low045120
edetic acidethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid
anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
1986201324.5low010010
phenylethyl alcoholbenzenes;
primary alcohol
Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
2009200915.0low000100
tyrosineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
2011201710.0low000020
cysteamineamine;
thiol
geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
1986199335.2low031000
methoxamineamphetaminesalpha-adrenergic agonist;
antihypotensive agent
1989200327.7low011100
adenosine monophosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
1984198440.0low010000
methylene blueorganic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
1986200230.4low024100
leucineamino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1993199728.7low003000
methacholine chloridequaternary ammonium salt1988199832.8low022000
androstenedione17-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
1985199035.7low012000
uridine triphosphatepyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate
Escherichia coli metabolite;
mouse metabolite
1996199628.0low001000
1,2-dipalmitoylphosphatidylcholine1997199727.0low001000
desoxycorticosterone20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1985199833.3low033000
colchicinealkaloid;
colchicine
anti-inflammatory agent;
gout suppressant;
mutagen
1986199135.5low011000
strophanthidin14beta-hydroxy steroid;
19-oxo steroid;
3beta-hydroxy steroid;
5beta-hydroxy steroid;
cardenolides;
steroid aldehyde
1986198638.0low010000
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1980199934.0low01813000
egtazic aciddiether;
tertiary amino compound;
tetracarboxylic acid
chelator1985199633.3low033000
dimethyl sulfonesulfone1983198341.0low010000
norethindrone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol
progestin;
synthetic oral contraceptive
1984200030.0low314000
tubercidinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
1981198143.0low010000
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
1991200227.5low001100
medroxyprogesterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester
adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
1985201623.5low010010
valineL-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2001200123.0low000100
mestranol17beta-hydroxy steroid;
aromatic ether;
terminal acetylenic compound
prodrug;
xenoestrogen
1990199233.0low002000
tryptophanerythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan
antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1981200428.4low013100
n,n'-diphenyl-4-phenylenediamineN-substituted diamine;
secondary amino compound
antioxidant1983198341.0low010000
argininearginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1988200629.6low2132300
phosgeneacyl chloride1996199628.0low001000
tert-butylhydroperoxidealkyl hydroperoxideantibacterial agent;
oxidising agent
1983199834.7low042000
phencyclidinebenzenes;
piperidines
anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
1989198935.0low010000
tromethamineprimary amino compound;
triol
buffer1981199733.0low012000
taurocholic acidamino sulfonic acid;
bile acid taurine conjugate
human metabolite1984200930.5low057200
skatolemethylindolehuman metabolite;
mammalian metabolite
1989199333.0low011000
methylprednisolone6-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
1981200434.3low1107100
isosorbide dinitrateglucitol derivative;
nitrate ester
nitric oxide donor;
vasodilator agent
1984198738.5low060000
thymolmonoterpenoid;
phenols
volatile oil component1984198440.0low010000
quinoxalinesmancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
2003200321.0low000100
phenidone1991200028.5low002000
xanthenesxanthene2001200123.0low000100
quinuclidinesquinuclidines;
saturated organic heterobicyclic parent
2006200618.0low000100
pyrrolespyrrole;
secondary amine
2005200817.0low000500
thiophenesmancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound
non-polar solvent1984200932.5low032100
1-hexanolhexanol;
primary alcohol
alarm pheromone;
antibacterial agent;
fragrance;
plant metabolite
1992199232.0low001000
ergotaminepeptide ergot alkaloidalpha-adrenergic agonist;
mycotoxin;
non-narcotic analgesic;
oxytocic;
serotonergic agonist;
vasoconstrictor agent
1983198639.5low020000
methylergonovineergoline alkaloid1983198341.0low010000
framycetinaminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
1990199631.7low003000
pyrazolanthroneanthrapyrazole;
aromatic ketone;
cyclic ketone
antineoplastic agent;
c-Jun N-terminal kinase inhibitor;
geroprotector
2005200519.0low000100
diatrizoate megluminemonocarboxylic acid anionradioopaque medium1985198638.7low030000
megluminehexosamine;
secondary amino compound
1985198539.0low010000
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1988198836.0low010000
shikimic acidalpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2002200321.5low000200
ethyl acetateacetate ester;
ethyl ester;
volatile organic compound
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
1990199034.0low001000
pregnenolone20-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid
human metabolite;
mouse metabolite
1983199336.0low011000
20-alpha-dihydroprogesterone20-hydroxypregn-4-en-3-onehuman metabolite;
mouse metabolite
1983198341.0low010000
yohimbinemethyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
1982200134.6low042100
potassium cyanidecyanide salt;
one-carbon compound;
potassium salt
EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin
1987198737.0low010000
dydrogesterone20-oxo steroid;
3-oxo-Delta(4) steroid
progestin2006200618.0low100100
catechincatechinantioxidant;
plant metabolite
2001201616.8low100320
quinazolinesazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
1982201431.3low041110
indazolesindazole2014201410.0low000010
cyclopentanecycloalkane;
cyclopentanes;
volatile organic compound
non-polar solvent1997199727.0low001000
isoxazolesisoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1998201818.8low202110
oxazoles1,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1984198440.0low010000
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1999200822.6low104100
pyrazinesdiazine;
pyrazines
Daphnia magna metabolite1990201626.4low4015310
triphenyltetrazoliumorganic cation2004200420.0low000100
calcium gluconatecalcium saltnutraceutical1985199036.5low011000
muscarinemonosaccharide1986198638.0low010000
hydrazineazane;
hydrazines
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor1985201231.5low045010
monocrotalinepyrrolizidine alkaloid1985201625.6low045230
triflusalbenzoic acids;
carboxylic ester;
salicylates
1985199334.0low113000
methysergideergoline alkaloid1986198638.0low010000
phenylbenzoquinone1998199826.0low001000
betamethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
1981198143.0low110000
5-methylpyrazole-3-carboxylic acidmonocarboxylic acid;
pyrazoles
metabolite1982198242.0low010000
cyanamidenitrile;
one-carbon compound
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor1987198737.0low010000
cyproterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
chlorinated steroid;
steroid ester
androgen antagonist;
geroprotector;
progestin
1989198935.0low010000
fluorobenzenesmonofluorobenzenesNMR chemical shift reference compound2013201311.0low000010
rheindihydroxyanthraquinone1989198935.0low110000
dihydralazinephthalazines1984199635.7low021000
sodium carbonatecarbonate salt;
organic sodium salt
1987198737.0low010000
phoronedialkenyl ketone1993199331.0low001000
alpha-aminopyridine1983198639.5low020000
dihydroergotamineergot alkaloid;
semisynthetic derivative
dopamine agonist;
non-narcotic analgesic;
serotonergic agonist;
sympatholytic agent;
vasoconstrictor agent
1988198836.0low010000
medroxyprogesterone17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone
contraceptive drug;
progestin;
synthetic oral contraceptive
1985198539.0low010000
dihydrotestosterone17beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
2007200717.0low000100
gluconic acidgluconic acidchelator;
Penicillium metabolite
1997199727.0low101000
copper gluconateorganic molecular entity1984199735.0low122000
methoxyhydroxyphenylglycolmethoxybenzenes;
phenols
1984198440.0low110000
muscone2006200618.0low000200
malondialdehydedialdehydebiomarker1984201926.5low110271260
3-hexen-1-olalkenyl alcohol;
homoallylic alcohol;
primary alcohol;
volatile organic compound
plant metabolite1992199232.0low001000
myristic acidlong-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite
1989199333.0low111000
n-hexadecanelong-chain alkanenon-polar solvent;
plant metabolite;
volatile oil component
1990199034.0low001000
trinitrobenzenesulfonic acidarenesulfonic acid;
C-nitro compound
epitope;
explosive;
reagent
1990201425.2low003010
3-hydroxyflavoneflavonols;
monohydroxyflavone
1993199729.0low002000
alpha-naphthoflavoneextended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound
aryl hydrocarbon receptor agonist;
aryl hydrocarbon receptor antagonist;
EC 1.14.14.14 (aromatase) inhibitor
1989198935.0low010000
erythromycincyclic ketone;
erythromycin
2000200024.0low001000
dehydroepiandrosterone sulfate17-oxo steroid;
steroid sulfate
EC 2.7.1.33 (pantothenate kinase) inhibitor;
human metabolite;
mouse metabolite
1984199534.5low011000
chromonarcoumarins1982199137.8low041000
methylnitrosoureaN-nitrosoureasalkylating agent;
carcinogenic agent;
mutagen;
teratogenic agent
1983198341.0low010000
levonorgestrel17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound
contraceptive drug;
female contraceptive drug;
progestin;
synthetic oral contraceptive
1984199534.2low123000
2-cyclohexen-1-onecyclohexenone1984198440.0low010000
dimethoxonorganic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
2010201014.0low000100
tetramethylpyrazinealkaloid;
pyrazines
antineoplastic agent;
apoptosis inhibitor;
bacterial metabolite;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
1991200627.7low3014200
3,4-dihydroxyacetophenoneacetophenones;
catechols;
dihydroxyacetophenone
metabolite1989199333.0low011000
durapatite2004200420.0low000100
sodium hydroxidealkali metal hydroxide1984198639.0low020000
d-alpha tocopherolalpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
1981200433.2low31318100
tocopherols1981198342.0low020000
methyl tert-butyl etheretherfuel additive;
metabolite;
non-polar solvent
1990199034.0low001000
paraquatorganic cationgeroprotector;
herbicide
1986199235.0low022000
amiloridearomatic amine;
guanidines;
organochlorine compound;
pyrazines
diuretic;
sodium channel blocker
1986198737.5low120000
methylprednisolone hemisuccinatecorticosteroid hormone;
hemisuccinate
1985199036.5low011000
c.i. direct blue 11996199628.0low001000
ethamsylateorganosulfur compound;
sulfonic acid derivative
1986198638.0low110000
nitrohydroxyiodophenylacetate2-nitrophenols;
organoiodine compound;
phenylacetic acids
antigen1997199727.0low001000
fluorescein-5-isothiocyanatefluorescein isothiocyanate1984198440.0low010000
sabinenethujeneplant metabolite2007200717.0low000100
mannoseD-aldohexose;
D-mannose;
mannopyranose
metabolite1988198836.0low010000
tranylcypromine2-phenylcyclopropan-1-amine1981200436.1low072100
carbonatescarbon oxoanion1987199035.5low011000
iodinated glyceroldioxolane1985198539.0low010000
carbaspirin calcium1996199628.0low101000
n-methylaspartateamino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound
neurotransmitter agent1989199929.8low013000
3-deazaadenosine1981198143.0low010000
manganeseelemental manganese;
manganese group element atom
Escherichia coli metabolite;
micronutrient
1998199826.0low001000
mercuryelemental mercury;
zinc group element atom
neurotoxin202120213.0low000001
technetiummanganese group element atom1987198737.0low010000
cadmiumcadmium molecular entity;
zinc group element atom
1982199833.3low012000
vanadiumelemental vanadium;
vanadium group element atom
micronutrient1983198341.0low010000
magnesium sulfatemagnesium salt;
metal sulfate;
organic magnesium salt
anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent
1983200029.6low116000
mercuric chloridemercury coordination entitysensitiser1987198936.0low030000
galactosamineD-galactosamine;
primary amino compound
toxin1987199433.0low013000
hypochlorous acidchlorine oxoacid;
reactive oxygen species
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
1996199628.0low001000
ferric chlorideiron coordination entityastringent;
Lewis acid
2007201414.0low000210
deuteriumdihydrogen1980199638.4low041000
fluorinediatomic fluorine;
gas molecular entity
NMR chemical shift reference compound1989198935.0low010000
chlorinediatomic chlorine;
gas molecular entity
bleaching agent1990199034.0low001000
ozoneelemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen
antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
1987199732.2low113000
sodium seleniteinorganic sodium salt;
selenite salt
nutraceutical1999199925.0low001000
trolamine salicylate1989199830.0low313000
sodium tungstate(vi)inorganic sodium saltreagent2010201014.0low000100
apazonebenzotriazinesnon-steroidal anti-inflammatory drug;
uricosuric drug
1993199331.0low101000
diacereinanthraquinone1989198935.0low110000
tiletamine hydrochloride1984198440.0low010000
cromolyn sodiumorganic sodium saltanti-asthmatic drug;
drug allergen
1987198737.0low010000
isosorbide-5-mononitrateglucitol derivative;
nitrate ester
nitric oxide donor;
vasodilator agent
1985198738.0low020000
tetradecanoylphorbol acetateacetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester
antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
1980199833.5low01926000
fluorideshalide anion;
monoatomic fluorine
1989199532.7low012000
clonixinaminopyridine;
organochlorine compound;
pyridinemonocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
vasodilator agent
1982199835.8low0103000
dibenz(b,f)(1,4)oxazepine-10(11h)-carboxylic acid, 8-chloro-, 2-acetylhydrazide2004200420.0low000100
iodinehalide anion;
monoatomic iodine
human metabolite1981198143.0low010000
phosphotyrosineL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid;
O(4)-phosphotyrosine
Escherichia coli metabolite;
immunogen
1996199827.0low002000
phenyl acetatebenzenes;
phenyl acetates
1985201629.9low043110
isothiuronium2006200618.0low000100
proquazonepyrimidines1985200330.0low010100
4-methoxyamphetamine1998199826.0low001000
du-21220benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
1983198838.5low140000
8-bromo cyclic adenosine monophosphate3',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
organobromine compound
antidepressant;
protein kinase agonist
1981198938.2low050000
6-methoxy-2-naphthylacetic acidmethoxynaphthalene;
monocarboxylic acid
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
xenobiotic metabolite
1990199233.0low002000
transferrin1992199232.0low001000
alkenes1994199430.0low001000
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
1989199432.0low012000
bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide1992199232.0low001000
adenosine diphosphate riboseADP-sugarEscherichia coli metabolite;
mouse metabolite
1986198638.0low010000
timololtimololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
1984198639.0low120000
almitrinepiperazines;
triamino-1,3,5-triazine
central nervous system stimulant1983198838.2low040000
vanadyl sulfatemetal sulfate;
vanadium coordination entity
2010201014.0low000100
nicergolineorganic heterotetracyclic compound;
organonitrogen heterocyclic compound
1990199034.0low001000
dehydrocorydalinalkaloid1989198935.0low010000
3,4,3',4'-tetrachlorobiphenyldichlorobenzene;
tetrachlorobiphenyl
1986198638.0low010000
3,4,5,3',4',5'-hexachlorobiphenylhexachlorobiphenyl;
trichlorobenzene
1986198638.0low010000
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
1987200629.2low029200
imidazole-2-hydroxybenzoate1992199232.0low101000
phorbol 12,13-dibutyratebutyrate ester;
phorbol ester;
tertiary alpha-hydroxy ketone
1991200427.0low002100
flunixinaminopyridine;
organofluorine compound;
pyridinemonocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1985198539.0low010000
diltiazem5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
1984199734.0low158000
flunixin meglumineorganoammonium saltantipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1982199737.2low091000
vecuronium bromideorganic bromide salt;
quaternary ammonium salt
muscle relaxant;
neuromuscular agent;
nicotinic antagonist
2000200024.0low101000
ng-nitroarginine methyl esteralpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor1992201523.3low00181710
dexibuprofenibuprofennon-narcotic analgesic;
non-steroidal anti-inflammatory drug
2010201014.0low000100
benoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
monochlorobenzenes
antipsoriatic;
antipyretic;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
hepatotoxic agent;
nephrotoxin;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
1984199336.3low021000
desogestrel17beta-hydroxy steroid;
terminal acetylenic compound
contraceptive drug;
progestin;
synthetic oral contraceptive
1987198737.0low010000
torsemideaminopyridine;
N-sulfonylurea;
secondary amino compound
antihypertensive agent;
loop diuretic
1999199925.0low001000
epirubicinaminoglycoside;
anthracycline antibiotic;
anthracycline;
deoxy hexoside;
monosaccharide derivative;
p-quinones;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
antimicrobial agent;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
1989198935.0low010000
prenalterolaromatic ether1983198341.0low010000
nufenoxole1984198440.0medium010000
enkephalin, methionine1987199632.3low012000
nafazatrom1983198739.1medium1100000
nitrosobis(2-oxopropyl)amineketone;
nitrosamine
carcinogenic agent2000200024.0low001000
orpanoxin1993199331.0medium001000
captoprilalkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1981201533.4low42315210
bopindololaromatic ether;
benzoate ester;
methylindole;
secondary amino compound
1990199034.0low001000
nicorandilnitrate ester;
pyridinecarboxamide
potassium channel opener;
vasodilator agent
2014201410.0low000010
bw-755c1983199138.1low061000
colforsinacetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol
adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
1985200432.7low064100
nedocromildicarboxylic acid;
organic heterotricyclic compound
anti-allergic agent;
anti-asthmatic drug;
non-steroidal anti-inflammatory drug
1994199430.0low001000
daurisolineisoquinolines2005200519.0low000100
pirazolac1990199034.0low001000
sulotroban1985199334.8low135000
fomesafenaromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
1991199133.0low001000
dazoxiben1981200237.4medium54010100
lovastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)
anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
2002200222.0low000100
dazmegrel1983200136.0medium2244100
bm 135051989199531.7low012000
simvastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
2005200817.0low200300
pravastatin3-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)
anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
2013201311.0low000010
quinaprildicarboxylic acid monoester;
ethyl ester;
isoquinolines;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
1984200229.2low112100
cicletanineorganochlorine compound1985199933.6low276000
mifepristone3-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound
abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
1991200029.2low004000
moexiprilat1993199331.0low001000
pirmagrel1983199237.0high1113000
loxtidinearomatic ether;
piperidines;
primary alcohol;
triazoles
H2-receptor antagonist1995199529.0low001000
imazodan1990199034.0low001000
rolafagrel1990199034.0low001000
cilazapril, anhydrousdicarboxylic acid monoester;
ethyl ester;
pyridazinodiazepine
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
1992199331.5low102000
fura-21987199730.4low014000
tepoxalinaromatic ether;
hydroxamic acid;
monochlorobenzenes;
pyrazoles
antipyretic;
apoptosis inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
immunomodulator;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1996199827.0low102000
zileuton1-benzothiophenes;
ureas
anti-asthmatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor;
leukotriene antagonist;
non-steroidal anti-inflammatory drug
201620168.0low000010
clopidogrelmethyl ester;
monochlorobenzenes;
thienopyridine
anticoagulant;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
1999201815.5low001120
mibefradiltetralinsT-type calcium channel blocker1995199529.0low001000
tenidap1997199727.0low001000
remifentanilalpha-amino acid ester;
anilide;
monocarboxylic acid amide;
piperidinecarboxylate ester
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
sedative
2010201213.0low200110
atorvastatinaromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)
environmental contaminant;
xenobiotic
2007201514.5low100310
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2001200123.0low000100
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
1983201431.1low3810310
3-n-butylphthalidebenzofurans1997199926.0low003000
vanadatestrivalent inorganic anion;
vanadium oxoanion
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
1983199833.0low013000
dimethylhydrazines1995199529.0low001000
scarlet redazobenzenes;
bis(azo) compound;
naphthols
carcinogenic agent;
fluorochrome;
histological dye
1995199529.0low001000
caloreen1989198935.0low010000
isosorbide-2-mononitrate1987198737.0low010000
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
1980201731.9low01011120
anisodamine1985199235.6low094000
n-methylnicotinamidepyridinecarboxamidemetabolite2007200717.0low000100
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite2010201014.0low000100
1,2-distearoyllecithin1992199232.0low001000
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucosegallate ester;
galloyl beta-D-glucose
anti-inflammatory agent;
antineoplastic agent;
geroprotector;
hepatoprotective agent;
plant metabolite;
radiation protective agent;
radical scavenger
201720177.0low000010
pyrrolidine dithiocarbamatedithiocarbamic acids;
pyrrolidines
anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
1999201218.5low001010
glutathione disulfideglutathione derivative;
organic disulfide
Escherichia coli metabolite;
mouse metabolite
2013201311.0low000010
cephalosporin ccephalosporinfungal metabolite2004200818.0low000200
tienoxolol1993199331.0medium001000
tretoquinolisoquinolines1992199232.0low001000
nictindole1983198341.0low010000
nafagrel1990199730.6high108000
web 2086organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
1989199831.7low027000
bepafant1994199430.0low001000
xenon radioisotopes1993199331.0low001000
1,7-phenanthrolinephenanthroline1988199333.3low012000
triazoles1,2,3-triazole1989201429.4low0211010
esaprazole1990199034.0low001000
cloricromencoumarins1982199137.8low041000
timegadine1985198539.0low010000
fenflumizole1984198838.3medium030000
3-methylhistamine1999199925.0low001000
cromakalim2000200024.0low001000
flosulide2001200123.0low000100
masoprocolnordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
1983199833.4low067000
alaceprildipeptide;
thioacetate ester
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor1986198638.0low010000
morniflumate(trifluoromethyl)benzenes1984198440.0low010000
phorbol-12,13-diacetate1995199529.0low001000
honokiolbiphenyls2005200519.0low000100
sesaminbenzodioxoles;
furofuran;
lignan
antineoplastic agent;
neuroprotective agent;
plant metabolite
2000200024.0low001000
coptisinealkaloidmetabolite1992199232.0low001000
teleocidin b-41991199531.0low002000
tosyllysine chloromethyl ketonesulfonic acid derivative1988199731.5low011000
dauricinearomatic ether;
bisbenzylisoquinoline alkaloid;
isoquinolines;
phenols;
tertiary amino compound
plant metabolite1987200530.0low011100
1-benzylimidazole1987198936.0low020000
fc 75alkyltetrahydrofuran;
organofluorine compound
2004200420.0low000100
noracycline1990199034.0low001000
ro 22-35811982198640.7high030000
3,4-dihydroxyphenylethanolcatechols;
primary alcohol
antineoplastic agent;
antioxidant;
metabolite
2009200915.0low000100
ketorolac tromethamineorganoammonium saltanalgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor
1995199529.0low001000
clarithromycinmacrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
2000200024.0low001000
coenzyme aadenosine 3',5'-bisphosphatecoenzyme;
Escherichia coli metabolite;
mouse metabolite
1988199333.5low011000
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
1982200334.0low299100
fibrinogeniditolfungal metabolite1983202029.5low389030
17-alpha-hydroxypregnenolone17alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
hydroxypregnenolone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1980198044.0low010000
homocysteineamino acid zwitterion;
homocysteine;
serine family amino acid
fundamental metabolite;
mouse metabolite
1986201922.8low012210
acetylsalicylic acid lysinate1985199036.7low021000
8-((4-chlorophenyl)thio)cyclic-3',5'-amp3',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
aryl sulfide;
organochlorine compound
protein kinase agonist1989198935.0low010000
tetrakis-mu-acetylsalicylato-dicopper(ii)1997199727.0low001000
zofenoprilaryl sulfide;
L-proline derivative;
N-acyl-L-amino acid;
thioester
anticonvulsant;
apoptosis inhibitor;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug;
vasodilator agent
1989198935.0low010000
1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine1994199430.0low001000
mci 9038peptide2006200618.0low000100
firefly luciferin1,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate
luciferin1997199727.0low001000
cortisol 21-mesylate1986198638.0medium010000
cv 65041991199133.0low001000
3,7-dimethyl-1-propargylxanthine1992199232.0low001000
foxes1992199232.0low002000
enkephalinamide-met, ala(2)-1987198737.0low010000
cobaltcobalt group element atom;
metal allergen
micronutrient1986199036.0low011000
p-methoxy-n-methylphenethylaminearomatic ether;
secondary amino compound
metabolite1992199530.5low002000
fulvestrant17beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide
antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
1993199331.0low001000
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acidpolyamino carboxylic acid;
tetracarboxylic acid
chelator1996199628.0low001000
monocrotaline pyrrole1988199134.0low012000
arginyl-glycyl-aspartic acidoligopeptide2010201014.0low000100
1,4-dihydropyridine2002200222.0low000100
bosentan anhydrousprimary alcohol;
pyrimidines;
sulfonamide
antihypertensive agent;
endothelin receptor antagonist
1997199727.0low002000
u 74006fcorticosteroid hormone1993199928.0low002000
diacetyldichlorofluorescein2003200321.0low000100
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazoleether;
imidazoles;
monomethoxybenzene
TRP channel blocker1993199331.0low001000
sr 489682006200618.0low000100
fluo-3xanthene dyefluorochrome2001200123.0low000100
fpl 55712aromatic ketone1983199137.2low072000
bradykinin, des-arg(9)-oligopeptidebradykinin receptor B2 agonist1991199332.0low002000
indobufenisoindoles1986199633.0low111000
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate1,1-diunsubstituted alkanesulfonate1992199232.0low001000
cv 39881995200225.5low001100
sivelestatN-acylglycine;
pivalate ester
1994200425.7low002100
22-hydroxycholesterolcholanoid1990199034.0low001000
propionylcarnitineO-acylcarnitineanalgesic;
antirheumatic drug;
cardiotonic drug;
human metabolite;
peripheral nervous system drug
1990199432.0low002000
cv 62091989199134.0low011000
methoctraminehydrochloridemuscarinic antagonist1991199133.0low001000
perindoprilalpha-amino acid ester;
dicarboxylic acid monoester;
ethyl ester;
organic heterobicyclic compound
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1992199431.0low002000
fr 1393171995199827.5low002000
procyanidinproanthocyanidin2001201319.0low100310
sri 63-4411989198935.0low010000
tesmilifenediarylmethane1990199034.0low001000
1-hexadecyl-2-acetyl-glycero-3-phosphocholine2-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
1983200233.0low03051100
exp3174biphenylyltetrazole;
imidazoles;
organochlorine compound
metabolite1998199826.0low001000
deoxyglucose1985199434.2low022000
thromboxanes1979201737.9medium22271411040
gastrodinglycoside1997199727.0low001000
2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran1991199133.0low001000
sc 58125organofluorine compound;
pyrazoles;
sulfone
antineoplastic agent;
cyclooxygenase 2 inhibitor
1996201421.0low002010
hwa 1381993199331.0low001000
bw 373u86diarylmethane2002200222.0low000200
nitroaspirincarbonyl compound2000200123.7low002100
lithospermate b1993199430.5low002000
astilbin3'-hydroxyflavanones;
4'-hydroxyflavanones;
alpha-L-rhamnoside;
flavanone glycoside;
monosaccharide derivative;
tetrahydroxyflavanone
anti-inflammatory agent;
plant metabolite;
radical scavenger
1997199727.0low001000
2-aminomethyl-4-t-butyl-6-iodophenol1991199133.0low001000
ar 124631987198836.5medium020000
n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine1993199728.7low003000
mozavaptanbenzamidesaquaretic1995199529.0low101000
caprylatesfatty acid anion 8:0;
straight-chain saturated fatty acid anion
human metabolite;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
ah 6809xanthones2004200420.0low000100
3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid1988199334.2medium032000
valdecoxibisoxazoles;
sulfonamide
antipyretic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2006200618.0low100100
parecoxibisoxazoles;
N-sulfonylcarboxamide
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2006200618.0low100100
(20s)-20-hydroxycholesterol20-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
human metabolite;
mouse metabolite
1990199034.0low001000
l 6587582004200818.0low000200
sinitrodil1995199529.0low001000
ly 255283aromatic ketone1993199331.0low001000
dx 9065a2006200618.0low000100
l 6513921989199333.0low011000
fpl 572311986198837.2medium050000
procyanidin b2biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin
antioxidant;
metabolite
2013201311.0low000010
dehydroacetic acidketone;
pyran-2,4-dione
antibacterial agent;
fungicide;
plasticiser
1987198737.0low010000
peroxynitrous acidnitrogen oxoacid2001201717.3low000420
mk 0663bipyridines;
organochlorine compound;
sulfone
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2007200717.0low100100
glycyl-prolyl-arginyl-proline1994199430.0low001000
bay x 10051997199727.0low001000
cgp 42112abenzyl ester;
oligopeptide;
pyridinecarboxamide
angiotensin receptor agonist;
anti-inflammatory agent;
antineoplastic agent;
neuroprotective agent;
vasodilator agent
1993199331.0low001000
angiotensin ii, des-phe(8)-amino acid zwitterion;
angiotensin
vasodilator agent1995201520.0low001110
2-chloro-n(6)cyclopentyladenosine1994199430.0low001000
3-tyr-octreotide1997199727.0low001000
ramatrobanorganic molecular entity1994199430.0low001000
bq 6102002200222.0low000100
lipid xN-acyl-D-glucosamine 1-phosphateEscherichia coli metabolite1988198836.0low010000
pd 1450651993199828.5low002000
glycerophosphoinositol 4,5-bisphosphate1991199133.0low001000
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
1987199134.7low012000
ph cl 28a1990199332.5high002000
l 6400351985198539.0low010000
ar 124561988198836.0medium010000
6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride1992199232.0medium001000
ro 22-91941996199628.0low001000
sipi 5491993199331.0low001000
l 670596carbazoles1992199232.0low001000
l 6364991988198836.0medium010000
e 58801996199628.0low001000
mdl 734041997199727.0low001000
cgs 226521993199331.0medium001000
ici d87311993199331.0low001000
l 7036062006200618.0low000100
omega-n-methylarginineamino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
1992200927.6low3021300
prolineamino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid
algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1981199736.6low043000
kc 7641992199431.0high102000
ezetimibeazetidines;
beta-lactam;
organofluorine compound
anticholesteremic drug;
antilipemic drug;
antimetabolite
2008200816.0low000100
4-((3-pyridinylmethyl)amino)benzoic acid1983198341.0medium010000
is 7412000200024.0low001000
phorbolsditerpene;
terpenoid fundamental parent
1980198640.0low050000
2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha1980198243.0high030000
chinoin 1271992199232.0medium001000
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1984201030.4low994600
hydroxyl radicaloxygen hydride;
oxygen radical;
reactive oxygen species
1985198539.0low010000
atrasentanpyrrolidines1998199826.0low001000
prostaglandins b1981199337.0low011000
methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate1993199331.0medium002000
fk 33112001200123.0medium000300
technetium tc 99m pentetate1987199833.0low121000
trilobineisoquinolines1991199133.0low001000
aminopterindicarboxylic acidEC 1.5.1.3 (dihydrofolate reductase) inhibitor;
mutagen
1991199133.0low001000
biotinbiotins;
vitamin B7
coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
1987198737.0low010000
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite1981201731.7low449471160
6,15-diketo-13,14-dihydroprostaglandin f1alpha1981199940.0high0101000
atropine1984199234.6low023000
4-aminobenzoic acid-n-mannoside1988198836.0medium010000
7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acidprostanoid1994200524.5low101100
ropivacainepiperidinecarboxamide;
ropivacaine
local anaesthetic1997199727.0low001000
lu 1352521998200224.0low001100
scutellaringlucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antineoplastic agent;
proteasome inhibitor
1989199333.0low011000
esculentin steroid1993199331.0low001000
uk 347871986198638.0medium010000
cholic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
bile acid;
C24-steroid;
trihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
2004200420.0low000100
cortisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1993199331.0low001000
3-nitrotyrosine2-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
2011201710.0low000020
2-hydroxyestradiol17beta-hydroxy steroid;
2-hydroxy steroid
carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug
1981198441.3low030000
benzofurans1986200932.6low096100
sodium bromidebromide salt;
inorganic sodium salt
1995199529.0low001000
acetylstrophanthidinacetate esteranti-arrhythmia drug1986198638.0low010000
sorbinilazaspiro compound;
chromanes;
imidazolidinone;
organofluorine compound;
oxaspiro compound
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor
1989199134.3low021000
dihydropyridines1990200228.0low001100
lithium chlorideinorganic chloride;
lithium salt
antimanic drug;
geroprotector
1991199133.0low001000
glycogen1994199728.5low002000
fibrinpeptide1982199934.9low075000
bradykininoligopeptidehuman blood serum metabolite;
vasodilator agent
1981200831.6low345471100
glucosamineD-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
1983198341.0low010000
elastinoligopeptide2012201212.0low000010
raffinoseraffinose family oligosaccharide;
trisaccharide
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2001200123.0low100100
oxytocinheterodetic cyclic peptide;
peptide hormone
oxytocic;
vasodilator agent
1980200131.9low056200
3,4-dihydroxyphenyllactic acid2-hydroxy monocarboxylic acid;
catechols
1986201420.7low010110
inositol 1,4,5-trisphosphatemyo-inositol trisphosphatemouse metabolite1987199633.3low021000
ouabain11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone
anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
1983200034.4low032000
puromycinpuromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
1982199635.0low021000
tosylphenylalanyl chloromethyl ketonealpha-chloroketone;
sulfonamide
alkylating agent;
serine proteinase inhibitor
1988199731.0low012000
monoiodotyrosineamino acid zwitterion;
L-tyrosine derivative;
monoiodotyrosine;
non-proteinogenic L-alpha-amino acid
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor;
human metabolite;
mouse metabolite
1989198935.0low010000
nitroarginineguanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
1991200427.6low0022500
adenosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue1988198836.0low010000
2-hydroxyestrone2-hydroxy steroid;
catechols
human metabolite1981198143.0low010000
pentazocinebenzazocine1990199034.0low001000
pancuroniumacetate ester;
steroid ester
cholinergic antagonist;
muscle relaxant;
nicotinic antagonist
1986198638.0low110000
ryanodine1985199732.0low012000
ginsenoside rg112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
beta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
neuroprotective agent;
pro-angiogenic agent
1998199826.0low101000
lignans2000200521.5low001100
bq 123cyclic peptide1993200426.5low006200
n-formylmethionine leucyl-phenylalaninetripeptide1983199933.2low088000
sodium arsenitearsenic molecular entity;
inorganic sodium salt
antibacterial agent;
antifungal agent;
antineoplastic agent;
carcinogenic agent;
herbicide;
insecticide;
rodenticide
1992199232.0low001000
ergonovineergot alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
diagnostic agent;
fungal metabolite;
oxytocic;
toxin
1985198937.0low020000
betadexcyclodextrin1995199529.0low001000
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
1985198539.0low010000
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1981202134.2low113081613372
prostaglandin h2olefinic compound;
oxylipin;
prostaglandins H;
secondary alcohol
mouse metabolite1982200434.0low01511200
phosphoramidondeoxyaldohexose phosphate;
dipeptide
bacterial metabolite;
EC 3.4.24.11 (neprilysin) inhibitor;
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
1998200423.0low001100
resveratrolresveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
2005200917.0low000200
retinolretinol;
vitamin A
human metabolite;
mouse metabolite;
plant metabolite
1992199630.0low002000
oleic acidoctadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
1982200430.0low127200
tacrolimusmacrolide lactambacterial metabolite;
immunosuppressive agent
1993201423.4low303110
ferulic acidferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
1988199035.0low011000
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
1994199629.3low003000
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
1994200127.8low103100
eicosapentaenoic acidicosapentaenoic acid;
omega-3 fatty acid
anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1981200733.5low21311400
thapsigarginbutyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone
calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
1996200324.5low001100
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
2001201816.0low100210
tetragastrinpeptidyl amide;
tetrapeptide
anxiogenic;
human metabolite
1986198638.0low010000
zithromaxmacrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
2000200024.0low001000
adenosine-5'-(n-ethylcarboxamide)adenosines;
monocarboxylic acid amide
adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
1993199331.0low001000
prostaglandin d2prostaglandins Dhuman metabolite;
mouse metabolite
1982201332.2low246291240
h 89N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide2004200420.0low000100
imidazolidinesazacycloalkane;
imidazolidines;
saturated organic heteromonocyclic parent
1989199134.3low021000
kt 5720carboxylic ester;
gamma-lactam;
hemiaminal;
indolocarbazole;
organic heterooctacyclic compound;
semisynthetic derivative;
tertiary alcohol
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor2005200718.0low000200
dactinomycinactinomycinmutagen1980199735.3low0104000
gamma-sitosterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols
marine metabolite;
plant metabolite
2005200519.0low000100
melphalanL-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
1987198737.0low010000
enkephalin, leucinepentapeptide;
peptide zwitterion
analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
1996199628.0low001000
1-deaza-2-chloro-n(6)-cyclopentyladenosine1992199232.0medium001000
sodium bicarbonateone-carbon compound;
organic sodium salt
antacid;
food anticaking agent
1989199333.0low011000
sodium acetate, anhydrousorganic sodium saltNMR chemical shift reference compound1984198440.0low010000
dipyroneorganic sodium saltanti-inflammatory agent;
antipyretic;
antirheumatic drug;
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug;
prodrug
1985198638.5low020000
cholestane-3,5,6-triol2002200222.0low000100
tolfenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1983198540.0low120000
carbenoxolone sodiumtriterpenoid1985199235.5low011000
elaidic acidoctadec-9-enoic acidfood component2001200123.0low100100
glycosides1993199331.0low001000
stilbenesstilbene1995200921.0low001200
phenyl-n-tert-butylnitrone1992199232.0low001000
buprenorphinemorphinane alkaloiddelta-opioid receptor antagonist;
kappa-opioid receptor antagonist;
mu-opioid receptor agonist;
opioid analgesic
2000200024.0low101000
lypressincyclic peptide1985198936.0low040000
arginine vasopressinvasopressincardiovascular drug;
hematologic agent;
mitogen
1983200933.7low2146300
sesquiterpenes1985198638.5low020000
sb 3667912007200717.0low000200
ag-2131998199826.0low001000
5-(4-chlorophenyl)-2-furanpropionic acid1993199331.0medium001000
cotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
1988202021.7low111010
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
1997200921.0low001100
methimazole1,3-dihydroimidazole-2-thionesantithyroid drug1985198539.0low010000
sulindacmonocarboxylic acid;
organofluorine compound;
sulfoxide
analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
1983199937.1low8223000
capsaicincapsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
1990200922.5low0051000
enclomiphene1985198738.0low020000
metiamideimidazoles1986198638.0low010000
tosylarginine methyl esterguanidines;
L-arginine ester;
methyl ester;
sulfonamide
1988198836.0low010000
chlorogenic acidcinnamate ester;
tannin
food component;
plant metabolite
2013201311.0low000010
thiobarbituric acidbarbituratesallergen;
reagent
1985198539.0low010000
1,3-dimethylthiourea1985198837.5low020000
thioureaone-carbon compound;
thioureas;
ureas
antioxidant;
chromophore
1985198837.5low020000
D-fructopyranosecyclic hemiketal;
D-fructose;
fructopyranose
sweetening agent1989201621.9low012310
thioacetamidethiocarboxamidehepatotoxic agent2005200519.0low000100
tempoaminoxyls;
piperidines
catalyst;
ferroptosis inhibitor;
radical scavenger
2004200420.0low000100
capsazepinebenzazepine;
catechols;
monochlorobenzenes;
thioureas
capsaicin receptor antagonist1994200920.2low001500
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazolebenzoic acid;
imidazolines;
organic radical
apoptosis inhibitor;
radical scavenger
2001200123.0low000100
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
1985199533.0low012000
sodium taurodeoxycholatebile acid taurine conjugatehuman metabolite1995199529.0low001000
nadp1978198144.0low030000
1,1-diphenyl-2-picrylhydrazyl2009200915.0low000100
tetrachlorodecaoxide1990199034.0low001000
rhyncophylline1991199133.0low001000
thiopentalbarbituratesanticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic
1982198640.0low120000
ranitidineC-nitro compound;
furans;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
1986200729.3low111100
4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2h)-pyridazinone1990199034.0low001000
lithiumalkali metal atom1991199829.5low102000
nitrogen dioxidenitrogen oxide1986200129.0low011100
dermatan sulfateamino disaccharide;
glycosylgalactose derivative;
iduronic acids;
oligosaccharide sulfate
2005200519.0low000100
nizatidine1991199133.0low001000
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester1993199331.0low001000
indium oxine1997199727.0low001000
dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium1999199925.0low001000
gea 31621997199727.0low001000
lysine clonixinateorganoammonium saltantipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
vasodilator agent
1995199827.5low002000
cytellin2005200519.0low000100
ginsenosides1986199830.8low115000
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosineadenosines;
dicarboxylic acid monoamide;
monocarboxylic acid
adenosine A2A receptor agonist;
anti-inflammatory agent
1992199431.0low002000
ovalbumin1983201829.8low045110
4-aminopyrrolidine-2,4-dicarboxylic acid1997199727.0low001000
sodium dodecyl sulfateorganic sodium saltdetergent;
protein denaturant
1991199133.0low001000
l 663536aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
2002200421.0low000200
naphthoquinones1993199331.0low002000
sc 560aromatic ether;
monochlorobenzenes;
organofluorine compound;
pyrazoles
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 1 inhibitor;
non-steroidal anti-inflammatory drug
2001201418.3low000820
diethyl maleateethyl ester;
maleate ester
glutathione depleting agent1984199333.6low014000
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
1990201323.6low003110
bilirubinbiladienes;
dicarboxylic acid
antioxidant;
human metabolite;
mouse metabolite
1990200526.5low001100
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
1979202133.3low41612466105101
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1979201634.4low183131484070
leukotriene a4epoxy fatty acid;
leukotriene;
long-chain fatty acid;
oxylipin;
polyunsaturated fatty acid
human metabolite;
mouse metabolite;
plant metabolite
1990200230.2low003100
arachidonyltrifluoromethanefatty acid derivative;
ketone;
olefinic compound;
organofluorine compound
EC 3.1.1.4 (phospholipase A2) inhibitor2007200717.0low000100
linoleic acidoctadecadienoic acid;
omega-6 fatty acid
algal metabolite;
Daphnia galeata metabolite;
plant metabolite
1982200831.2low388500
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1985199234.2low013000
beta carotenecarotenoid beta-end derivative;
cyclic carotene
antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
2007200717.0low100100
leukotriene b4dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid
human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
1981201631.1low636841020
leukotriene c4leukotrienebronchoconstrictor agent;
human metabolite;
mouse metabolite
1994200626.2low4024500
thromboxane a2epoxy monocarboxylic acid;
thromboxanes A
mouse metabolite1980201732.9medium4524319643100
8,11,14-eicosatrienoic acidfatty acid 20:3;
long-chain fatty acid
fungal metabolite;
human metabolite;
nutraceutical
1985200529.8low046200
rumenic acidoctadeca-9,11-dienoic acid2007201513.0low000110
15-keto-13,14-dihydroprostaglandin e2prostaglandins E1980199738.9medium1121000
15-ketoprostaglandin e2prostaglandins E1981198242.5low020000
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
1979201734.1low53316610
5-hydroxy-6,8,11,14-eicosatetraenoic acidHETEhuman metabolite;
mouse metabolite
1985199833.8low086000
cholecalciferolD3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone
geroprotector;
human metabolite
1991199133.0low001000
rutindisaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
2013201311.0low000010
leukotriene d4dipeptide;
leukotriene;
organic sulfide
bronchoconstrictor agent;
human metabolite;
mouse metabolite
1994200922.6low005300
leukotriene e4amino dicarboxylic acid;
L-cysteine thioether;
leukotriene;
non-proteinogenic L-alpha-amino acid;
secondary alcohol
1983200231.0low2411200
prostaglandin a2prostaglandins Ahuman metabolite1983199836.0low031000
prostaglandin b2prostaglandins Bhuman metabolite1993199331.0low001000
prostaglandin g2prostaglandins Ghuman metabolite;
mouse metabolite
1987200228.7low011100
9-deoxy-delta-9-prostaglandin d2prostaglandins Jhuman metabolite2004201117.3low000210
15-ketoprostaglandin f2alphaprostaglandins Falpha1984198440.0low010000
6-ketoprostaglandin e1prostaglandins Emetabolite;
platelet aggregation inhibitor
1981201737.0medium0141010
11-dehydro-thromboxane b2thromboxanehuman metabolite1986201824.7medium194401570
arachidonic acid omega-9 hydroperoxideHPETEmouse metabolite1985198539.0low010000
lipoxin a4hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid
human metabolite;
metabolite
1989201422.5low010010
gamma-linolenic acidlinolenic acid;
omega-6 fatty acid
human metabolite;
mouse metabolite;
plant metabolite
1985200032.9low354000
alpha-linolenic acidlinolenic acid;
omega-3 fatty acid
micronutrient;
mouse metabolite;
nutraceutical
1984200730.0low026100
leukotriene f-4dipeptide;
leukotriene;
organic sulfide
human metabolite1985199136.0medium011000
prostaglandin f1prostaglandins Falphahuman metabolite1981200435.5low182200
prostaglandin f3alphaprostaglandins Falpha2004200420.0low000100
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
1997201020.5low001100
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
1991199232.5low002000
carboprosthydroxy monocarboxylic acidabortifacient;
oxytocic
1980198143.5low020000
astaxanthinecarotenol;
carotenone
animal metabolite;
anticoagulant;
antioxidant;
food colouring;
plant metabolite
201720177.0low000010
okaninbenzenetriol;
chalcones
plant metabolite202220222.0low000001
esculetinhydroxycoumarinantioxidant;
plant metabolite;
ultraviolet filter
1987198737.0low010000
zearalenonemacrolide;
resorcinols
fungal metabolite;
mycoestrogen
1994199430.0low001000
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
2000200422.0low001100
rosmarinic acidrosmarinic acidgeroprotector;
plant metabolite
1985198539.0low010000
rottlerinaromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone
anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
2004200420.0low000100
prostaglandin a1prostaglandins A1984198440.0low010000
anandamideendocannabinoid;
N-acylethanolamine 20:4
human blood serum metabolite;
neurotransmitter;
vasodilator agent
2006200717.3low000300
astragalinbeta-D-glucoside;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone
plant metabolite;
trypanocidal drug
202020204.0low000010
lafutidineorganic molecular entity2006200717.5low000200
plaunotolditerpenoid;
primary alcohol
anti-ulcer drug;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
nephroprotective agent;
plant metabolite;
vulnerary
1985198539.0low010000
8-epi-prostaglandin f2alphaF2-isoprostanebiomarker;
bronchoconstrictor agent;
vasoconstrictor agent
1994201520.1low406750
4-hydroxyestradiol4-hydroxy steroidmetabolite1981198143.0low010000
misoprostol1986199633.0low212000
ozagrelcinnamic acids1983201032.5medium23033600
ethamolinlong-chain fatty acid1989198935.0low010000
trans-10,cis-12-conjugated linoleic acidoctadeca-10,12-dienoic acid201520159.0low000010
13-hydroxy-9,11-octadecadienoic acidoctadecadienoic acid1987199333.7low012000
15-keto-13,14-dihydroprostaglandin f2alphaketone;
prostaglandins Falpha
metabolite1979199737.9low2338000
prostaglandin i3prostanoid1983198937.7medium030000
16,16-dimethylprostaglandin e2cyclopentanones;
monocarboxylic acid;
prostanoid;
secondary allylic alcohol
anti-ulcer drug;
gastrointestinal drug;
radiation protective agent
1984199436.9low061000
2,3-dinor-6-ketoprostaglandin f1alpha4-oxo monocarboxylic acid;
prostanoid;
secondary alcohol
metabolite1980201830.6high3978872480
leukotriene b5dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid
anti-inflammatory agent;
human xenobiotic metabolite;
rat metabolite
2001200123.0low100100
thromboxane b2thromboxanes Bhuman metabolite;
mouse metabolite
1979202132.8high1771,103953167621
2,3-dinor-thromboxane b2thromboxane1986200932.3high123835700
20-hydroxy-5,8,11,14-eicosatetraenoic acidHETE;
hydroxy monocarboxylic acid
human metabolite;
mouse metabolite
1998200224.0low001100
arachidonic acid 5-hydroperoxideHPETEhuman xenobiotic metabolite2007200717.0low000100
5,6-epoxy-8,11,14-eicosatrienoic acidEETmouse metabolite1991200326.8low003100
8,9-epoxyeicosatrienoic acidEETmouse metabolite1991199730.0low002000
cyproterone17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
chlorinated steroid;
tertiary alpha-hydroxy ketone
androgen antagonist1989198935.0low010000
naloxonemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol
antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
1988198836.0low010000
sirolimusantibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
1993200920.3low101200
brefeldin amacrolide antibioticPenicillium metabolite1997199727.0low001000
morphinemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
1987200822.5low110300
2-methylthio-atp1996199628.0low001000
7-benzylidenenaltrexonephenanthrenes2002200222.0low000100
acipimoxpyrazinecarboxylic acid1990199034.0low101000
ah 23848(4Z)-7-{5-[([1,1'-biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl}hept-4-enoic acid1999199925.0low001000
bay u9773benzoic acids;
dicarboxylic acid;
organic sulfide;
polyunsaturated fatty acid;
secondary alcohol
leukotriene antagonist2000200024.0low002000
cicaprostmonoterpenoid1992200424.3low001200
clobetasol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug;
SMO receptor agonist
1981198143.0low110000
deamino arginine vasopressinheterodetic cyclic peptidediagnostic agent;
renal agent;
vasopressin receptor agonist
1982200934.4low063100
fr 1736572005200519.0low000100
kallidinpeptide1984198440.0low010000
iloprostcarbobicyclic compound;
monocarboxylic acid;
secondary alcohol
platelet aggregation inhibitor;
vasodilator agent
1983200928.5low28151100
enprostil1987198737.0low010000
lysophosphatidylcholines1-O-acyl-sn-glycero-3-phosphocholine1989200725.8low012100
cytochalasin bcytochalasin;
lactam;
lactone;
organic heterotricyclic compound
actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
2009200915.0low000100
neurokinin a1989199332.7low012000
neurokinin bpolypeptide1989199332.7low012000
ono 37081991200330.2medium0010100
pd 123319imidazopyridineangiotensin receptor antagonist;
endothelin receptor antagonist;
vasoconstrictor agent
1994199430.0low001000
u 44069prostanoid1984200433.0low020100
rioprostilaliphatic alcohol1989198935.0low010000
sq 295481985201231.5low045010
onapristone1991199331.8low004000
s 145monoterpenoid1992200029.2low004000
sulprostoneprostanoid2005200519.0low000100
12-hydroxy-8,10-heptadecadienoic acidlong-chain fatty acid1980198044.0medium010000
12-hydroxy-5,8,10-heptadecatrienoic acidhydroxy polyunsaturated fatty acid;
long-chain fatty acid;
trienoic fatty acid
metabolite1981200933.4low053200
erbstatin1995199529.0low001000
ag 5561999199925.0low001000
ag-490catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide
anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
2008200816.0low000100
ag 1271996199628.0low001000
sulindac sulfidearyl sulfide;
monocarboxylic acid;
organofluorine compound
antineoplastic agent;
apoptosis inducer;
non-steroidal anti-inflammatory drug
1985198638.5low020000
11-hydroxy-5,8,12,14-eicosatetraenoic acid1982199136.7low021000
12-hydroxy-5,8,10,14-eicosatetraenoic acid1981200734.0low11713100
15-hydroxy-5,8,11,13-eicosatetraenoic acid1982200732.8low069100
8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid1988198836.0low010000
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid1979201229.7low11013710
rubidiumalkali metal atom1989198935.0low010000
aluminumboron group element atom;
elemental aluminium;
metal atom
1986199036.2low131000
arsenicmetalloid atom;
pnictogen
micronutrient1986199234.3low012000
indiumboron group element atom1983198739.0low020000
naltrexonecyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound
antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
2002200222.0low000100
lisinoprildipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor1990199631.3low103000
ramiprilazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester
bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
1986201726.0low123210
ridogrel(trifluoromethyl)benzenes1990200130.0medium009100
sulfurchalcogen;
nonmetal atom
macronutrient2000200024.0low001000
muskmacrolide1997199727.0low001000
puerarinC-glycosyl compound;
isoflavonoid
1990201223.0low101010
7-hydroxymethotrexatefolic acids1990199034.0low001000
enalaprildicarboxylic acid monoester;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
1985200730.0low666400
cysteinecysteiniumfundamental metabolite1988200624.5low012300
siliconcarbon group element atom;
metalloid atom;
nonmetal atom
1982198540.5low020000
enalaprilat anhydrousdicarboxylic acid;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1989198935.0low020000
ramiprilatazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid;
dipeptide
bradykinin receptor B2 agonist;
cardioprotective agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor
1993200526.7low002100
ay 25,2051982198242.0low010000
methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketonealpha-chloroketone;
methyl ester;
tripeptide
EC 3.4.21.37 (leukocyte elastase) inhibitor1988198836.0low010000
oxyfedrinearomatic ketone1988199632.0low011000
trioleintriglycerideCaenorhabditis elegans metabolite;
plant metabolite
1983198341.0low010000
ono 13011997199727.0low001000
saralasinoligopeptide1984199935.7low052000
tetrodotoxinazatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid
animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
1991199133.0low001000
seleniumchalcogen;
nonmetal atom
micronutrient1984200731.1low158200
aluminum hydroxide, magnesium hydroxide, drug combination1990199034.0low001000
maxacalcitolorganic molecular entity1992199232.0low001000
dizocilpine maleatemaleate salt;
tetracyclic antidepressant
anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
1993199430.3low003000
pregnanediol1991199133.0low001000
cilastatincarboxamide;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid;
organic sulfide
EC 3.4.13.19 (membrane dipeptidase) inhibitor;
environmental contaminant;
protease inhibitor;
xenobiotic
1994199430.0low101000
6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid2000200223.0high001100
carboprostacyclinprostanoid1985200929.8low012100
1-oleoyl-2-acetylglycerol1,2-diglyceride1986198638.0low010000
15-hydroperoxy-5,8,11,13-eicosatetraenoic acidHPETEhuman xenobiotic metabolite1980198741.8low050000
linoleylanilideanilide;
fatty amide
1990199034.0low001000
manoalidebutenolide;
lactol;
sesterterpenoid
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite
1988198836.0low010000
piriprost1986198737.7low030000
2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid1981199039.7medium0161000
bwa 4c1991199133.0low001000
7-oxoprostaglandin i21993199331.0low001000
op 25071994200625.4medium003200
limaprostlong-chain fatty acid2005200519.0low000100
19-hydroxyprostaglandin e11979197945.0low010000
u 75412e1993199331.0low001000
l 6518961989198935.0medium010000
13,14-dihydroxy-15-ketoprostaglandin f2alpha1988198836.0medium010000
ono 88091991199133.0low001000
op 41483-alpha-cyclodextrin1989198935.0low010000
5,6-dihydroprostacyclin1979198940.0medium020000
9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid1999199925.0low001000
11-dehydro-2,3-dinor-thromboxane b22007200717.0medium100100
terbogrelditerpene glycoside2004200420.0low100100
verlukast1998200024.7low003000
isbogrel1986199633.3low012000
beta-escin1986202221.1low116051
s-nitroso-n-acetylpenicillaminenitroso compound;
nitrosothio compound
nitric oxide donor;
vasodilator agent
1996199628.0low001000
ergolinediamine;
ergoline alkaloid;
indole alkaloid fundamental parent;
indole alkaloid;
organic heterotetracyclic compound
1990199034.0low001000
adenosine-3',5'-cyclic phosphorothioatenucleoside 3',5'-cyclic phosphorothioate1994199430.0low001000
sq-23377cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid
calcium ionophore;
metabolite
1988199732.7low025000
tomoxiprole1984198440.0medium010000
beraprostenyne;
monocarboxylic acid;
organic heterotricyclic compound;
secondary alcohol;
secondary allylic alcohol
anti-inflammatory agent;
antihypertensive agent;
platelet aggregation inhibitor;
prostaglandin receptor agonist;
vasodilator agent
1996201222.4low104210
vapiprost1989200028.2low015000
u 62840carbotricyclic compound;
carboxylic acid
antihypertensive agent;
cardiovascular drug;
human blood serum metabolite;
platelet aggregation inhibitor;
vasodilator agent;
vitamin K antagonist
202120213.0low000001
hexarelin1997200025.5low006000
staurosporineammonium ion derivative1990199630.2low005000
ep 0451984198539.5medium020000
l 7453371997199826.5low002000
ono4819benzyl ether2005200519.0low000100
ono 87112007200717.0low000100
sincalideoligopeptide1990199034.0low001000
cg1006492012201212.0low100010
pentagastrinorganic molecular entity1980198938.8low140000
mocetinostataminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
1987201724.0low03111110
sc 2361999200123.7low001200
ticagreloraryl sulfide;
hydroxyether;
organofluorine compound;
secondary amino compound;
triazolopyrimidines
P2Y12 receptor antagonist;
platelet aggregation inhibitor
2014201410.0low000010
lipid adodecanoate ester;
lipid A;
tetradecanoate ester
Escherichia coli metabolite1988198836.0low020000
psd 5021999199925.0low001000
mre 269aromatic amine;
ether;
monocarboxylic acid;
pyrazines;
sulfonamide;
tertiary amino compound
drug metabolite;
orphan drug;
platelet aggregation inhibitor;
prostacyclin receptor agonist;
vasodilator agent
201620168.0low000010
g(m1) gangliosidealpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine;
sialotetraosylceramide
1988199433.0low022000
4-hydroxyestrone17-oxo steroid;
3-hydroxy steroid;
4-hydroxy steroid;
catechols;
phenolic steroid
carcinogenic agent;
estrogen;
human urinary metabolite
1981198143.0low010000
n-(1-methylethyl)-1,1,2-trimethylpropylamine2008200816.0low000100
bismuth tripotassium dicitrate1991199133.0low001000
tribulus2011201113.0low000010
ro32447942009200915.0low000100
oxadiazoles1983201725.3low021210
ucn 1028 c1996199628.0low001000
2-chlorohexadecanoic acid2008200816.0medium000100
palytoxinpolyoltoxin1986198638.0low010000
linoleic acid hydroperoxide1990199034.0low001000
losartan potassium1994200524.8low002200
norgestimate1995199529.0low101000
calcimycinbenzoxazole1980200434.9low07457300
indocyanine green1,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
1995199529.0low001000
pituitrin1983199834.8low175000
2-(4-(3-methyl-2-thienyl)phenyl)propionic acid1996199628.0low001000
acid phosphatase1986199036.0low011000
ataprost1991199630.5low002000
butaprost2004200420.0low000100
icatibant1992200625.3low105200
nadorganophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
1978198941.3low030000
tin mesoporphyrin2002200222.0low000100
mf63 compound201620168.0low000010
cosyntropin1982198540.5low020000
melitten1983199635.7low052000
ceruletideoligopeptidediagnostic agent;
gastrointestinal drug
1992200627.0low002100
motilin2007200717.0low000100
atrial natriuretic factorpolypeptide1985201528.9low8916330
thrombin receptor peptide (42-55)1991200426.5low001100
fibrinopeptide b1989198935.0low010000
gastrins1986200727.3low011100
glucagonpeptide hormone1983200132.0low243100
beta-endorphin1992199829.0low102000
neuropeptide y1988199732.0low013000
s6c sarafotoxin1993199530.0low002000
iberiotoxin1998199826.0low001000
angiotensinogen2001200521.0low000200
irl 16201995199728.3low003000
cyn 1548062009200915.0low000100
c-peptide1985200230.5low010100
natriuretic peptide, c-type1997199727.0low001000
celluloseglycoside1985199136.3low121000
endothelin-11994202021.2low1003729140
phosphatidylcholines1,2-diacyl-sn-glycero-3-phosphocholine1985199932.4low235000
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one21-hydroxy steroid1996199628.0low101000
thimerosalalkylmercury compoundantifungal drug;
antiseptic drug;
disinfectant;
drug allergen
1992200028.0low002000
sodium salicylateorganic molecular entity1985200132.5low021100
ubiquinone1991199133.0low001000
calpain1997199727.0low001000
hoe k86-43211990199034.0low001000
menotropins1985198738.0low020000
bucladesine3',5'-cyclic purine nucleotide1983200433.3low0108200
rs 51861991199431.5low002000
y 208111986199234.8medium022000
r 592741990199034.0low001000
cortisol succinate, sodium saltorganic molecular entity1992199232.0low001000
s-adenosylmethionineorganic cation;
sulfonium compound
coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1997199727.0low001000
albiflorinbenzoate ester;
beta-D-glucoside;
bridged compound;
gamma-lactone;
monoterpene glycoside;
secondary alcohol
neuroprotective agent;
plant metabolite
201720177.0low000010
cardiovascular agents1987201424.0low120310
neurotensinpeptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
1997199727.0low001000
fibrinopeptide a1985199435.2low433000
mannans1995199529.0low001000
aspirin eugenol ester201620168.0low000010
3,4-oxoisopropylideneshikimic acid2003200321.0medium000100
11,12-epoxy-5,8,14-eicosatrienoic acid11,12-EEThuman xenobiotic metabolite1991200526.3low002100
2-chlorohexadecanal2008200816.0low000100
glycolipids1985198837.5low020000
piperidines1984201621.7low214620
interleukin-81997201421.3low003310
myrtucommulone aaromatic ketone2009200915.0low000100
fosinopril1991199929.0low102000
aplysiatoxinaplysiatoxins;
bromophenol;
cyclic hemiketal;
ether;
organic heterotricyclic compound;
secondary alcohol;
spiroketal
algal metabolite;
carcinogenic agent;
cyanotoxin;
marine metabolite;
protein kinase C agonist
1995199529.0low001000
isoquercitrin2013201311.0low000010
vasoactive intestinal peptide1984201427.0low012010
heme2002200222.0low000100
heparitin sulfate2005200519.0low000100
tuftsinpeptide1990199034.0low001000
ascorbic acidascorbic acid;
vitamin C
coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
1981200437.7low050100
minocycline1988198836.0low010000
salicylatesmonohydroxybenzoateplant metabolite1983199834.4low479000
piroxicambenzothiazine;
monocarboxylic acid amide;
pyridines
analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1984199635.4low484000
mobic1,3-thiazoles;
benzothiazine;
monocarboxylic acid amide
analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
1999200822.6low104100
isoxicambenzothiazine;
isoxazoles;
monocarboxylic acid amide
antirheumatic drug;
non-steroidal anti-inflammatory drug
1989198935.0low110000
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
1982199337.0low031000
teriflunomide(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide
drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
1998199925.5low002000
epidermal growth factor1985200532.1low097200
kaolinitealuminosilicate mineral;
mixture
antidiarrhoeal drug;
excipient
1989199631.5low011000
transforming growth factor beta1993201126.0low007110
okadaic acidketal1988199632.3low012000
tcv 3091993199331.0low001000
phosphatidylethanol1992199729.5low002000
lipoxin b4hydroxy fatty acid anion;
lipoxin anion
1989198935.0low010000
kiss1 protein, human201520159.0low000010
hirudin1987199931.7low012000
caseins1991200327.0low001100
limbrel201620168.0low000010
oligomycins1994199430.0low001000
asbestos, crocidolite2010201014.0low000100
g(m3) gangliosidealpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide;
sialodiosylceramide;
sialotriaosylceramide
mouse metabolite1993199331.0low001000
nitrophenols1996199628.0low001000
hydroxytyrosyl acetate2009200915.0low000100
1 alpha,24-dihydroxyvitamin d31991199133.0low001000
angiotensin iangiotensin;
peptide zwitterion
human metabolite;
neurotransmitter agent
1986201527.5low016210
siagosidelactone;
sialotetraosylceramide
1988198836.0low010000
hyaluronoglucosaminidase1997199727.0low001000
adrenomedullin2014201410.0low000010
angiotensin iii1983199435.5low011000
sta 22004200420.0low000100
ginkgolide b1989200230.7low018100
neferine1995199728.0low002000
t-2 toxin1985198638.5low020000
peoniflorin201420178.5low000020
vitamin b 12201920195.0low000010
norgestrel1984199534.8low122000
transforming growth factor alpha1999199925.0low001000
cyclosporine1991201826.6low7022710
apyrase1986198638.0low010000
thromboplastin1987201523.7low021210
muramidase1990199034.0low001000
chondroitin sulfates2005200519.0low000100
cyclic gmp3',5'-cyclic purine nucleotide;
guanyl ribonucleotide
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1982201328.5low49431110
guanosine monophosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
1998199826.0low001000
guanosine triphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
1984200032.7low012000
guanine2-aminopurines;
oxopurine;
purine nucleobase
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1999199925.0low001000
hypoxanthinenucleobase analogue;
oxopurine;
purine nucleobase
fundamental metabolite1987198737.0low110000
inosineinosines;
purines D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1987198737.0low110000
folic acidfolic acids;
N-acyl-amino acid
human metabolite;
mouse metabolite;
nutrient
201920195.0low000010
guanosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue1990199034.0low001000
zaprinasttriazolopyrimidines1988198836.0low010000
allopurinolnucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
1989200827.1low126400
2,2'-(hydroxynitrosohydrazono)bis-ethanamine2000200024.0low001000
guanylyl imidodiphosphatenucleoside triphosphate analogue1982198242.0low010000
bw 540c1987198737.0medium010000
8-bromocyclic gmp3',5'-cyclic purine nucleotide;
organobromine compound
muscle relaxant;
protein kinase G agonist
1989198935.0low010000
trypan blue1992199630.0low002000
coelenterazine2008200816.0low000100
n,n'-monomethylenebis(pyridiniumaldoxime)1987198737.0low010000
defibrotide1986200032.2low1410000
flm 50111988198836.0medium010000
eye1984198738.5low020000
acetylcellulose1991199133.0low101000
concanavalin a1988199134.5low011000
metallothionein1996199628.0low001000
leptin2001200620.5low000200
pyrimidinones1992199232.0low001000
tetrafluoroaluminate1989198935.0low010000
filipin2001200123.0low000100
phenanthrenes1996201620.0low002010
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
47,XX,+2102010201014.0low000100
Abdominal Aortic Aneurysm02012201212.0low100010
Abdominal Migraine01985200733.0low051100
Abdominal Pain01989198935.0low010000
Abnormality, Heart01987201028.2low012100
Abortion, Habitual01983199733.7low012000
Abortion, Recurrent01983199733.7low012000
Abortion, Spontaneous01985199335.0low011000
Abortion, Tubal01985199335.0low011000
Abortion, Veterinary01985200927.0low110100
Abruptio Placentae01981198143.0low010000
Abscess01984198440.0low010000
Abscess, Periapical01996199628.0low001000
Absence Seizure01998201418.0low001010
ACD-MPV01990199133.5low002000
Ache01984201626.2low125110
Acidosis01992199829.8low005000
Acidosis, Diabetic01982199636.4low163000
Acquired Nephrogenic Diabetes Insipidus01998199826.0low001000
Active Hyperemia01981201331.2low045110
Acute Bacterial Prostatitis02002200222.0low000100
Acute Brain Injuries01987201325.7low131020
Acute Confusional Senile Dementia02010201014.0low100100
Acute Disease01980200932.7low42222500
Acute Edematous Pancreatitis01985200731.2low0510200
Acute Hepatic Failure02005200519.0low000100
Acute Hypercapnic Respiratory Failure01984199136.6low052000
Acute Kidney Failure01981201533.3low0162120
Acute Kidney Injury01981201533.3low0162120
Acute Kidney Tubular Necrosis01987199833.0low021000
Acute Liver Injury, Drug-Induced01990201027.2low004100
Acute Lymphoid Leukemia01988199433.0low011000
Acute Myelogenous Leukemia01987199434.3low021000
Acute Necrotizing Pancreatitis01997201321.0low002210
Acute Post-operative Pain01987200824.3low310200
Acute Respiratory Distress Syndrome01984200430.9low31014200
Acute-Phase Reaction01989198935.0low010000
Adamantiades-Behcet Disease01984198639.0low030000
Addison Disease and Cerebral Sclerosis01993199331.0low001000
Adenocarcinoma01983200231.1low152300
Adenocarcinoma Of Kidney01998201020.0low101100
Adenocarcinoma, Basal Cell01983200231.1low152300
Adenoma01998199826.0low001000
Adenoma, Basal Cell01998199826.0low001000
Adenoma, beta-Cell02004200420.0low000100
Adenoma, Prostatic01981198143.0low010000
Adenomatous Polyposis Coli01998201220.7low002010
Adenomatous Polyposis Coli, Familial01998201220.7low002010
Adhesions, Tissue01982199236.3low021000
Adjuvant Arthritis01985201623.5low010010
Adnexitis01984198639.0low020000
ADPKD01992199232.0low001000
Adrenoleukodystrophy01993199331.0low001000
Agenesis of Hemidiaphragm01984199236.2low022000
Aging01981201534.3low03118510
Agnogenic Myeloid Metaplasia01991199133.0low001000
Agoraphobia01984198440.0low110000
Agranulocytosis01986198638.0low010000
AIDS Seroconversion02000200024.0low001000
Air Embolism01986198737.7low030000
Airflow Obstruction, Chronic02012201212.0low000010
Airway Hyper-Responsiveness01988199333.5low011000
Albuminuria01989201327.8low018210
Alcohol Abuse01987198836.6low050000
Alcohol Drinking01987200829.8low122100
Alcohol Related Neurodevelopmental Disorder01988200828.0low011100
Alcoholic Cirrhosis01986201427.8low021010
Alcoholic Hepatitis01984198440.0low010000
Alcoholic Intoxication01984200033.7low121000
Alcoholic Liver Diseases01994199430.0low002000
Alcoholism01987198836.6low050000
Aldosteronism01980198641.8low080000
Aldosteronism with Hyperplasia of the Adrenal Cortex01980200537.2low191200
Alkalosis01986198936.5low020000
Allergic Conjunctivitis01991199133.0low001000
Allergic Encephalomyelitis01984198639.3low030000
Allergic Reaction01994199430.0low001000
Allodynia01989200626.5low111200
Alloxan Diabetes01981201532.1low03923450
Altitude Hypoxia01989200726.0low110100
Altitude Sickness01989200726.0low110100
Alveolar Bone Atrophy01996199628.0low001000
Alveolitis, Fibrosing01982199437.7low021000
Alzheimer Disease02010201014.0low100100
Ameloblastoma01984198440.0low010000
Anaphylactic Reaction01983199735.2low076000
Anaphylaxis01983199735.2low076000
Anaplastic Astrocytoma01984199833.0low011000
Anasarca01981200632.7low077100
Anemia, Aplastic02001200123.0low100100
Anemia, Hemolytic01986198638.0low010000
Anemia, Hemolytic, Acquired01986198638.0low010000
Anemia, Hypoplastic02001200123.0low100100
Anemia, Sickle Cell01982201731.1low054110
Anesthesia01980201932.5low0113210
Aneurysm, Anterior Cerebral Artery01985199436.1low072000
Aneurysm, Aortic01981198938.3low130000
Angiitis02005200519.0low000100
Angina at Rest01986200433.8low273100
Angina Pectoris01981201035.2low82513100
Angina Pectoris, Variant01985198539.0low030000
Angina, Unstable01986200433.8low273100
Angioblastic Meningioma01984199334.7low012000
Angioedema0201720177.0low000010
Angiogenesis, Pathologic01993201420.8low102120
Angiohemophilia01987199035.5low011000
Angioneurotic Edema0201720177.0low000010
Angiospasm, Intracranial02012201212.0low100010
Angor Pectoris01981201035.2low82513100
Anoxemia01981200932.0low030241000
Anoxia-Ischemia, Brain02003200321.0low000100
Anoxia, Brain01987199633.0low022000
Anoxia, Fetal01993199331.0low001000
ANS (Autonomic Nervous System) Diseases01985198738.0low020000
Anterior Choroidal Artery Infarction01988201526.2low228030
Anterior Circulation Transient Ischemic Attack01985199934.9low0159000
Anti-Phospholipid Antibody Syndrome01991199730.0low002000
Antibiotic-Associated Colitis01988198836.0low010000
Antiphospholipid Syndrome01991199730.0low002000
Aortic Aneurysm01981198938.3low130000
Aortic Aneurysm, Abdominal02012201212.0low100010
Aortic Coarctation02004200420.0low000100
Aortic Diseases02009200915.0low000100
Aortic Stenosis01987198737.0low010000
Aortic Valve Stenosis01987198737.0low010000
Aortitis Syndrome02001200123.0low000100
Aphakia01988198836.0low010000
Aphthae01993199331.0low001000
Apnea01999199925.0low001000
Apnea, Obstructive Sleep02004201612.7low100120
Apnea, Sleep01991199829.5low002000
Apolipoprotein B-100, Familial Defective01997199727.0low001000
Apoplexy02000201514.5low101120
Aqueductal Stenosis01986199134.8low013000
Arrhythmia01984200034.6low098000
Arrhythmias, Cardiac01984200034.6low098000
Arterial Diseases, Carotid01984200929.8low030200
Arterial Obstructive Diseases01981200732.6low376300
Arterial Occlusive Diseases01981200732.6low376300
Arteriosclerosis01982200733.0low53115700
Arteriosclerosis Obliterans01981198939.0low060000
Arteriosclerosis, Coronary01987201223.9low113420
Arthritides, Bacterial01982198441.0low020000
Arthritis01989199830.0low313000
Arthritis, Degenerative01991200426.5low103100
Arthritis, Juvenile01981198143.0low010000
Arthritis, Juvenile Chronic01981198143.0low010000
Arthritis, Rheumatoid01981200135.0low3118100
Arthropathies01992199630.0low002000
Arthus Phenomenon01982198242.0low010000
Ascites01986198638.0low030000
Aseptic Necrosis of Femur Head02004200420.0low000100
Asphyxia01996199628.0low001000
Asphyxia Neonatorum01989200329.0low011100
Aspiration, Meconium01991199133.0low001000
Asthma01980201831.2low5617010
Asthma, Bronchial01980201831.2low5617010
Asthma, Exercise-Induced01989199134.0low111000
Astrocytoma01984199833.0low011000
Astrocytoma, Grade IV01984199833.0low011000
Asymmetric Diabetic Proximal Motor Neuropathy01987200130.6low024100
Asystole01998199826.0low001000
Atelectasis01985199235.5low011000
Atherogenesis02009201513.1low100540
Atheroma02013201311.0low000010
Atherosclerosis02009201513.1low100540
Atopic Hypersensitivity01981200234.8low030100
Atrial Fibrillation01990199133.5low002000
Atrial Septal Defect01998199826.0low101000
Atypical Ductal Hyperplasia01985198539.0low010000
Aura01992199232.0low001000
Auricular Fibrillation01990199133.5low002000
Autoimmune Diabetes01983201334.0low1143110
Autoimmune Disease01986199634.3low021000
Autoimmune Diseases01986199634.3low021000
Autolysis, Dental Pulp01996199628.0low001000
Autonomic Failure, Progressive01985198539.0low010000
Autosomal Hemophilia A01986198638.0low010000
B16 Melanoma01994199430.0low001000
Bacteremia01994200126.8low003100
Bacterial Disease01984199136.0low031000
Bacterial Infections01984199136.0low031000
Bacterial Infections, Gram-Negative02000200123.5low001100
Bacterial Vaginitides01992199232.0low001000
Bacteroides Infections01984198440.0low010000
Bancroftian Elephantiasis02013201311.0low000010
Basal Ganglia Hemorrhage02009200915.0low000100
Basedow Disease01983198739.0low020000
Basophilic Leukemia, Acute01997199727.0low001000
Behcet Syndrome01984198639.0low030000
Bends02002200222.0low000100
Benign Meningeal Neoplasms01984199334.7low012000
Benign Neoplasms02002200222.0low000100
Benign Neoplasms, Brain01984199832.6low014000
Benign Supratentorial Neoplasms01993199331.0low001000
Berger Disease01989198935.0low010000
Besnier-Boeck Disease01984198440.0low010000
Bilateral Headache02007200717.0low100100
Bile Duct Obstruction01982199633.8low024000
Bile Duct Obstruction, Extrahepatic01996199628.0low001000
Bile Duct Obstruction, Intrahepatic01990199034.0low001000
Biliary Cirrhosis01993200726.3low002100
Biliary Tract Cancer02000200024.0low001000
Biliary Tract Neoplasms02000200024.0low001000
Birth Weight01981200527.0low013100
Bladder Diseases01991199133.0low001000
Bleb01981199138.3low121000
Bleeding01984201133.5low185010
Bleeding Between Periods01988198836.0low010000
Blood Clot01982202226.4low421281592
Blood Coagulation Disorders01997202115.2low002021
Blood Loss, Surgical01997199727.0low001000
Blood Platelet Disorders01990199332.5low102000
Blood Poisoning01984201931.0low0910110
Blood Pressure, High01981201732.0low3194842450
Blood Pressure, Low01980201730.4low4125530
Blood Vessel Tumors01986198638.0low010000
Blunt Injuries01994199430.0low001000
Body Weight01981201630.3low729331510
Bone Cancer01985199734.2low023000
Bone Cysts01984198440.0low010000
Bone Fractures01996199628.0low001000
Bone Loss, Osteoclastic01980199836.0low0123000
Bone Neoplasms01985199734.2low023000
Bordetella Infections01991199133.0low001000
Bouillaud Disease01990199034.0low001000
Bovine Diseases01986199434.3low042000
Bradyarrhythmia01996199628.0low001000
Bradycardia01996199628.0low001000
Brain Concussion01989198935.0low010000
Brain Damage, Chronic01994199430.0low001000
Brain Diseases01992199232.0low001000
Brain Disorders01992199232.0low001000
Brain Edema01985201328.9low075320
Brain Embolism and Thrombosis01987198737.0low010000
Brain Hemorrhage, Cerebral01985200532.4low275100
Brain Inflammation02009200915.0low000100
Brain Injuries01987201325.7low131020
Brain Ischemia01985200832.6low21616300
Brain Neoplasms01984199832.6low014000
Brain Swelling01985201328.9low075320
Brain Vascular Disorders01986199931.9low137000
Branch Retinal Artery Occlusion01999199925.0low001000
Branch Vein Occlusion01993199928.0low002000
Brazilian Spotted Fever01990200626.0low001100
Break-Bone Fever01990199034.0low001000
Breast Cancer01983200136.9low061100
Breast Diseases01985198539.0low010000
Breast Neoplasms01983200136.9low061100
Bright Disease01982200533.8low297200
Bronchial Hyperreactivity01992200227.7low206100
Bronchial Spasm01988198935.5low120000
Bronchitis01990199034.0low001000
Bronchopulmonary Dysplasia01986199732.5low211000
Bronchospasm01988198935.5low120000
Bronchospasm, Exercise-Induced01989199134.0low111000
Bruise01992199928.5low002000
Buerger Disease01981201428.2low031020
Burns01981201632.2low1913010
Burns, Inhalation01986199335.2low031000
Cadaver01984200131.5low110100
Cadmium Poisoning01998199826.0low001000
Calcium Pyrophosphate Deposition Disease01991199133.0low001000
Cancer of Colon01986200627.8low012200
Cancer of Digestive System01989198935.0low010000
Cancer of Esophagus02008200816.0low100100
Cancer of Gallbladder01984199932.5low011000
Cancer of Gastrointestinal Tract0201920195.0low000010
Cancer of Head01984198838.0low020000
Cancer of Intestines01993200026.3low003000
Cancer of Jaw01983198341.0low010000
Cancer of Kidney01986201029.0low121100
Cancer of Larynx01990199332.5low002000
Cancer of Liver01990200627.1low104300
Cancer of Lung01984200430.0low144300
Cancer of Mouth01987198737.0low010000
Cancer of Ovary01983200235.7low150100
Cancer of Pancreas01984200427.3low010200
Cancer of Pelvis01986199135.5low011000
Cancer of Pituitary01986198638.0low010000
Cancer of Prostate01981200234.7low020100
Cancer of Skin01992199232.0low001000
Cancer of Stomach01998200124.5low001100
Cancer of the Uterus01984199236.1low054000
Cancer, Embryonal01996199628.0low001000
Canine Diseases01995201021.5low001100
Capillary Leak Syndrome02002200222.0low000100
Carbon Tetrachloride Poisoning01999199925.0low001000
Carcinoma01986198638.0low010000
Carcinoma, Anaplastic01986198638.0low010000
Carcinoma, Embryonal01996199628.0low001000
Carcinoma, Epidermoid01984200832.4low243100
Carcinoma, Hepatocellular01993200228.0low002100
Carcinoma, Intraductal, Noninfiltrating01985198539.0low010000
Carcinoma, Non-Small Cell Lung01993200427.0low002100
Carcinoma, Non-Small-Cell Lung01993200427.0low002100
Carcinoma, Oat Cell01987198737.0low010000
Carcinoma, Renal Cell01998201020.0low101100
Carcinoma, Small Cell01987198737.0low010000
Carcinoma, Squamous Cell01984200832.4low243100
Carcinosarcoma02003200321.0low000100
Cardiac Complex, Premature01991199133.0low002000
Cardiac Death01998199826.0low001000
Cardiac Diseases01984201030.5low036200
Cardiac Failure01986200831.8low354100
Cardiac Neurosis01990199034.0low001000
Cardiac Rupture, Traumatic01992199232.0low001000
Cardiac Septal Defect02000200024.0low101000
Cardiac Tamponade02003200321.0low000100
Cardiometabolic Syndrome02006201613.0low000320
Cardiomyopathies01993200127.0low001100
Cardiomyopathies, Primary01993200127.0low001100
Cardiomyopathy, Congestive01991200827.3low002100
Cardiomyopathy, Dilated01991200827.3low002100
Cardiomyopathy, Hypertrophic01991199133.0low001000
Cardiomyopathy, Hypertrophic Obstructive01991199133.0low001000
Cardiovascular Diseases01990201222.4low304210
Cardiovascular Pregnancy Complications01981200433.3low41717200
Cardiovascular Stroke01981201829.4low626311340
Caries, Dental01999199925.0low001000
Carotid Arteriopathies, Traumatic01999200124.3low002100
Carotid Artery Diseases01984200929.8low030200
Carotid Artery Narrowing01999199925.0low002000
Carotid Artery Thrombosis01982202218.8low112241
Carotid Stenosis01999199925.0low002000
Cataract01996199628.0low001000
Cataract, Membranous01996199628.0low001000
CBS Deficiency01993199331.0low001000
Celiac Disease01984198440.0low010000
Celiac Sprue01984198440.0low010000
Cell Transformation, Neoplastic01987200827.7low011100
Cells, Neoplasm Circulating01988198836.0low010000
Central Hypothyroidism01987198737.0low010000
Centriacinar Emphysema02009200915.0low000100
Cerebral Arteriosclerosis01991199133.0low001000
Cerebral Concussion01989198935.0low010000
Cerebral Hemorrhage01985200532.4low275100
Cerebral Hemorrhage, Hypertensive02007200816.5low000200
Cerebral Infarction01988201526.2low228030
Cerebral Infarction, Middle Cerebral Artery02011201510.7low000030
Cerebral Ischemia01985200832.6low21616300
Cerebro-Hepato-Renal Syndrome01993199331.0low001000
Cerebrovascular Disorders01986199931.9low137000
Chemical and Drug Induced Liver Injury01990201027.2low004100
Chemical Dependence01982198242.0low010000
Cholangitis01990200029.0low102000
Cholecystitis01990199930.8low009000
Cholelithiasis01990199233.0low002000
Cholera Infantum01994199430.0low001000
Cholestasis01982199633.8low024000
Cholestasis, Intrahepatic01990199034.0low001000
Cholesteatoma01988198836.0low010000
Chondroblastoma01997199727.0low001000
Chondrocalcinosis01991199133.0low001000
Chondrodysplasia Punctata01993199331.0low001000
Choriocarcinoma01991199133.0low001000
Chronic Disease01980201031.5low41516600
Chronic Illness01980201031.5low41516600
Chronic Kidney Failure01981200735.0low2176400
Chronic Lung Injury01985199933.9low043000
Circulatory Collapse01983200332.5low147100
Cirrhoses, Experimental Liver01988201423.0low011110
Cirrhosis01990201521.5low001010
Cirrhosis, Liver01986201631.1low189310
Claustrophobia01984198440.0low110000
Cleft Palate01982198242.0low010000
Cleft Palate, Isolated01982198242.0low010000
Closed Head Injuries02013201311.0low000010
Coagulation Disorders, Blood01997202115.2low002021
Coagulation, Disseminated Intravascular01981199037.6low041000
Coarctation of Aorta02004200420.0low000100
Cold Fingers, Hereditary01981201833.6low292010
Colicky Pain01989198935.0low010000
Colitis01988201625.7low023020
Colitis Gravis01982199535.7low033000
Colitis, Granulomatous01982198640.0low040000
Colitis, Ulcerative01982199535.7low033000
Colonic Inertia02007200717.0low100100
Colonic Neoplasms01986200627.8low012200
Colorectal Cancer02008201711.5low100110
Colorectal Neoplasms02008201711.5low100110
Compensatory Hyperinsulinemia01989199631.5low011000
Complication, Intraoperative01989201718.5low310210
Complication, Postoperative01986201924.6low343330
Complications of Diabetes Mellitus01994201418.3low001110
Complications, Hematologic Pregnancy02001200123.0low100100
Complications, Infectious Pregnancy01989199631.7low012000
Complications, Labor01984198440.0low010000
Complications, Pregnancy01981199239.3low081000
Congenital Thrombotic Thrombocytopenic Purpura01981198641.0low040000
Congenital Zika Syndrome0202020204.0low000010
Conjunctivitis, Allergic01991199133.0low001000
Constipation02007200717.0low100100
Constriction, Pathologic01985201128.8low012010
Constriction, Pathological01985201128.8low012010
Contusions01992199928.5low002000
Conus Medullaris Syndrome01988200430.0low011100
Convalescence01999199925.0low001000
Cor Pulmonale01987201027.1low016200
Coronary Artery Disease01987201223.9low113420
Coronary Artery Vasospasm01985200431.0low043200
Coronary Disease01981200735.8low107238200
Coronary Heart Disease01981200735.8low107238200
Coronary Restenosis02001200123.0low000100
Coronary Thrombosis01986201131.4low034010
Coronary Vasospasm01985200431.0low043200
Cough01997199727.0low101000
Craniocerebral Injuries01981198739.7low030000
Craniocerebral Trauma01981198739.7low030000
Critical Illness01992201520.5low001010
Crohn Disease01982198640.0low040000
Cruveilhier-Baumgarten Syndrome01985200728.6low0310400
Cryptogenic Fibrosing Alveolitis02014201410.0low000010
Curling Ulcer01983199337.1low161000
Cyst01992200127.5low001100
Cyst, Dental Root01984198440.0low010000
Cystadenocarcinoma01989198935.0low010000
Cystic Echinococcosis02002200222.0low000100
Cystic Fibrosis01986198638.0low120000
Cystic Fibrosis of Pancreas01986198638.0low120000
Cytomegalic Inclusion Disease02001200123.0low100100
Cytomegalovirus Infections02001200123.0low100100
DDD MPGNII01989198935.0low010000
Deafness, Sudden01997199727.0low101000
Death, Sudden01982200336.2low050100
Decerebrate Posturing01983198341.0low010000
Deep Vein Thrombosis02001202013.1low100250
Deficiency Diseases01991199133.0low001000
Deficiency, Magnesium01986200826.7low011100
Deficiency, Vitamin D0201920195.0low000010
Deficiency, Vitamin E01981199537.4low053000
Deficiency, Yang01992199331.5low102000
Deficiency, Yin01992199729.8low204000
Delayed Hypersensitivity01983198341.0low010000
Delayed Postpartum Hemorrhage01998199826.0low001000
Dengue01990199034.0low001000
Dental Caries01999199925.0low001000
Dental Pulp Exposure01996199628.0low001000
Dental Tissue Neoplasms01984198440.0low010000
Dentigerous Cyst01985198937.0low020000
Dermatitis, Atopic01987200431.6low122100
Dermatitis, Contact, Phototoxic01997199727.0low001000
Dermatoses01983198938.0low020000
Diabetes Insipidus01983199437.3low021000
Diabetes Mellitus01980199937.4low0173000
Diabetes Mellitus, Adult-Onset01984201527.0low4920940
Diabetes Mellitus, Gestational01998200224.0low001100
Diabetes Mellitus, Type 101983201334.0low1143110
Diabetes Mellitus, Type 201984201527.0low4920940
Diabetes, Gestational01998200224.0low001100
Diabetic Angiopathies01981200732.9low063200
Diabetic Glomerulosclerosis01987200328.4low426400
Diabetic Ketoacidosis01982199636.4low163000
Diabetic Nephropathies01987200328.4low426400
Diabetic Neuropathies01987200130.6low024100
Diabetic Retinopathy01981200334.7low054100
Diaphragmatic Hernia01984199236.2low022000
Diarrhea01993200724.0low101100
Diathesis01988200032.0low122000
Diffuse Mixed Small and Large Cell Lymphoma01987198737.0low010000
Diffuse Parenchymal Lung Disease02001200123.0low100100
Digestive System Diseases01989198935.0low010000
Digestive System Disorders01989198935.0low010000
Digestive System Neoplasms01989198935.0low010000
Dilatation, Pathologic01984198440.0low010000
Disc, Herniated01991199133.0low001000
Disease01987198737.0low010000
Disease Exacerbation01999201615.7low001420
Disease Models, Animal01981202125.2low0415340271
Disease, Pulmonary01981200832.9low11716400
Diseases in Twins01988198836.0low010000
Diseases, Occupational01990199034.0low001000
Disseminated Intravascular Coagulation01981199037.6low041000
Distorted Hearing01994199430.0low001000
Dizziness01989198935.0low010000
Dizzyness01989198935.0low010000
Down Syndrome02010201014.0low000100
Drowning02002200222.0low000100
Drug Withdrawal Symptoms01987199634.0low021000
Ductus Arteriosus, Patent01984200834.4low3111200
Duodenal Diseases01991199133.0low001000
Duodenal Ulcer01983199337.1low161000
Dysentery, Bacillary01991199133.0low001000
Dysentery, Shiga bacillus01991199133.0low001000
Dyslipidemia02009200915.0low000100
Dyslipidemias02009200915.0low000100
Dysmenorrhea01983201126.0low313210
E coli Infections01984201331.3low0710210
Eclampsia01984198440.0low010000
Eczema, Atopic01987200431.6low122100
Edema01981200632.7low077100
Edema-Proteinuria-Hypertension Gestosis01981201531.3low62946710
Edema, Pulmonary01982200434.1low01715200
EHS Tumor01984199335.7low021000
Electrolytes01983200732.7low397200
Elephantiasis, Filarial02013201311.0low000010
Elevated Cholesterol01982200930.7low049100
Embolism, Fat01990199731.5low004000
Embolism, Pulmonary01981201433.6low0143410
Embryopathies01989199134.0low011000
Emesis01982198738.7low030000
Empyema, Gall Bladder01990199930.8low009000
Encephalitis02009200915.0low000100
Encephalitis, Polio02011201113.0low000010
Encephalopathy, Hepatic02006201613.0low000110
Endometrial Diseases01996200125.5low001100
Endometrioma01981201532.5low4127120
Endometriosis01981201532.5low4127120
Endometritis02013201311.0low000010
Endomyometritis02013201311.0low000010
Endotoxemia01996200725.0low009400
Endotoxin Shock01980200835.2low04825300
Enterocolitis, Pseudomembranous01988198836.0low010000
Eosinophilia01987198737.0low010000
Eosinophilia, Tropical01987198737.0low010000
Eosinophilic Granuloma01997199727.0low001000
Epilepsy01992199232.0low001000
Equine Diseases01982199934.2low185000
Erectile Dysfunction01992199431.0low002000
Erythema01983198341.0low020000
Erythremia01985199136.0low011000
Escherichia coli Infections01984201331.3low0710210
Esophageal and Gastric Varices01986198936.5low020000
Esophageal Neoplasms02008200816.0low100100
Esophageal Varices01986198936.5low020000
Ewing Sarcoma01985198638.5low020000
Experimental Hepatoma01988200625.0low010200
Experimental Leukemia01983198341.0low010000
Experimental Lung Inflammation01985200931.6low032200
Experimental Mammary Neoplasms01983198838.0low050000
Experimental Radiation Injuries01984199633.0low033000
Exposure, Dental Pulp01996199628.0low001000
Extramembranous Glomerulopathy01998199925.5low002000
Extravascular Hemolysis01985200230.5low010100
Eye Diseases01996199628.0low001000
Eye Disorders01996199628.0low001000
Eye Injuries, Penetrating01998199826.0low001000
Facial Neoplasms01983198341.0low010000
Fallot's Tetralogy01986198638.0low010000
Familial Primary Pulmonary Hypertension02011201113.0low000010
Fasting Hypoglycemia01985198539.0low010000
Fatty Liver02004201116.5low000110
Female Genital Diseases01985199036.0low021000
Female Genital Neoplasms01982199038.0low031000
Fetal Death01981199239.4low041000
Fetal Distress01986198638.0low010000
Fetal Growth Restriction01981201129.3low128110
Fetal Growth Retardation01981201129.3low128110
Fetal Hypoxia01993199331.0low001000
Fever01985201626.7low111010
Fibroid01985199235.5low022000
Fibromuscular Dysplasia01984198440.0low010000
Fibrosarcoma01987198836.5low020000
Fibrosis01990201521.5low001010
Fistula01981198640.5low020000
Flaccid Quadriplegia01992199232.0low001000
Flushing01984201923.8low531220
Focal Segmental Glomerulosclerosis01995199529.0low001000
Foot Diseases01999199925.0low001000
Foreign-Body Granuloma01990199034.0low001000
Foreign-Body Reaction01986199036.3low021000
Fractures, Bone01996199628.0low001000
Frostbite01997199826.3low003000
Gallbladder Neoplasms01984199932.5low011000
Gallstone Disease01990199233.0low002000
Gasser Syndrome01981200235.8low062100
Gastric Diseases01985201224.7low034510
Gastric Fistula01992199232.0low001000
Gastric Ulcer01983201529.3low0149730
Gastritis01989201528.7low023010
Gastroduodenal Ulcer01985201632.3low054010
Gastroenteritis01985198539.0low010000
Gastrointestinal Hemorrhage01984199436.0low131000
Genetic Predisposition02011201113.0low000010
Genital Diseases, Female01985199036.0low021000
Genital Neoplasms, Female01982199038.0low031000
Genito-urinary Cancer01986198638.0low010000
Germinoblastoma01991199133.0low001000
Gestational Hypertension02004200420.0low100100
Giant Osteoid Osteoma01997199727.0low001000
Gingival Hyperplasia01992199232.0low001000
Gingivitis01985199235.5low011000
Glial Cell Tumors01984198440.0low010000
Glioblastoma01984199833.0low011000
Glioma01984198440.0low010000
Glomerulonephritis01982200533.8low297200
Glomerulonephritis, IGA01989198935.0low010000
Glomerulonephritis, Lupus01987200128.7low114100
Glomerulonephritis, Membranoproliferative01989198935.0low010000
Glomerulonephritis, Membranous01998199925.5low002000
Glomerulonephritis, Minimal Change01986200032.7low021000
Glomerulosclerosis, Focal Segmental01995199529.0low001000
Glucose Intolerance01998201220.5low101210
Glycosuria01987198737.0low010000
Goldblatt Syndrome01984200535.9low0121100
Graft Occlusion, Vascular01985199733.7low054000
Graft vs Host Disease02001200123.0low100100
Graft-Versus-Host Disease02001200123.0low100100
Gram-Negative Bacterial Infections02000200123.5low001100
Granulocytic Leukemia01985198539.0low010000
Granulocytic Leukemia, Chronic01991199133.0low001000
Granuloma01979198543.0low040000
Granuloma, Hodgkin01987198737.0low010000
Granulomas01979198543.0low040000
Graves Disease01983198739.0low020000
Group A Strep Infection01984199336.0low063000
Hay Fever01987198737.0low010000
HbS Disease01982201731.1low054110
Head and Neck Neoplasms01984198838.0low020000
Headache02007200717.0low100100
Heart Arrest01998199826.0low001000
Heart Defects, Congenital01987201028.2low012100
Heart Disease, Ischemic01992201624.7low4019710
Heart Diseases01984201030.5low036200
Heart Failure01986200831.8low354100
Heart Septal Defects, Ventricular01998199826.0low101000
Heart Valve Diseases02010201014.0low000100
Heavy Menstrual Bleeding01981199237.5low031000
Helicobacter Infections01993200326.0low001100
HELLP Syndrome01997199727.0low001000
Hematochezia01984199436.0low131000
Hematoma01984198738.5low020000
Hemolysis01985200230.5low010100
Hemolysis, Elevated Liver Enzymes, Lowered Platelets01997199727.0low001000
Hemolytic-Uremic Syndrome01981200235.8low062100
Hemophilia A01986198638.0low010000
Hemorrhage01984201133.5low185010
Hemorrhage, Oral01987198737.0low110000
Hemorrhage, Subarachnoid01983201234.9low1166010
Hemorrhage, Uterine0202020204.0low000010
Hemorrhagic Diathesis01996199628.0low001000
Hemorrhagic Disorders01996199628.0low001000
Hemorrhagic Fever with Renal Syndrome01990199233.0low004000
Hemorrhagic Fever, Epidemic01990199233.0low004000
Hemorrhagic Shock01985199732.4low0210000
Hemorrhagic Thrombocythemia01991201419.0low101110
Hepatic Encephalopathy02006201613.0low000110
Hepatic Failure02001200123.0low000100
Hepatic Veno Occlusive Disease01996199827.0low002000
Hepatic Veno-Occlusive Disease01996199827.0low002000
Hepatitis B01990199730.5low002000
Hepatitis B Virus Infection01990199730.5low002000
Hepatitis, Alcoholic01984198440.0low010000
Hepatitis, Viral, Human01992199232.0low001000
Hepato-Pulmonary Syndrome02014201410.0low000010
Hepatocellular Carcinoma01993200228.0low002100
Hepatopulmonary Syndrome02014201410.0low000010
Heritable Pulmonary Arterial Hypertension02011201113.0low000010
Hernias, Diaphragmatic, Congenital01984199236.2low022000
Herpes Simplex01989198935.0low010000
Herpes Simplex Virus Infection01989198935.0low010000
Hibernation, Myocardial01996200225.2low003100
HIV Coinfection02000200024.0low001000
HIV Infections02000200024.0low001000
Hives01991199133.0low001000
Hodgkin Disease01987198737.0low010000
Homocystinuria01993199331.0low001000
Hyaline Membrane Disease01992199232.0low001000
Hydatid Mole01984198440.0low010000
Hydatidiform Mole01984198440.0low010000
Hydronephrosis01981199735.2low023000
Hyperaldosteronism01980198641.8low080000
Hyperammonemia0201520159.0low000010
Hypercapnia01984200928.8low036400
Hypercholesterolemia01982200930.7low049100
Hyperchylomicronemia Late Onset01986198638.0low010000
Hypercoagulability02004200420.0low000100
Hyperemia01981201331.2low045110
Hyperesthesia01989198935.0low010000
Hyperglycemia01997200025.5low002000
Hyperglycemia, Postprandial01997200025.5low002000
Hyperinsulinism01989199631.5low011000
Hyperkalemia01986198638.0low010000
Hyperlipemia01986201727.3low0410320
Hyperlipidemias01986201727.3low0410320
Hyperlipoproteinemia01986198638.0low010000
Hyperlipoproteinemia Type II01997199727.0low001000
Hyperlipoproteinemias01986198638.0low010000
Hyperoxia01998200224.0low001100
Hyperplasia01991200028.5low002000
Hyperpotassemia01986198638.0low010000
Hypersensitivity01994199430.0low001000
Hypersensitivity, Type III01991199133.0low001000
Hypertension01981201732.0low3194842450
Hypertension, Portal01985200728.6low0310400
Hypertension, Pregnancy-Induced02004200420.0low100100
Hypertension, Pulmonary01982202130.0low229301331
Hypertension, Renal01985201525.6low031310
Hypertension, Renovascular01984200535.9low0121100
Hyperthyroid01987198737.0low010000
Hyperthyroidism01987198737.0low010000
Hypertriglyceridemia01988198836.0low010000
Hypertrophy01986201521.3low010110
Hypertrophy, Left Ventricular01993199430.5low002000
Hypertrophy, Right Ventricular02004201615.5low000310
Hyperuricemia02008200816.0low000100
Hyperventilation01981200334.7low032100
Hypoglycemia01985198539.0low010000
Hypokalemia01982200433.2low121100
Hypomenorrhea01987200727.0low010100
Hypotension01980201730.4low4125530
Hypotension, Orthostatic01985198539.0low010000
Hypotension, Postural01985198539.0low010000
Hypothermia01994200226.0low001100
Hypothermia, Accidental01994200226.0low001100
Hypothyroidism01987198737.0low010000
Hypoxia01981200932.0low030241000
Hypoxia-Ischemia, Brain02003200321.0low000100
Icterus01983198341.0low010000
Icterus Gravis Neonatorum01985198539.0low010000
Idiopathic Inflammatory Myopathies01988198836.0low010000
Idiopathic Pulmonary Fibrosis02014201410.0low000010
Impaired Glucose Tolerance01998201220.5low101210
Impotence01992199431.0low002000
Inadequate Sleep01997199727.0low001000
Infant, Premature, Diseases01983199037.8low381000
Infant, Small for Gestational Age02000200024.0low001000
Infantile Respiratory Distress Syndrome01982200235.5low2133100
Infarct01999200223.5low001100
Infarction, Middle Cerebral Artery02011201510.7low000030
Infection01989199632.3low012000
Infection, Postoperative Wound01987198737.0low010000
Infection, Wound01984198639.0low020000
Infections01989199632.3low012000
Infections, Helicobacter01993200326.0low001100
Infections, Listeria01987198737.0low010000
Infections, Paramyxoviridae01991199133.0low001000
Infections, Pasteurella01985198539.0low010000
Infections, Plasmodium01984198639.0low020000
Infections, Pneumococcal01991199829.5low002000
Infections, Pseudomonas01985199037.1low061000
Infections, Respiratory Syncytial Virus02004200420.0low000100
Infections, Respirovirus01989198935.0low010000
Infections, Yersinia01984198440.0low010000
Infertility01984199634.0low011000
Infertility, Female01981200136.1low051100
Infertility, Male01979197945.0low010000
Inflammation01979201728.3low216171530
Inflammation, Endodontic01987199931.2low022000
Inflammatory Response Syndrome, Systemic01996200125.7low102100
Inhalation Injury, Smoke01993200525.0low001100
Injuries01986199634.8low041000
Injuries, Multiple01991202118.0low001001
Injuries, Spinal01993199331.0low001000
Injuries, Spinal Cord01985200730.4low055300
Injury, Ischemia-Reperfusion01988201625.5low11351740
Injury, Myocardial Reperfusion01989201525.4low22251020
Innate Inflammatory Response01979201728.3low216171530
Insulin Resistance02002201516.0low000310
Insulin Sensitivity02002201516.0low000310
Insulinoma02004200420.0low000100
Intermittent Claudication01988199730.3low112000
Interstitial Nephritis01994199430.0low001000
Intervertebral Disc Displacement01991199133.0low001000
Intestinal Diseases01988201425.0low011010
Intestinal Neoplasms01993200026.3low003000
Intestinal Perforation01995199529.0low001000
Intracranial Aneurysm01985199436.1low072000
Intracranial Arteriosclerosis01991199133.0low001000
Intradural-Extramedullary Spinal Cord Neoplasms01988198836.0low010000
Intraocular Pressure02000200024.0low001000
Intraventricular Septal Defects01998199826.0low101000
Invasiveness, Neoplasm01991200227.5low001100
Ischemia01981200731.3low21727900
Ischemic Attack, Transient01985199934.9low0159000
Itching02004200718.7low000300
Jaundice01983198341.0low010000
Jaundice, Neonatal01985198539.0low010000
Jaundice, Spirochetal01991199133.0low001000
Jaw Diseases01985198539.0low010000
Joint Diseases01992199630.0low002000
Kahler Disease02006200618.0low000100
Kawasaki Disease01988199135.0low121000
Keratocysts01984198639.0low020000
Kidney Diseases01986201328.5low399810
Kidney Failure01999201517.0low001010
Kidney Failure, Chronic01981200735.0low2176400
Kidney Neoplasms01986201029.0low121100
Kidney Tubular Necrosis, Acute01987199833.0low021000
Kidney, Polycystic02009200915.0low000100
Labor, Premature01981200033.0low145000
Laryngeal Neoplasms01990199332.5low002000
Laryngitis01990199034.0low001000
Left Ventricular Dysfunction01998200025.0low002000
Left Ventricular Hypertrophy01993199430.5low002000
Left Ventricular Outflow Obstruction01993199331.0low001000
Leiomyoma01985199235.5low022000
Leucocythaemia02001200123.0low100100
Leukemia02001200123.0low100100
Leukemia, Basophilic, Acute01997199727.0low001000
Leukemia, Lymphocytic01987198737.0low010000
Leukemia, Lymphoid01987198737.0low010000
Leukemia, Myelogenous, Chronic, BCR-ABL Positive01991199133.0low001000
Leukemia, Myeloid01985198539.0low010000
Leukemia, Myeloid, Acute01987199434.3low021000
Leukocytopenia01986200029.3low018000
Leukocytosis01988198836.0low010000
Leukopenia01986200029.3low018000
Libman-Sacks Disease01985199634.2low033000
Lichen Simplex Chronicus01989198935.0low010000
Liver Cirrhosis01986201631.1low189310
Liver Cirrhosis, Alcoholic01986201427.8low021010
Liver Cirrhosis, Biliary01993200726.3low002100
Liver Diseases01984200629.6low027200
Liver Diseases, Alcoholic01994199430.0low002000
Liver Dysfunction01984200629.6low027200
Liver Failure02001200123.0low000100
Liver Failure, Acute02005200519.0low000100
Liver Neoplasms01990200627.1low104300
Liver Steatosis02004201116.5low000110
Local Neoplasm Recurrence01983198341.0low010000
Lung Diseases01981200832.9low11716400
Lung Diseases, Interstitial02001200123.0low100100
Lung Diseases, Obstructive01984201030.5low014100
Lung Neoplasms01984200430.0low144300
Lupus Erythematosus, Systemic01985199634.2low033000
Lupus Nephritis01987200128.7low114100
Lymph Node Metastasis01983199337.2low031000
Lymphatic Diseases01981198640.5low020000
Lymphoma01991199133.0low001000
Lymphoma, Non-Hodgkin01987198737.0low010000
Maculopapular Cutaneous Mastocytosis01983199933.0low011000
Magnesium Deficiency01986200826.7low011100
Malaria01984198639.0low020000
Marasmus01988198836.0low010000
Mastitis, Bovine01991199133.0low001000
Maxillary Neoplasms01987198737.0low010000
Meconium Aspiration Syndrome01991199133.0low001000
Meningeal Neoplasms01984199334.7low012000
Meningioma01984199334.7low012000
Meningitis01989198935.0low010000
Menopause01982199337.1low082000
Menorrhagia01981199237.5low031000
Menstruation, Painful01983201126.0low313210
Mesenteric Vascular Occlusion01989198935.0low010000
Metabolic Acidosis01992199829.8low005000
Metabolic Syndrome02006201613.0low000320
Metastase01981200237.4low070100
Metrorrhagia01988198836.0low010000
Middle Ear Effusion01988199134.3low012000
Middle Ear Inflammation01988199831.0low011000
Migraine Disorders01985200733.0low051100
Mitral Incompetence01985201026.5low010100
Mitral Stenosis01990199929.5low002000
Mitral Valve Insufficiency01985201026.5low010100
Mitral Valve Stenosis01990199929.5low002000
MODS01991200528.8low1011100
Morphine Abuse01987198737.0low010000
Morphine Dependence01987198737.0low010000
Mouth Neoplasms01987198737.0low010000
MS (Multiple Sclerosis)01985198937.3low030000
Mucocutaneous Lymph Node Syndrome01988199135.0low121000
Multiple Myeloma02006200618.0low000100
Multiple Organ Failure01991200528.8low1011100
Multiple Sclerosis01985198937.3low030000
Muscle Contraction01980201732.5low13025830
Muscle Relaxation01985201428.3low0610410
Muscle Spasm01999199925.0low001000
Myelopathy02007200717.0low000100
Myeloproliferative Disorders01985199136.7low021000
Myocardial Infarction01981201829.4low626311340
Myocardial Ischemia01992201624.7low4019710
Myositis01988198836.0low010000
Nasal Catarrh01993199729.0low002000
Nasal Polyps01987200029.8low014000
Nausea01987198737.0low010000
Necrosis01984199832.4low026000
Necrotizing Pyelonephritis01982199734.5low011000
Neoplasm Metastasis01981200237.4low070100
Neoplasms02002200222.0low000100
Neoplasms, Germ Cell and Embryonal01996199628.0low001000
Nephritis01987199533.2low023000
Nephritis, Interstitial01994199430.0low001000
Nephrosis01988198836.0low010000
Nephrosis, Lipoid01986200032.7low021000
Nephrotic Syndrome01982200531.1low234100
Nervous System Diseases02013201311.0low000010
Nervous System Disorders02013201311.0low000010
Neurodermatitis01989198935.0low010000
Neutropenia01986198638.0low010000
Obesity01996201519.6low104420
Obstructive Lung Diseases01984201030.5low014100
Oligomenorrhea01992199232.0low001000
Osteoarthritis01991200426.5low103100
Osteogenic Sarcoma01983199734.8low032000
Osteoid Osteoma01991199232.7low003000
Osteomyelitis01991199133.0low001000
Osteosarcoma01983199734.8low032000
Otitis Media01988199831.0low011000
Otitis Media with Effusion01988199134.3low012000
Ovarian Diseases01994199430.0low101000
Ovarian Hyperstimulation Syndrome01991199133.0low001000
Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous01991199133.0low001000
Ovarian Neoplasms01983200235.7low150100
Ovine Diseases01985199137.0low021000
Pachymeningitis01989198935.0low010000
Pain01984201626.2low125110
Pain, Postoperative01987200824.3low310200
Palmoplantaris Pustulosis01983198937.3low030000
Pancreatic Neoplasms01984200427.3low010200
Pancreatitis01985200731.2low0510200
Paramyxoviridae Infections01991199133.0low001000
Parasitemia02013201311.0low000010
Parodontosis01996199628.0low001000
Paroxysmal Reciprocal Tachycardia01986200628.0low110100
Patency of the Ductus Arteriosus01984200834.4low3111200
Pelvic Inflammatory Disease01984198639.0low020000
Peptic Ulcer01985201632.3low054010
Periapical Cyst01986198638.0low010000
Pericementitis01985200632.2low021100
Periodontal Diseases01996199628.0low001000
Periodontal Pocket01986198638.0low010000
Periodontitis01985200632.2low021100
Peritonitis01982200234.8low0105200
Persistent Fetal Circulation Syndrome01990199133.5low002000
Phlegmasia Alba Dolens01987199632.7low124000
Phobic Disorders01984198440.0low110000
Pituitary Neoplasms01986198638.0low010000
Placenta Diseases01981201226.0low011210
Placental Abruption01981198143.0low010000
Placental Insufficiency01981198143.0low010000
Plant Poisoning01985198539.0low010000
Pleural Effusion01986198638.0low010000
Pleurisy01984200331.7low059100
Plica Syndrome01983199236.5low011000
Pneumococcal Infections01991199829.5low002000
Pneumonia01985200931.6low032200
Pneumonia, Pneumococcal01987200329.0low010100
Pocket, Periodontal01986198638.0low010000
Poliomyelitis02011201113.0low000010
Polyarthritis01989199830.0low313000
Polycystic Kidney Diseases02009200915.0low000100
Polycystic Kidney, Autosomal Dominant01992199232.0low001000
Polycythemia Vera01985199136.0low011000
Polyuria01985200031.6low234000
Post-operative Vasoplegic Syndrome0201920195.0low000010
Postoperative Complications01986201924.6low343330
Postpartum Hemorrhage01998199826.0low001000
Potassium Deficiency01989199234.2low131000
Pre-Eclampsia01981201531.3low62946710
Pre-Hypertension02013201311.0low100010
Precursor Cell Lymphoblastic Leukemia-Lymphoma01988199433.0low011000
Pregnancy01980202033.5low151911472380
Pregnancy in Diabetes01981200233.5low087200
Premenstrual Syndrome01985198539.0low110000
Premenstrual Tension01985198539.0low110000
Primary Myelofibrosis01991199133.0low001000
Primary Peritonitis01982200234.8low0105200
Prinzmetal Angina01985198539.0low030000
Prostatic Hyperplasia01981198143.0low010000
Prostatic Neoplasms01981200234.7low020100
Prostatitis02002200222.0low000100
Protein-Energy Malnutrition01988198836.0low010000
Proteinuria01982200729.6low1617600
Pruritus02004200718.7low000300
Pseudomonas Infections01985199037.1low061000
Psoriasis01983198937.3low030000
Puerperal Disorders01986198638.0low010000
Pulmonary Arterial Remodeling0201620168.0low000010
Pulmonary Disease, Chronic Obstructive02012201212.0low000010
Pulmonary Edema01982200434.1low01715200
Pulmonary Embolism01981201433.6low0143410
Pulmonary Fibrosis01982199437.7low021000
Pulmonary Hypertension01982202130.0low229301331
Pulpitis01987199931.2low022000
Purpura, Thrombocytopenic01985198937.0low020000
Purpura, Thrombopenic01985198937.0low020000
Purpura, Thrombotic Thrombocytopenic01981198641.0low040000
Pyelonephritis01982199734.5low011000
Pyometra0201620168.0low000010
Pyrexia01985201626.7low111010
Raynaud Disease01981201833.6low292010
Recrudescence01986200431.4low127100
Renal Artery Obstruction01988198836.0low010000
Renal Artery Stenosis01988198836.0low010000
Renal Insufficiency01999201517.0low001010
Reperfusion Injury01988201625.5low11351740
Reproductive Sterility01984199634.0low011000
Respiratory Distress Syndrome01984200430.9low31014200
Respiratory Distress Syndrome, Newborn01982200235.5low2133100
Respiratory Insufficiency01984199136.6low052000
Respiratory Syncytial Virus Infections02004200420.0low000100
Respiratory Tract Diseases01993199729.0low102000
Retinal Artery Occlusion01999199925.0low001000
Retinal Detachment01983198838.0low030000
Retinal Pigment Epithelial Detachment01983198838.0low030000
Retinal Vein Occlusion01993199928.0low002000
Retinopathy of Prematurity01984198838.0low020000
Retrolental Fibroplasia01984198838.0low020000
Rheumatic Heart Disease01990199034.0low001000
Rheumatoid Arthritis01981200135.0low3118100
Rhinitis01993199729.0low002000
Rhinitis, Allergic, Seasonal01987198737.0low010000
Right Ventricular Dysfunction0201620168.0low000020
Rocky Mountain Spotted Fever01990200626.0low001100
Rupture, Spontaneous01985198737.8low040000
Salmonella Infections, Animal01982198242.0low010000
Salpingitis01986198638.0low010000
Sarcoidosis01984198440.0low010000
Sarcoma, Ewing01985198638.5low020000
Sarcoma, Synovial01985198539.0low010000
Scleroderma, Systemic01983201832.9low051010
Sclerosis, Systemic01983201832.9low051010
Segond Fracture01998199826.0low001000
Seizures01998201418.0low001010
Sensitivity and Specificity01992201224.1low009410
Sepsis01984201931.0low0910110
Shock01983200332.5low147100
Shock, Septic01980200835.2low04825300
Shock, Surgical01990199034.0low001000
Shock, Traumatic01992199331.5low002000
Sinus Infections02000200024.0low001000
Sinusitis02000200024.0low001000
Skin Diseases01983198938.0low020000
Skin Neoplasms01992199232.0low001000
Sleep Apnea Syndromes01991199829.5low002000
Sleep Apnea, Obstructive02004201612.7low100120
Smoking Cessation01992199331.3low103000
Sneezing01987198737.0low010000
Spasm01999199925.0low001000
Spinal Cord Diseases02007200717.0low000100
Spinal Cord Injuries01985200730.4low055300
Spinal Cord Neoplasms01988198836.0low010000
Spinal Diseases02007200717.0low000100
Sterility, Female01981200136.1low051100
Sterility, Male01979197945.0low010000
Stomach Neoplasms01998200124.5low001100
Stomach Ulcer01983201529.3low0149730
Stomatitis, Aphthous01993199331.0low001000
Streptococcal Infections01984199336.0low063000
Stroke02000201514.5low101120
Subarachnoid Hemorrhage01983201234.9low1166010
Substance Withdrawal Syndrome01987199634.0low021000
Substance-Related Disorders01982198242.0low010000
Suffocation01996199628.0low001000
Swine Diseases01998201318.5low001010
Symptom Cluster01981201927.1low666420
Syndrome01981201927.1low666420
Synovioma01985198539.0low010000
Synovitis01983199236.5low011000
Systemic Inflammatory Response Syndrome01996200125.7low102100
Tachyarrhythmia01989201721.4low311210
Tachycardia01989201721.4low311210
Tachycardia, Paroxysmal01986200628.0low110100
Tachycardia, Supraventricular01986200628.0low110100
Takayasu Arteritis02001200123.0low000100
Temporomandibular Disorders01998199826.0low101000
Temporomandibular Joint Disorders01998199826.0low101000
Tetralogy of Fallot01986198638.0low010000
Thalassemia01991199133.0low001000
Thalassemias01991199133.0low001000
Thrombocythemia01982198739.3low030000
Thrombocythemia, Essential01991201419.0low101110
Thrombocytopathy01990199332.5low102000
Thrombocytopenia01980199438.0low1114000
Thromboembolism01991200426.3low003300
Thrombopenia01980199438.0low1114000
Thrombophilia02004200420.0low000100
Thrombophlebitis01987199632.7low124000
Thrombosis01982202226.4low421281592
Tibial Fractures01998199826.0low001000
Toxemia01985199534.8low032000
Trichostrongylosis01991199133.0low001000
Ulcer01988201423.0low010010
Uremia01980200535.3low063100
Ureteral Obstruction01981200530.8low026100
Urethral Obstruction02001200123.0low000100
Urinary Incontinence01991199133.0low001000
Urogenital Neoplasms01986198638.0low010000
Urticaria01991199133.0low001000
Uterine Diseases01996200125.5low001100
Uterine Hemorrhage0202020204.0low000010
Uterine Neoplasms01984199236.1low054000
Vaginosis, Bacterial01992199232.0low001000
Varices01985199932.2low013000
Varicose Veins01985199932.2low013000
Vascular Diseases01985200831.5low174200
Vasculitis02005200519.0low000100
Vasospasm, Intracranial02012201212.0low100010
Venous Insufficiency01992199630.0low002000
Venous Thrombosis02001202013.1low100250
Ventricular Dysfunction, Left01998200025.0low002000
Ventricular Fibrillation01984199534.4low023000
Vesico-Ureteral Reflux01997199727.0low001000
Vesicoureteral Reflux01997199727.0low001000
Viral Hepatitis, Human01992199232.0low001000
Vitamin D Deficiency0201920195.0low000010
Vitiligo01983198341.0low010000
Vomiting01982198738.7low030000
von Willebrand Diseases01987199035.5low011000
Water Intoxication01992199232.0low101000
Water-Electrolyte Imbalance01982198242.0low010000
Weight Gain01989200328.7low011100
Weight Loss02003200420.7low000300
Weight Reduction02003200420.7low000300
Wounds and Injuries01986199634.8low041000
Zellweger Syndrome01993199331.0low001000
Zika Virus Infection0202020204.0low000010

Safety/Toxicity (28)

ArticleYear
Attenuation of ciclosporin-induced nephrotoxicity by dietary supplementation of seal oil in Sprague-Dawley rats.
The Journal of pharmacy and pharmacology, , Volume: 57, Issue:11
2005
Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 71, Issue:5
2004
Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity.
The Journal of nutritional biochemistry, , Volume: 14, Issue:11
2003
Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity.
The Journal of nutritional biochemistry, , Volume: 14, Issue:8
2003
Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
Kidney & blood pressure research, , Volume: 24, Issue:2
2001
Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 63, Issue:5
2000
Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 56, Issue:4
1997
Stimulation of prostaglandin production by quinolone phototoxicity in Balb/c 3T3 mouse fibroblast cells in vitro.
Fundamental and applied toxicology : official journal of the Society of Toxicology, , Volume: 36, Issue:2
1997
Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
Toxicology and applied pharmacology, , Volume: 143, Issue:1
1997
Dialysis fluid cytotoxicity and inhibition of host defence in cultured human mesothelial cells are neutralized rapidly with incubation in the peritoneum.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, , Volume: 11, Issue:12
1996
Gastric toxicity and prostaglandin content in rats dosed with two chemically similar, nonsteroidal anti-inflammatory agents.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 202, Issue:2
1993
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat.
Biochemical pharmacology, , Dec-03, Volume: 46, Issue:11
1993
Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation.
Transplantation, , Mar-27, Volume: 57, Issue:6
1994
Alteration of cyclosporine (CsA)-induced nephrotoxicity by gamma linolenic acid (GLA) and eicosapentaenoic acid (EPA) in Wistar rats.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 50, Issue:1
1994
[Prevention of toxicity of cyclosporine A on rat pancreatic islet beta-cells by Ligustrazine].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, , Volume: 13, Issue:9
1993
Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue.
Nephron, , Volume: 67, Issue:1
1994
Effect of corticosteroid treatment on salicylate ototoxicity.
The Annals of otology, rhinology, and laryngology, , Volume: 103, Issue:11
1994
Prostanoids and cyclosporin-mediated nephrotoxicity in rats: a critical appraisal.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 52, Issue:1
1995
Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats.
The Journal of toxicological sciences, , Volume: 19, Issue:4
1994
Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?
Clinical nephrology, , Volume: 25 Suppl 1
1986
Endotoxin protection against pulmonary oxygen toxicity and plasma prostaglandin levels in the rat.
Advances in experimental medicine and biology, , Volume: 215
1987
Plasma prostaglandin levels in patients with gynecologic malignancies and its fluctuations during chemotherapeutically-induced gastrointestinal toxicity.
Japanese journal of clinical oncology, , Volume: 17, Issue:3
1987
Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Dietary protection by fish oil.
Transplantation, , Volume: 45, Issue:1
1988
Asbestos-induced endothelial cell activation and injury. Demonstration of fiber phagocytosis and oxidant-dependent toxicity.
The American review of respiratory disease, , Volume: 138, Issue:4
1988
Prostacyclin release and cytotoxicity of peritoneal cells are inversely related in pregnant and non-pregnant mice infected with herpes simplex virus.
American journal of reproductive immunology (New York, N.Y. : 1989), , Volume: 20, Issue:4
1989
Cellular and eicosanoid composition of bronchoalveolar lavage fluid in endotoxin protection against pulmonary oxygen toxicity.
Critical care medicine, , Volume: 17, Issue:3
1989
Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins.
Clinical rheumatology, , Volume: 8 Suppl 1
1989
Attenuation of endotoxin-induced cytotoxicity and prostacyclin production in cultured bovine pulmonary artery endothelial cells by phosphodiesterase inhibition.
Experimental lung research, , Volume: 14, Issue:5
1988

Long-term Use (19)

ArticleYear
Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits.
American journal of physiology. Heart and circulatory physiology, , Volume: 297, Issue:5
2009
Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion.
The Journal of nutritional biochemistry, , Volume: 17, Issue:4
2006
Effects of antioxidants on coronary microvascular spasm induced by epicardial coronary artery endothelial injury in pigs.
Coronary artery disease, , Volume: 15, Issue:1
2004
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Proceedings of the National Academy of Sciences of the United States of America, , Mar-13, Volume: 98, Issue:6
2001
Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, , Volume: 8 Suppl B
1998
Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.
Journal of applied physiology (Bethesda, Md. : 1985), , Volume: 80, Issue:1
1996
Hemodynamic and biochemical changes after chronic administration of cilazapril to hypertensive patients.
Cardiology, , Volume: 82, Issue:4
1993
Pyrazolopyridine derivative acts as a novel cyclooxygenase inhibitor: antiplatelet effect in aged patients with ischemic stroke.
Journal of the American Geriatrics Society, , Volume: 42, Issue:6
1994
Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration.
European journal of rheumatology and inflammation, , Volume: 14, Issue:2
1994
Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat.
Hypertension (Dallas, Tex. : 1979), , Volume: 6, Issue:2 Pt 2
In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt-resistant rats.
Hypertension (Dallas, Tex. : 1979), , Volume: 5, Issue:5
Effect of cyclosporine administration on renal hemodynamics in conscious rats.
Kidney international, , Volume: 28, Issue:5
1985
Effects of sulindac on renal and extrarenal eicosanoid synthesis.
Clinical pharmacology and therapeutics, , Volume: 41, Issue:4
1987
Ethanol administration in the rat decreases prostacyclin production by isolated brain microvessels.
Journal of neurochemistry, , Volume: 46, Issue:5
1986
In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
The New England journal of medicine, , Apr-10, Volume: 314, Issue:15
1986
Effect of high-dose etodolac on renal function.
Clinical pharmacology and therapeutics, , Volume: 42, Issue:3
1987
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Circulation, , Volume: 73, Issue:6
1986
Thromboxane synthesis inhibition and renal allograft function.
Transplantation proceedings, , Volume: 21, Issue:1 Pt 1
1989
Compared effects of isoxicam and indomethacin on the urinary excretion of prostaglandins in degenerative articular diseases.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 38, Issue:2
1989

Pharmacokinetics (13)

ArticleYear
Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects.
British journal of clinical pharmacology, , Volume: 58, Issue:1
2004
Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 64, Issue:2
2001
Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus.
Journal of atherosclerosis and thrombosis, , Volume: 1, Issue:2
1994
Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
The Journal of pharmacy and pharmacology, , Volume: 48, Issue:4
1996
Pharmacokinetic and pharmacodynamic profiles of CS-518, a selective, long-lasting thromboxane synthase inhibitor, after single and multiple oral administration to healthy volunteers.
Journal of clinical pharmacology, , Volume: 34, Issue:1
1994
Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women.
American journal of obstetrics and gynecology, , Volume: 171, Issue:3
1994
Urinary excretion of prostaglandin F2 alpha and 6-keto-prostaglandin F1 alpha during volume expansion in patients with glomerulonephritis.
Acta medica Scandinavica, , Volume: 212, Issue:5
1982
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects.
Thrombosis research, , Jan-15, Volume: 29, Issue:2
1983
Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation.
Acta pharmacologica et toxicologica, , Volume: 57, Issue:2
1985
Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis.
Obstetrics and gynecology, , Volume: 68, Issue:2
1986
Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids.
British journal of clinical pharmacology, , Volume: 25, Issue:3
1988
Excretion of primary prostanoids and their metabolites during acute volume expansion.
Prostaglandins, , Volume: 35, Issue:2
1988
The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis.
Journal of clinical pharmacology, , Volume: 32, Issue:1
1992

Onset of Action (1)

ArticleYear
CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
European journal of pharmacology, , Jan-20, Volume: 133, Issue:3
1987

Bioavailability (12)

ArticleYear
Vascular Nitric Oxide-Superoxide Balance and Thrombus Formation after Acute Exercise.
Medicine and science in sports and exercise, , Volume: 50, Issue:7
2018
Enhanced external counterpulsation improves peripheral artery function and glucose tolerance in subjects with abnormal glucose tolerance.
Journal of applied physiology (Bethesda, Md. : 1985), , Volume: 112, Issue:5
2012
NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy.
Basic research in cardiology, , Volume: 103, Issue:5
2008
Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
International journal of cardiology, , Feb-15, Volume: 107, Issue:2
2006
Role of peroxynitrite in the process of vascular tone regulation by nitric oxide and prostanoids--a nanotechnological approach.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 72, Issue:2
2005
Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2.
Clinical science (London, England : 1979), , Volume: 95, Issue:1
1998
Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla.
The Annals of otology, rhinology, and laryngology, , Volume: 107, Issue:3
1998
Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats.
Alimentary pharmacology & therapeutics, , Volume: 11, Issue:5
1997
Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation.
Acta pharmacologica et toxicologica, , Volume: 57, Issue:2
1985
Biological half-life of prostacyclin and 6-oxo-PGF1 alpha levels in plasma of patients with colonic cancer.
Prostaglandins, leukotrienes, and medicine, , Volume: 22, Issue:3
1986
Increased bioavailability of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after portacaval shunting.
Hepatology (Baltimore, Md.), , Volume: 10, Issue:2
1989
3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Journal of medicinal chemistry, , Feb-21, Volume: 35, Issue:4
1992

Dosage (103)

ArticleYear
Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model.
BMC veterinary research, , Jun-14, Volume: 12, Issue:1
2016
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.
Clinical pharmacology in drug development, , Volume: 4, Issue:5
2015
Anti-myocardial ischemia effect of Syringa pinnatifolia Hemsl. by inhibiting expression of cyclooxygenase-1 and -2 in myocardial tissues of mice.
Journal of ethnopharmacology, , Jul-01, Volume: 187
2016
The effect of kisspeptin on the regulation of vascular tone.
Canadian journal of physiology and pharmacology, , Volume: 93, Issue:9
2015
A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers.
Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 27, Issue:12
2014
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia.
Thrombosis and haemostasis, , Jul-03, Volume: 112, Issue:1
2014
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:4
2009
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet.
Journal of clinical pharmacology, , Volume: 47, Issue:12
2007
Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension.
World journal of gastroenterology, , Oct-14, Volume: 13, Issue:38
2007
Isolated liver perfusion for regional chemotherapy in rats.
Hepatobiliary & pancreatic diseases international : HBPD INT, , Volume: 6, Issue:4
2007
[Physiological effects of cold and cool Chinese herbal medicine of channel tropism of stomach on rats with stomach-heat syndrome].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 32, Issue:11
2007
Human pharmacology of naproxen sodium.
The Journal of pharmacology and experimental therapeutics, , Volume: 322, Issue:2
2007
Protective effect of Weikang decoction and partial ingredients on model rat with gastric mucosa ulcer.
World journal of gastroenterology, , Feb-28, Volume: 11, Issue:8
2005
Endothelin-induced constriction of the ductus venosus in fetal sheep: developmental aspects and possible interaction with vasodilatory prostaglandin.
British journal of pharmacology, , Volume: 142, Issue:4
2004
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Circulation, , Mar-30, Volume: 109, Issue:12
2004
Allogeneic heart transplantation following xenogeneic bridging.
Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 5 Suppl 1
1992
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
Hepatology (Baltimore, Md.), , Volume: 37, Issue:1
2003
Determination of prostacyclin in plasma through a bioluminescent immunoassay for 6-keto-prostaglandin F1alpha: implication of dosage in patients with primary pulmonary hypertension.
Analytical chemistry, , Aug-01, Volume: 74, Issue:15
2002
[Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets].
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 33, Issue:1
1998
Serotonin hypersensitivity in aorta of two kidney-two clip hypertensive rats: calcium contribution and prostanoids-nitric oxide interactions.
Archives of physiology and biochemistry, , Volume: 109, Issue:1
2001
Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
Kidney & blood pressure research, , Volume: 24, Issue:2
2001
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Proceedings of the National Academy of Sciences of the United States of America, , Mar-13, Volume: 98, Issue:6
2001
Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
Chest, , Volume: 117, Issue:3
2000
AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta.
The Journal of pharmacology and experimental therapeutics, , Volume: 290, Issue:1
1999
Transient loss of prostaglandin synthetic capacity in rabbit iris-ciliary body following anterior chamber paracentesis.
Ocular immunology and inflammation, , Volume: 6, Issue:4
1998
Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Japanese journal of pharmacology, , Volume: 78, Issue:4
1998
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
Proceedings of the National Academy of Sciences of the United States of America, , Jan-05, Volume: 96, Issue:1
1999
Prostaglandin-independent stimulation of bone resorption in mouse calvariae and in isolated rat osteoclasts by thyroid hormones (T4, and T3).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 217, Issue:2
1998
Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats.
Alimentary pharmacology & therapeutics, , Volume: 11, Issue:5
1997
[The injury of liver sinusoidal endothelial cells in a rat's isolated liver perfusion (ILP) model for regional chemotherapy].
Zhonghua wai ke za zhi [Chinese journal of surgery], , Volume: 34, Issue:1
1996
Effect of aspirin dosage and enteric coating on platelet reactivity.
The American journal of cardiology, , Jul-15, Volume: 80, Issue:2
1997
Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], , Volume: 46, Issue:5
1997
Differential effect of benexate hydrochloride betadex on prostaglandin levels in stomach and inflammatory site in rats.
Japanese journal of pharmacology, , Volume: 72, Issue:2
1996
Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Lupus, , Volume: 5, Issue:2
1996
[Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Journal of cardiology, , Volume: 27, Issue:4
1996
Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
Transplantation, , May-27, Volume: 61, Issue:10
1996
Low-dose aspirin does not attenuate platelet aggregation or atherosclerosis in miniature swine but decreases production of aortic wall prostacyclin.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 53, Issue:5
1995
Gastric toxicity and prostaglandin content in rats dosed with two chemically similar, nonsteroidal anti-inflammatory agents.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 202, Issue:2
1993
Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.
Digestive diseases and sciences, , Volume: 38, Issue:8
1993
Tumor prostaglandin levels correlate with edema around supratentorial meningiomas.
Neurosurgery, , Volume: 33, Issue:2
1993
The effect of regular and enteric-coated aspirin on bleeding time, thromboxane, and prostacyclin.
Prostaglandins, leukotrienes, and essential fatty acids, , Volume: 49, Issue:1
1993
Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Hepatology (Baltimore, Md.), , Volume: 18, Issue:3
1993
Effects of ridogrel on the prostacyclin-thromboxane ratio in nulliparous third trimester-pregnant rhesus monkeys.
Prostaglandins, , Volume: 45, Issue:6
1993
Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolac.
Digestive diseases and sciences, , Volume: 39, Issue:3
1994
Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves.
American journal of veterinary research, , Volume: 54, Issue:12
1993
Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women.
American journal of obstetrics and gynecology, , Volume: 171, Issue:3
1994
Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
Placenta, , Volume: 15, Issue:8
1994
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Contraception, , Volume: 51, Issue:1
1995
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
Journal of the American College of Cardiology, , Volume: 22, Issue:4
1993
Aspirin, prostacyclin and post-occlusive reactive hyperaemia in man.
Prostaglandins, leukotrienes, and medicine, , Volume: 9, Issue:4
1982
Prostacyclin substitution for heparin in long-term hemodialysis.
The American journal of medicine, , Volume: 73, Issue:5
1982
Comparison of alpha- and gamma-thrombin on lung fluid balance in anesthetized sheep.
Journal of applied physiology: respiratory, environmental and exercise physiology, , Volume: 57, Issue:5
1984
Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
The American journal of cardiology, , Sep-01, Volume: 52, Issue:5
1983
Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog.
Investigative radiology, , Volume: 18, Issue:2
Urinary excretion of prostacyclin and thromboxane A2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients.
Prostaglandins, leukotrienes, and medicine, , Volume: 11, Issue:2
1983
Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
Journal of clinical psychopharmacology, , Volume: 4, Issue:2
1984
Purinoceptor mediated stimulation of prostacyclin release in the porcine pulmonary vasculature.
British journal of pharmacology, , Volume: 83, Issue:2
1984
Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect.
Anesthesiology, , Volume: 63, Issue:6
1985
The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Stroke, , Volume: 16, Issue:2
Kinetics of ibuprofen effect on platelet and endothelial prostanoid release.
Clinical pharmacology and therapeutics, , Volume: 37, Issue:3
1985
Study of the effects of cicletanine on prostanoids.
Arzneimittel-Forschung, , Volume: 35, Issue:11
1985
Experimental T-2 toxicosis in swine. I. Changes in cardiac output, aortic mean pressure, catecholamines, 6-keto-PGF1 alpha, thromboxane B2, and acid-base parameters.
Fundamental and applied toxicology : official journal of the Society of Toxicology, , Volume: 5, Issue:5
1985
[The effect of trapidil and the trapidil derivative AR 12463 on blood pressure and thromboxane formation in spontaneously hypertensive rats].
Die Pharmazie, , Volume: 42, Issue:5
1987
Dissociation between thromboxane generation and metastatic potential in cells from a murine fibrosarcoma. Studies with a selective thromboxane synthase inhibitor.
International journal of cancer, , Apr-15, Volume: 39, Issue:4
1987
A new combination therapy for selective and prolonged antiplatelet effect: results in the dog.
Stroke, , Volume: 17, Issue:3
The antihypertensive action of hydrochlorothiazide and renal prostacyclin.
Clinical pharmacology and therapeutics, , Volume: 39, Issue:1
1986
Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation.
American journal of veterinary research, , Volume: 47, Issue:11
1986
Individually controlled acetylsalicyclic acid (ASA) in the long-term treatment of patients with arteriosclerosis.
Biomedica biochimica acta, , Volume: 47, Issue:10-11
1988
Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.
Life sciences, , Mar-25, Volume: 36, Issue:12
1985
Possible prostacyclin involvement on disparate tonic responses to "in vitro" norepinephrine in circular and in longitudinal preparations from rat thoracic aorta.
Prostaglandins, leukotrienes, and medicine, , Volume: 30, Issue:1
1987
CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
European journal of pharmacology, , Jan-20, Volume: 133, Issue:3
1987
Gender-related variations and interaction of human neutrophil cyclooxygenase and oxidative burst metabolites.
Journal of leukocyte biology, , Volume: 40, Issue:2
1986
Human peritoneal eosinophils and formation of arachidonate cyclooxygenase products.
Scandinavian journal of immunology, , Volume: 23, Issue:5
1986
Correlation between trypsin binding to a specific receptor and prostacyclin production in cultured vascular endothelial cells.
Journal of cellular physiology, , Volume: 122, Issue:1
1985
A subchronic study of the effect of etodolac on the gastric mucosal prostaglandin levels in the rat.
Agents and actions, , Volume: 19, Issue:3-4
1986
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Circulation, , Volume: 73, Issue:6
1986
[Inhibitory effects of new-breviscapine on thrombosis in vivo].
Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, , Volume: 9, Issue:1
1989
[Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones].
Medizinische Klinik (Munich, Germany : 1983), , Jun-15, Volume: 84, Issue:6
1989
Hypertension in bone marrow transplanted patients.
Acta clinica Belgica, , Volume: 44, Issue:5
1989
Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha 2-adrenergic agonists.
Journal of cardiovascular pharmacology, , Volume: 7, Issue:4
[Relation of changes in plasma TXB2 PGF1alpha and differentiation of signs and symptoms in traditional Chinese medicine in severe icteric hepatitis].
Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, , Volume: 10, Issue:3
1990
[Effects of Codonopsis pilosulae on the synthesis of thromboxane A2 and prostacyclin].
Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, , Volume: 10, Issue:7
1990
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
Thrombosis research, , Feb-15, Volume: 57, Issue:4
1990
Effects of kinins on cultured arterial smooth muscle.
The American journal of physiology, , Volume: 258, Issue:2 Pt 1
1990
Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
Australian and New Zealand journal of medicine, , Volume: 20, Issue:5
1990
Age does not influence acute aspirin-induced gastric mucosal damage.
Gastroenterology, , Volume: 100, Issue:6
1991
Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Journal of molecular and cellular cardiology, , Volume: 23, Issue:4
1991
Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction.
The Annals of thoracic surgery, , Volume: 52, Issue:4
1991
[Treatment of acute cerebral infarction with PGI2--evaluating the clinical effect and observation of dynamic changes in plasma TXB2 and 6-keto PGF1 alpha levels].
Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, , Volume: 24, Issue:3
1991
Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
Acta medica Hungarica, , Volume: 48, Issue:3-4
1991
Imbalance between plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha during subacute endotoxin-induced hyperdynamic sepsis or multiple organ failure syndrome in sheep.
Circulatory shock, , Volume: 35, Issue:2
1991
Dose-related action of gonadotropin-releasing hormone on basal prostanoid production from the human term placenta.
American journal of obstetrics and gynecology, , Volume: 165, Issue:6 Pt 1
1991
The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis.
Journal of clinical pharmacology, , Volume: 32, Issue:1
1992
Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.
American heart journal, , Volume: 123, Issue:2
1992
In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
Journal of cardiovascular pharmacology, , Volume: 17, Issue:4
1991
Influence of repeated administration of lithium on urinary excretion of prostaglandins in rats.
Japanese journal of pharmacology, , Volume: 57, Issue:4
1991
Noradrenaline-induced prostaglandin production by sympathetic postganglionic neurons is mediated by alpha 2-adrenergic receptors.
Journal of neurochemistry, , Volume: 57, Issue:4
1991
In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages.
Thrombosis research, , Jan-01, Volume: 65, Issue:1
1992
Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
Clinical pharmacology and therapeutics, , Volume: 51, Issue:4
1992
Bridging to transplant: allogeneic heart transplantation after xenografting.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, , Volume: 11, Issue:4 Pt 2

Interactions (8)

ArticleYear
Panax Notoginseng Saponins Combined with Dual Antiplatelet Drugs Potentiates Anti-Thrombotic Effect with Alleviated Gastric Injury in A Carotid Artery Thrombosis Rat Model.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, , Volume: 31, Issue:8
2022
[Anti-platelet aggregation and anti-thrombotic mechanism of Trichosanthis Fructus combined with aspirin based on network pharmacology].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, , Volume: 44, Issue:8
2019
Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction.
PloS one, , Volume: 13, Issue:3
2018
Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats.
BMC complementary and alternative medicine, , Apr-08, Volume: 15
2015
Ibudilast, a phosphodiesterase inhibitor, in combination with low-dose aspirin potently inhibits guinea pig carotid artery thrombosis without extending bleeding time and causing gastric mucosal injury.
Arzneimittel-Forschung, , Volume: 62, Issue:12
2012
Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin.
Intensive care medicine, , Volume: 31, Issue:8
2005
Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
Kidney international, , Volume: 60, Issue:2
2001
Simultaneous determination of the primary prostanoids prostaglandin E2, prostaglandin F2 alpha and 6-oxoprostaglandin F1 alpha by immunoaffinity chromatography in combination with negative ion chemical ionization gas chromatography-tandem mass spectrometr
Journal of chromatography, , Sep-29, Volume: 494
1989